151
|
Xue J, Shi R, Ma J, Liu Z, Feng G, Chen QQ, Li Y, He Y, Ji S, Shi J, Zhu X, Zhou J. Concurrent Chemoradiotherapy plus Programmed Death-1 (PD-1) Blockade for Locally Advanced Cervical Cancer: Preliminary Results of a Single-Arm, Open-Label, Phase II Trial. Int J Radiat Oncol Biol Phys 2023; 117:e542-e543. [PMID: 37785675 DOI: 10.1016/j.ijrobp.2023.06.1838] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/04/2023]
Abstract
PURPOSE/OBJECTIVE(S) This study aims to assess the anti-tumor activity and safety of concurrent chemoradiotherapy plus PD-1 blockade in patients with locally advanced cervical cancer. MATERIALS/METHODS This is a single-arm, open-label, prospective phase II study. The key inclusion criteria were treatment-naive patients aged 18-75 years with stage II A2-IVA (FIGO 2018) locally advanced cervical cancer. All patients were treated with concurrent chemoradiotherapy including 2 cycle cisplatin (75mg/m2, for three days, every 3 weeks[Q3W]), nedaplatin or carboplatin can be selected for patients who can't tolerate cisplatin. After CCRT, patients achieving complete response (CR), partial responses(PR), stable disease(SD) received adjuvant chemotherapy (docetaxel 75 mg/m2 day 1+ cisplatin DDP 25 mg/m2 day 1-3, Q3W) for 2 cycle. PD-1 blockade Sintilimab and Tislelizumab was administered intravenously at 200 mg every 3 weeks up to 1 year or until disease progression, unacceptable toxicity, or withdrawal of consent. The primary endpoint was objective response rate (ORR) assessed by investigators per Response Evaluation Criteria In Solid Tumours (RECIST) version 1.1. Secondary endpoints were the 12, 24-month overall survival (OS) rates, the 12, 24-month disease free survival (DFS) rates and safety. RESULTS From February 2020 to June 2022, a total of 15 patients was enrolled. Median age was 57 years (range, 36-74 years). Stage IIA1 was documented in 2 patients, stage IIA2 in two patients, stage IIIA in one patient, stage IIIC1 in eight patients, and stage IVA in two patients. And 66.7% (10/15) of patients had Metastatic lymph node. Four patients received adjuvant chemotherapy. The ORR was 100%, with 4 patients achieving CR and 11 PR. The 12 and 24-month OS rates are 93.3% and 84%, the 12 and 24-month DFS rates are 86% and 75.4%, respectively. Treatment-related adverse events (TRAEs) occurred in 86.7% (13/15) of patients. Grade 3 TRAEs are leukocyte (n = 1), thrombocytopenia (n = 1), hepatitis (n = 1), skin reaction (n = 1). No treatment-related deaths occurred. And IFN-γ was significantly elevated after radiotherapy (p = 0.0073). CONCLUSION Concurrent chemoradiotherapy plus PD-1 blockade showed promising antitumor activity and manageable toxicities in patients with locally advanced cervical cancer. Long-term outcomes are still pending to further evaluate their therapeutic effects. (ChiCTR2000032856).
Collapse
Affiliation(s)
- J Xue
- Department of Radiation Oncology, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou, 215001, China., Suzhou, China
| | - R Shi
- Department of Radiation Oncology, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou, 215001, China., Suzhou, China
| | - J Ma
- The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou, China
| | - Z Liu
- Department of Radiation Oncology, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou, 215001, China., Suzhou, China
| | - G Feng
- Department of Gynecology, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou, 215001, China., Suzhou, China
| | - Q Q Chen
- Department of Radiation Oncology, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou, China
| | - Y Li
- Department of Radiation Oncology, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou, 215001, China., Suzhou, China
| | - Y He
- Department of Radiation Oncology, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou, 215001, China., Suzhou, China
| | - S Ji
- Department of Radiation Oncology, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou, China
| | - J Shi
- Department of Radiation Oncology, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou, 215001, China., Suzhou, China
| | - X Zhu
- Department of Radiation Oncology, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou, 215001, China., Suzhou, China
| | - J Zhou
- Department of Radiotherapy Oncology, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou, China
| |
Collapse
|
152
|
Qiu Z, Huang Z, Zhu L, Huang X, Wang WH, Tie J, Shen L, Shi M, Chen J, Liu M, Cheng J, Zhang J, Li Y, Wang S. A Nomogram to Predict Pathological Axillary Status in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy. Int J Radiat Oncol Biol Phys 2023; 117:e202. [PMID: 37784855 DOI: 10.1016/j.ijrobp.2023.06.1080] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/04/2023]
Abstract
PURPOSE/OBJECTIVE(S) This study aimed to identify factors influencing axillary pathological complete response (pCR) and to develop a predictive nomogram to evaluate axillary pCR rate in breast cancer patients treated with neoadjuvant chemotherapy (NAC). MATERIALS/METHODS A total of 2368 patients who received NAC and mastectomy between 2000 and 2014 from 12 grade A tertiary hospitals in China were analyzed retrospectively. The patients treated in three cancer hospitals (training set, n = 1629) were used to construct the nomogram based on multivariate logistic regression analyses. The nomograph was validated by the area under the receiver operating characteristic curve (AUC) and calibration curve in patients from 9 other general hospitals (validation set, n = 739). RESULTS The nomogram incorporated seven predicting factors including NACT cycles, response to NACT, clinical T stage, clinical N stage, grade, LVI, and molecular subtype. The AUC for the training set and validation set were 0.762 and 0.802, respectively. In addition, the calibration curve also showed good agreement between the nomogram-based predictions and the actual observations. CONCLUSION A nomogram was established to predict the status of axillary lymph nodes in breast cancer patients after NAC. The predictive model performed well both in the training set and external validation set.
Collapse
Affiliation(s)
- Z Qiu
- Department of Radiation Oncology, National Cancer Center/ National Clinical Research Center for Cancer/ Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
| | - Z Huang
- Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Radiation Oncology, Peking University Cancer Hospital and Institute, Beijing, China
| | - L Zhu
- Department of Radiation Oncology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
| | - X Huang
- Department of Radiation Oncology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China
| | - W H Wang
- Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Radiation Oncology, Peking University Cancer Hospital and Institute, Beijing, China
| | - J Tie
- Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Radiation Oncology, Peking University Cancer Hospital and Institute, Beijing, China
| | - L Shen
- Department of Oncology, Xiangya Hospital, Central South University, Changsha, China
| | - M Shi
- Department of Radiation Oncology, Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi, China
| | - J Chen
- Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
| | - M Liu
- Department of Radiation Oncology, the First Hospital, Jilin University, Changchun, China
| | - J Cheng
- Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
| | - J Zhang
- Department of Radiation Oncology, Forth Hospital of Hebei Medical University, Shijiazhuang, China
| | - Y Li
- Department of Radiation Oncology, National Cancer Center/ National Clinical Research Center for Cancer/ Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
| | - S Wang
- Department of Radiation Oncology, National Cancer Center/ National Clinical Research Center for Cancer/ Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
| |
Collapse
|
153
|
Li Y, Fan X, Pei Y, Wu K. Dynamic Effects of Thoracic Irradiation on Immune Status of Organs in and out of Radiation Field in Mice. Int J Radiat Oncol Biol Phys 2023; 117:e244. [PMID: 37784958 DOI: 10.1016/j.ijrobp.2023.06.1177] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/04/2023]
Abstract
PURPOSE/OBJECTIVE(S) Thoracic irradiation involves large blood vessels and hematopoietic tissues which was easily inducing lymphopenia. Lymphocytes are important components of immune response and lymphopenia is associated with poorer survival. However, the dynamic recovery of lymphocyte subsets after thoracic irradiation were rarely reported in the literature. This study focused on dynamic changes of lymphocytes subsets of mice after receiving thoracic irradiation in and out of radiation field. MATERIALS/METHODS C57BL/6 male mice aged 6-8 weeks received 2Gy*5fx whole thoracic irradiation and were sacrificed on the 1 day, 7 days, 15 days, 25 days after irradiation. Peripheral blood was harvested for mature lymphocyte subsets (B cells, T cells, CD4+T cells, CD8+T cells, NK cells) detection by performing flow cytometry, while thymus, femur bone marrow and sternal bone marrow for hematopoietic stem cells (Long-term Hematopoietic Stem Cell [LT-HSC], Short-term Hematopoietic Stem Cell [ST-HSC]) and progenitor cells (Multipotent Progenitor [MPP], Common Lymphoid Progenitor [CLP]). Absolute counts method was used in flow cytometry and data analysis were performed by scientific 2-D graphing and statistics software. RESULTS We found that the lymphocyte subsets were significantly reduced in peripheral blood of irradiated mice (all p<0.05). The mature lymphocyte subsets returned to normal 2-3 weeks after irradiation. After radiation, thymus weight was significantly decreased (p<0.0001). With the recovery of thymus weight, the number of hematopoietic stem cells returned to the baseline. For the femur bone marrow (out of the radiation field), hematopoietic stem cells and progenitor cells showed a proliferation tendency. MPP significantly increased in the 1day after irradiation (p = 0.0347) and LT-HSC increased in the 8 days (p = 0.0011). However, although ST-HSC and CLP were slightly increased after irradiation, there were no statistically significance. The sternal bone marrow (in the radiation field) reached the lowest value 1day after irradiation (all p<0.0001). Although hematopoietic stem cells and progenitor cells recovered gradually, but still far away from the level of the control group (all p<0.05). CONCLUSION The recovery of lymphocytes in the peripheral blood might mainly come from the supplement of bone marrow out of the irradiation field, while bone marrow in the field suffered serious destruction which did slightly help for lymphocytes recovery.
Collapse
Affiliation(s)
- Y Li
- Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China; Department of Radiation Oncology, Shanghai Proton and Heavy Ion Center, Fudan University Cancer Hospital, Shanghai, China
| | - X Fan
- Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China
| | - Y Pei
- Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China
| | - K Wu
- Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China; Department of Radiation Oncology, Shanghai Proton and Heavy Ion Center, Fudan University Cancer Hospital, Shanghai, China
| |
Collapse
|
154
|
Manzar GS, Rafei H, Kumar B, Shanley M, Acharya S, Liu B, Xu A, Wang XA, Islam S, Kaplan M, Basar R, Uprety N, Shrestha R, Garza LM, Li Y, Banerjee PP, Spiotto MT, Dabaja B, Rezvani K, Daher M. Radiation Therapy Sensitizes Head-and-Neck Cancer Cells to Killing by Chimeric Antigen Receptor (CAR)-NK Cells Targeting CD70. Int J Radiat Oncol Biol Phys 2023; 117:S167-S168. [PMID: 37784417 DOI: 10.1016/j.ijrobp.2023.06.268] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/04/2023]
Abstract
PURPOSE/OBJECTIVE(S) CAR-T cell therapy is limited by toxicity, high cost, logistical manufacturing issues in the autologous setting and risk of GVHD in the allogeneic setting. Substitution of T cells with NK cells opens the possibility for an allogeneic off-the-shelf product with a better safety profile. However, the inadequate efficacy of CAR-NK cells against solid tumors can be extrapolated from experience with CAR-T cells. There is limited but promising preclinical evidence that radiation therapy (RT) enhances CAR-T cell tumoricidal activity against solid tumors. However, there is no data examining the potential synergy between RT and CAR-NK cell therapy. MATERIALS/METHODS We engineered CAR-NK cells with CD27 receptor as extracellular domain to target its natural ligand CD70, which is overexpressed in head-and-neck cancers (HNSCC). CAR-NK cell killing was assessed real-time through xCELLigence cytotoxicity assays. CD70+ OQ01 human HNSCCs were used for most experiments. FaDu is a CD70- HNSCC (negative ctrl). UMRC3 is a CD70+ kidney cancer cell line (positive ctrl). CD70 expression pre- and post-RT was assessed by flow cytometry and Western blot. Ionizing RT was compared at 5 doses: 0, 1.75, 3.5, 7, and 14 Gy. A single dose of 3.5 Gy was used for most experiments. Post-radiation effects were generally assessed at 3 days or 9 days post-RT. Intracellular staining was used to assess NK cell expression of IFN-γ, CD107a, and TNF-α by flow cytometry. CD27/CD70 interaction blockade was through α-CD27 pre-treatment of CAR-NK cells. RESULTS OQ01 HNSCCs heterogeneously express CD70 and are killed by CD70 CAR-NK cells in vitro. Pre-conditioning low-dose RT of 3.5 Gy applied to OQ01 HNSCCs 3 days prior to coculture with NK cells enhances CD70 CAR-NK cell killing, with ∼30% increased cytotoxicity against the tumor cells. Low-dose RT by itself did not induce acute cytolysis. As a possible mechanism for the increased sensitivity of irradiated OQ01 cells to CD70 CAR-NK cells, we found that RT enhances CD70 expression among HNSCCs in a dose-dependent manner. There was no increase in NK cell expression of IFN-γ, CD107a, and TNF-α with exposure to irradiated target cells. CD27/CD70 blockade does not solely abrogate RT-induced sensitization toward CAR-NK cell killing. Despite RT induction of transient increased expression of CD70, which normalizes by 9 days post-RT, there is persistent increase in RT-synergized target cell killing even at this later timepoint. Thus, altogether, RT sensitizes CD70-expressing HNSCC cells to CAR-NK cell killing in vitro. CONCLUSION This work represents the first preclinical study to identify the synergy of RT and CAR-NK cell therapy in solid tumors and is the first demonstration of CAR-NK cell activity against human HNSCCs. We show significantly enhanced potency of CAR-NK cells against irradiated tumor cells in vitro. Collectively, this research will be vital to guide efforts expanding into other target antigens and tumor types.
Collapse
Affiliation(s)
- G S Manzar
- Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
| | - H Rafei
- The University of Texas MD Anderson Cancer Center, Houston, TX
| | - B Kumar
- Department of Radiation Oncology City of Hope, Duarte, CA
| | - M Shanley
- The University of Texas MD Anderson Cancer Center, Houston, TX
| | - S Acharya
- The University of Texas MD Anderson Cancer Center, Houston, TX
| | - B Liu
- MD Anderson Cancer Center, Houston, TX
| | - A Xu
- The University of Texas MD Anderson Cancer Center, Houston, TX
| | - X A Wang
- Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX
| | - S Islam
- The University of Texas MD Anderson Cancer Center, Houston, TX
| | - M Kaplan
- The University of Texas MD Anderson Cancer Center, Houston, TX
| | - R Basar
- The University of Texas MD Anderson Cancer Center, Houston, TX
| | - N Uprety
- The University of Texas MD Anderson Cancer Center, Houston, TX
| | - R Shrestha
- The University of Texas MD Anderson Cancer Center, Houston, TX
| | - L Melo Garza
- The University of Texas MD Anderson Cancer Center, Houston, TX
| | - Y Li
- The University of Texas MD Anderson Cancer Center, Houston, TX
| | - P P Banerjee
- The University of Texas MD Anderson Cancer Center, Houston, TX
| | - M T Spiotto
- Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
| | - B Dabaja
- Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
| | - K Rezvani
- The University of Texas MD Anderson Cancer Center, Houston, TX
| | - M Daher
- The University of Texas MD Anderson Cancer Center, Houston, TX
| |
Collapse
|
155
|
Li S, Zhu X, Song M, Xiang Y, Zhang Y, Wang HZ, Geng J, Liu Z, Teng H, Cai Y, Li Y, Wang W. Outcomes and Failure Patterns after Chemoradiotherapy for Locally Advanced Rectal Cancer with Positive Lateral Pelvic Lymph Nodes: A Propensity Score-Matched Analysis. Int J Radiat Oncol Biol Phys 2023; 117:e314. [PMID: 37785131 DOI: 10.1016/j.ijrobp.2023.06.2345] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/04/2023]
Abstract
PURPOSE/OBJECTIVE(S) Locally advanced rectal cancer (LARC) combined with positive lateral pelvic lymph nodes (LPLN) tends to present worse prognosis. However, for those patients it remains unclear whether other combination high-risk factors affect the prognosis. This study aimed to use propensity score matching (PSM) to examine long-term outcomes and failure patterns in patients with positive vs. negative LPLN. MATERIALS/METHODS Patients with LARC were retrospectively divided into LPLN-positive and LPLN-negative groups. LPLN-positivity was defined as lymph node short diameter greater than or equal to 7 mm with specific morphological features. Clinical characteristics were compared between the groups using the chi-square test. PSM was applied to balance these differences. Progression-free survival (PFS) and overall survival (OS), and local-regional recurrence (LRR) and distant metastasis (DM) rates were compared between the groups using the Kaplan-Meier method and log-rank tests. RESULTS Prior to PSM, a total of 651 LARC patients were included. The LPLN-positive group had higher rates of lower location (53.1% vs. 43.0%, P = 0.025), mesorectal fascia (MRF)-positive (53.9% vs. 35.4%, P<0.001) and extramural venous invasion (EMVI)-positive (51.2% vs. 27.2%, P<0.001) disease than the LPLN-negative group. After PSM, there were 114 patients for each group along with the balanced clinical factors, and both groups had comparable surgery, pathologic complete response (pCR), and ypN stage rates. The median follow-up time was 45.9 months, 3-year OS (88.3% vs. 92.1%, P = 0.276) and LRR (5.7% vs. 2.8%, P = 0.172) rates were comparable between LPLN-positive and LPLN-negative groups. Meanwhile, despite no statistical difference, 3-year PFS (78.8% vs. 85.9%, P = 0.065) and DM (20.4% vs. 13.3%, P = 0.061) rates slightly differed between the groups. Among 10 patients with LRR, seven (70.0%) had lateral pelvic recurrence, among them, five patients were LPLN-positive, and four (80.0%) of these patients did not receive simultaneous integrated boost intensity-modulated radiotherapy (SIB- IMRT).45 patients were diagnosed with DM, 11 (40.7%) LPLN-positive and 3 (17.6%) LPLN-negative patients were diagnosed with oligometastases (P = 0.109). CONCLUSION Our study shows there is a tendency of worse PFS and DM in LPLN-positive than LPLN-negative patients, for LPLN-positive patients, oligometastases account for a large proportion of all distant metastases.
Collapse
Affiliation(s)
- S Li
- Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Radiation Oncology, Peking University Cancer Hospital and Institute, Beijing, China
| | - X Zhu
- Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Radiation Oncology, Peking University Cancer Hospital and Institute, Beijing, China
| | - M Song
- Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Radiation Oncology, Peking University Cancer Hospital and Institute, Beijing, China
| | - Y Xiang
- Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Radiation Oncology, Peking University Cancer Hospital and Institute, Beijing, China
| | - Y Zhang
- Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Radiation Oncology, Peking University Cancer Hospital and Institute, Beijing, China
| | - H Z Wang
- Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Radiation Oncology, Peking University Cancer Hospital and Institute, Beijing, China
| | - J Geng
- Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Radiation Oncology, Peking University Cancer Hospital and Institute, Beijing, China
| | - Z Liu
- Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Radiation Oncology, Peking University Cancer Hospital and Institute, Beijing, China
| | - H Teng
- Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Radiation Oncology, Peking University Cancer Hospital and Institute, Beijing, China
| | - Y Cai
- Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Radiation Oncology, Peking University Cancer Hospital and Institute, Beijing, China
| | - Y Li
- Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Radiation Oncology, Peking University Cancer Hospital and Institute, Beijing, China
| | - W Wang
- Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Radiation Oncology, Peking University Cancer Hospital and Institute, Beijing, China
| |
Collapse
|
156
|
Ding S, Yin Y, Liu H, Liu B, Li Y, Wang B, Chen M, Liu M, Li R, Huang X, Chen Y. Inter-fractional Assessment during MR-guided Online Adaptive Radiotherapy for Glioblastoma. Int J Radiat Oncol Biol Phys 2023; 117:e99-e100. [PMID: 37786230 DOI: 10.1016/j.ijrobp.2023.06.867] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/04/2023]
Abstract
PURPOSE/OBJECTIVE(S) Magnetic resonance image (MRI) guided radiation therapy has the potential to improve outcomes for glioblastoma by adapting to tumor changes during radiation therapy. This study aimed to assess the feasibility and potential benefits of MR-guided online adaptive radiotherapy (MRgOART) for patients with glioblastoma. MATERIALS/METHODS Twenty consecutive patients with glioblastoma were treated with MRgOART of 60 Gy in 30 fractions by the 1.5 T MR-Linac. The MRgOART fractions employed daily MR scans and the contours were utilized to create each adapted plan. The gross tumor volume (GTV) and clinical target volume (CTV) were delineated on MRI of pre-treatment simulation (Fx0) and all fractions (Fx1, Fx2, Fx3 ... Fx30) to evaluate the inter-fractional changes. These changes were quantified using absolute/relative volume (∆V), Dice similarity coefficient (DSC) and Hausdorff distance (HD) metrics. The reference treatment plans were generated using step-and-shoot IMRT and utilized 7-9 beam groups on original CT. Before the treatment, a synthetic CT (sCT) quality assurance (QA) process was performed to assess the dose accuracy of bulk relative electron density (rED) assignment for online MRI based treatment plan in terms of gamma analysis, point dose comparison and dose volume histogram (DVH) parameters. Then, the online adaptative treatment plans were obtained by re-optimizing based on the contours on daily pre-treatment MRI by "adapt to shape" workflow. Non-adaptive plans for each patient were generated by recalculating the dose from the reference plans on daily online MRI by "adapt to position" workflow. GTV and CTV coverage and organ at risk (OAR) constraints were used to compare non-adaptive and adaptive plans. RESULTS For both criteria, the 1%/1mm (98.58%±0.15%) and 2%/2mm (99.88%±0.18%) gamma passing rate results were always clinically acceptable in sCT QA process. The differences on point dose and DVH parameters between the plans based on sCT and original CT were less than 1%. A total of 20 patients with 600 fractions were evaluated. The results showed that large inter-fractional changes for GTV limited the efficacy of radiation therapy (DSC: 0.78±0.08, HD: 20.94±3.64mm, ∆V: 2.92%±6.36%). The inter-fractional CTV changes were smaller (DSC: 0.91±0.04, HD: 15.31±3.09mm, ∆V: 1.41%±1.29%). GTV coverage of non-adaptive plans was below the prescribed coverage in 228/600 fractions (38%), with 90 (15%) failing by more than 10%. For CTV coverage of non-adaptive plans, the changes were less than 5%. Online adaptative plans improved GTV and CTV coverage significantly (p<0.001) to 99%. The adaptive plans also had lower dose to whole brain than non-adaptive plans (p<0.001). CONCLUSION Significant inter-fractional tumor changes could be found during radiotherapy in patients with glioblastoma treated by the 1.5 T MR-Linac. Daily MR-guided re-optimization of treatment plans corrected for day-to-day anatomical variations and resulted in adequate target coverage in all fractions.
Collapse
Affiliation(s)
- S Ding
- State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine; Department of Radiation Oncology, Sun Yat-sen University Cancer Center., Guangzhou, Guangdong, China
| | - Y Yin
- Department of Radiation Oncology, Affiliated Dongguan Hospital, Southern Medical University (Dongguan People's Hospital), Guangzhou, China
| | - H Liu
- State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine; Department of Radiation Oncology, Sun Yat-sen University Cancer Center., Guangzhou, China
| | - B Liu
- State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine; Department of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong 510060, P. R. China, Guangzhou, China
| | - Y Li
- State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine; Department of Radiation Oncology, Sun Yat-sen University Cancer Center., Guangzhou, China
| | - B Wang
- Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China
| | - M Chen
- Department of Radiation Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, China
| | - M Liu
- Sun Yat-sen University Cancer Center, Guangzhou, China
| | - R Li
- State Key Laboratory of Oncology in South China, Guangzhou, China
| | - X Huang
- Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine; Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, Guangdong, 510060, China, Guangzhou, China
| | - Y Chen
- State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, China
| |
Collapse
|
157
|
Ding S, Liu H, Li JY, Li Y, Wang B, Chen M, Liu B, Liu M, Li R, Huang X. Adaptive Auto-Segmentation for MRI-Guided Online Adaptive Radiotherapy of Cervical Carcinoma. Int J Radiat Oncol Biol Phys 2023; 117:e659-e660. [PMID: 37785954 DOI: 10.1016/j.ijrobp.2023.06.2094] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/04/2023]
Abstract
PURPOSE/OBJECTIVE(S) Accurate and efficient delineation of organs and targets on session images is critical in MRI-guided online adaptive radiotherapy (MRgOART). This study proposes a registration-guided deep learning image segmentation framework to assist online delineation of cervical carcinoma. MATERIALS/METHODS A total of 300 T2-weighted MR images were acquired for patients with cervical carcinoma treated by a 1.5T Unity MR-Linac. The CTV, bladder, rectum, pelvic bone and femoral joints were delineated on each MRI by the same radiation oncologist. To overcome these obstacles to online MRI segmentation, we propose a registration-guided DL (RgDL) segmentation framework that integrates image registration algorithms and DL segmentation models. Firstly, the DL segmentation model was trained using nnU-net. Then, for each treatment fraction, the deformable image registration (DIR) algorithm generates initial contours from previous treatment fraction, which were used as guidance by DL model to obtain the accurate current segmentation. The segmentation accuracy of alone DIR, DL and RgDL were evaluated by dice similarity coefficients (DSC) and other distance-based metrics. RESULTS Compared to the baseline approaches using the DIR and the DL alone, RgDL achieved a DSC of 91.12% on CTV, higher than DIR and DL alone by 15.54% and 10.13%. The DSC of RgDL were improved to 95.58%, 93.65%, 87.8% and 94.84% for bladder, pelvic bone, rectum and femoral joints, higher than DIR and DL alone by 9.61% on average. CONCLUSION The proposed adaptive auto-segmentation method can achieve accurate and efficient segmentation and potentially overcome these obstacles to MRgOART.
Collapse
Affiliation(s)
- S Ding
- State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine; Department of Radiation Oncology, Sun Yat-sen University Cancer Center., Guangzhou, Guangdong, China
| | - H Liu
- State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine; Department of Radiation Oncology, Sun Yat-sen University Cancer Center., Guangzhou, China
| | - J Y Li
- Sun Yat-sen University Cancer Center, Guangzhou, China; State Key Laboratory of Oncology in South China, Guangzhou, China
| | - Y Li
- State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine; Department of Radiation Oncology, Sun Yat-sen University Cancer Center., Guangzhou, China
| | - B Wang
- Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China
| | - M Chen
- Department of Radiation Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, China
| | - B Liu
- State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine; Department of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong 510060, P. R. China
| | - M Liu
- Sun Yat-sen University Cancer Center, Guangzhou, China
| | - R Li
- State Key Laboratory of Oncology in South China, Guangzhou, China
| | - X Huang
- Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine; Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, Guangdong, 510060, China, Guangzhou, China
| |
Collapse
|
158
|
Song Y, Kong J, Li N, Liu X, Li X, Zhu L, Wang Y, Fang H, Jing H, Tang Y, Li Y, Wang XH, Zhang J, Wang S. Comparison of Supraclavicular Surgery plus Radiotherapy vs. Radiotherapy Alone in Breast Cancer Patients with Synchronous Ipsilateral Supraclavicular Lymph Node Metastasis: A Multicenter Retrospective Study. Int J Radiat Oncol Biol Phys 2023; 117:e208. [PMID: 37784870 DOI: 10.1016/j.ijrobp.2023.06.1094] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/04/2023]
Abstract
PURPOSE/OBJECTIVE(S) To evaluate and compare the outcomes of supraclavicular lymph node dissection (SLND) plus radiotherapy (RT) and RT alone for patients with synchronous ipsilateral supraclavicular lymph node metastasis (sISLM). MATERIALS/METHODS In all, 293 patients with sISLM across three centers were included. Of these, 85 (29.0%) received SLND plus RT and 208 (71.0%) received RT alone. All patients received preoperative systemic therapy followed by mastectomy or lumpectomy and axillary dissection. Supraclavicular recurrence-free survival (SCRFS), locoregional recurrence-free survival (LRRFS), distant metastasis-free survival (DMFS), disease-free survival (DFS), and overall survival (OS) were evaluated by using the Kaplan-Meier method and multivariate Cox models. Multiple imputation was used for missing data. RESULTS The median follow-up duration of the RT and SLND+RT groups were 53.7 and 63.5 months, respectively. For the RT and SLND+RT groups, the 5-year SCRFS rates were 91.7% vs. 85.5% (P = 0.522), LRRFS rates were 79.1% vs. 73.1% (P = 0.412), DMFS rates were 60.4 vs. 58.8% (P = 0.708), DFS rates were 57.6% vs. 49.7% (P = 0.291), and OS rates were 71.9% vs. 62.2% (P = 0.272), respectively. There was no significant effect on any outcome when comparing SLND+RT versus RT alone in the multivariate analysis. Based on four risk factors of DFS, patients were classified into three risk groups: the intermediate- and high-risk groups had significantly lower survival outcomes than the low-risk group. SLND+RT did not improve outcomes of any risk group compared with RT alone. CONCLUSION Patients with sISLM may not benefit from SLND. Distant metastasis remained the major failure pattern, especially for intermediate- and high-risk groups with sISLM may not benefit from SLND. Distant metastasis remained the major failure pattern, especially for intermediate- and high-risk groups.
Collapse
Affiliation(s)
- Y Song
- Department of Radiation Oncology, National Cancer Center/ National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
| | - J Kong
- The Fourth Hospital of Hebei Medical University, Shijiazhuang, China
| | - N Li
- Department of Radiochemotherapy, Tangshan People's Hospital., Tangshan, Hebei, China
| | - X Liu
- Department of Radiation Oncology, Beijing Shijitan Hospital, Capital Medical University, Beijing, China
| | - X Li
- Department of Radiation Oncology, the Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, China
| | - L Zhu
- Department of Radiation Oncology, the Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, China
| | - Y Wang
- Department of Radiochemotherapy, Tangshan People's Hospital., Tangshan, Hebei, China
| | - H Fang
- Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
| | - H Jing
- Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
| | - Y Tang
- GCP center/Clinical research center, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
| | - Y Li
- Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
| | - X H Wang
- Department of Radiochemotherapy, People's Hospital of Tangshan City, Tangshan, China
| | - J Zhang
- Department of Radiation Oncology, Forth Hospital of Hebei Medical University, Shijiazhuang, China
| | - S Wang
- Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
| |
Collapse
|
159
|
Huang R, Geng H, Zhu L, Yan J, Li C, Li Y. CT radiomics can predict disease progression within 6 months after chimeric antigen receptor-modified T-cell therapy in relapsed/refractory B-cell non-Hodgkin's lymphoma patients. Clin Radiol 2023; 78:e707-e717. [PMID: 37407367 DOI: 10.1016/j.crad.2023.05.022] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/17/2023] [Revised: 05/05/2023] [Accepted: 05/30/2023] [Indexed: 07/07/2023]
Abstract
AIM To predict progression within 6 months after chimeric antigen receptor-modified (CAR) T-cell therapy for relapsed/refractory (R/R) B-cell non-Hodgkin's lymphoma (B-NHL) patients by radiomic indexes derived from contrast-enhanced computed tomography (CECT) examinations. MATERIALS AND METHODS Seventy R/R B-NHL patients who underwent CECT before treatment with CAR T-cells were examined retrospectively. In total, 297 volumes of interest for lesions were segmented from CECT images. Patients without and with disease progression were assigned to groups 1 and 2, respectively. Radiomic and combined predictive models were constructed by three machine-learning algorithms using features from the training set, respectively. Furthermore, predictive models were constructed based on multi-lesion-based and largest-lesion-based radiomic features, respectively. RESULTS In the test set, no marked differences were observed between the areas under the curves (AUCs) of the combined and radiomic models for all three machine-learning algorithms (all p>0.05). Differences in machine-learning algorithms did not significantly affect the predictive performances of the models. Radiomics and combined models constructed with multi-lesion-based radiomic features showed better predictive performances than those applying largest-lesion-based radiomic features (all p<0.05 for comparisons between combined models). CONCLUSION CECT-based radiomic features may be applied to predict disease progression in R/R B-NHL patients within 6 months after CAR T-cell treatment, and radiomic features from multiple lesions may have better predictive efficacy. Different machine-learning algorithms may not show significant differences in prediction performance.
Collapse
Affiliation(s)
- R Huang
- Department of Radiology, The First Affiliated Hospital of Soochow University, Suzhou City, Jiangsu province 215000, PR China
| | - H Geng
- Department of Hematology, The First Affiliated Hospital of Soochow University, Suzhou City, Jiangsu province 215000, PR China
| | - L Zhu
- Department of Ultrasound, The First Affiliated Hospital of Soochow University, Suzhou City, Jiangsu province, 215000, PR China
| | - J Yan
- Department of Radiology, The First Affiliated Hospital of Soochow University, Suzhou City, Jiangsu province 215000, PR China
| | - C Li
- Department of Hematology, The First Affiliated Hospital of Soochow University, Suzhou City, Jiangsu province 215000, PR China; National Clinical Research Center for Hematologic Diseases, The First Affiliated Hospital of Soochow University, Suzhou City, Jiangsu province 215000, PR China
| | - Y Li
- Department of Radiology, The First Affiliated Hospital of Soochow University, Suzhou City, Jiangsu province 215000, PR China; National Clinical Research Center for Hematologic Diseases, The First Affiliated Hospital of Soochow University, Suzhou City, Jiangsu province 215000, PR China; Institute of Medical Imaging, Soochow University, Suzhou City, Jiangsu province 215000, PR China.
| |
Collapse
|
160
|
Qiao Y, Zhang C, Li A, Wang D, Luo Z, Ping Y, Zhou B, Liu S, Li H, Yue D, Zhang Z, Chen X, Shen Z, Lian J, Li Y, Wang S, Li F, Huang L, Wang L, Zhang B, Yu J, Qin Z, Zhang Y. Correction: IL6 derived from cancer-associated fibroblasts promotes chemoresistance via CXCR7 in esophageal squamous cell carcinoma. Oncogene 2023; 42:3287-3288. [PMID: 37723312 DOI: 10.1038/s41388-023-02822-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 09/20/2023]
Affiliation(s)
- Y Qiao
- Biotherapy Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
- Cancer Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
| | - C Zhang
- Biotherapy Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
- Cancer Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
| | - A Li
- Biotherapy Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
- Cancer Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
| | - D Wang
- Biotherapy Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
- Cancer Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
| | - Z Luo
- Biotherapy Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
- Cancer Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
| | - Y Ping
- Biotherapy Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
| | - B Zhou
- Biotherapy Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
- School of Life Sciences, Zhengzhou University, Zhengzhou, China
| | - S Liu
- Biotherapy Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
- School of Life Sciences, Zhengzhou University, Zhengzhou, China
| | - H Li
- Biotherapy Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
| | - D Yue
- Biotherapy Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
- Cancer Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
| | - Z Zhang
- Biotherapy Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
| | - X Chen
- Biotherapy Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
- Cancer Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
| | - Z Shen
- Biotherapy Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
- Cancer Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
| | - J Lian
- Biotherapy Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
- School of Life Sciences, Zhengzhou University, Zhengzhou, China
| | - Y Li
- Biotherapy Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
- School of Life Sciences, Zhengzhou University, Zhengzhou, China
| | - S Wang
- Biotherapy Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
- Cancer Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
| | - F Li
- Biotherapy Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
| | - L Huang
- Biotherapy Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
| | - L Wang
- Cancer Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
| | - B Zhang
- Department of Hematology/Oncology, School of Medicine, Northwestern University, Chicago, IL, USA
| | - J Yu
- Department of Internal Medicine, College of Medicine, University of Cincinnati, Cincinnati, OH, USA
| | - Z Qin
- Medical Research Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
| | - Y Zhang
- Biotherapy Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
- Cancer Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
- School of Life Sciences, Zhengzhou University, Zhengzhou, China.
- Key Laboratory for Tumor Immunology and Biotherapy of Henan Province, Zhengzhou, China.
| |
Collapse
|
161
|
Xu J, Wang P, Li Y, Shi X, Yu J, Teng F. Using MRI Radiomics to Predict the Efficacy of Immunotherapy for Brain Metastasis in Patients with Non-small Cell Lung Cancer. Int J Radiat Oncol Biol Phys 2023; 117:e65. [PMID: 37785932 DOI: 10.1016/j.ijrobp.2023.06.790] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/04/2023]
Abstract
PURPOSE/OBJECTIVE(S) Despite immune checkpoint inhibitors (ICIs) has been proven effective in patients with advanced NSCLC, controversial therapeutic responses are seen in brain metastatic lesions. There are no robust biomarkers that predict benefit from this regimen. We evaluated the utility of novel imaging biomarkers (radiomics) to distinguish NSCLC patients with brain metastases (BMs) who will benefit from ICIs from those likely to progress despite therapy. MATERIALS/METHODS One-hundred and seventy-four NSCLC Patients with BMs treated with ICIs from June 2019 - June 2022 were identified. We collected patient clinical outcomes and pre-treatment MRI images. Images were split into training and test sets. Brain metastatic lesions were contoured on ITK-SNAP software and 3748 radiomic features capturing both intra- and peritumoral texture patterns were extracted. The primary endpoint of this study was intracranial progression-free survival (iPFS) and the secondary objective were progression-free survival (PFS) and overall survival (OS). We used the least absolute shrinkage and selection operator (LASSO) Cox regression model to build the radiomic signature for ORR. Based on the support vector machine (SVM) model, we construct the Clinical-radiomics nomogram (CRN). Multivariable Cox regression analysis were performed to evaluate the effect of each factor on iPFS. We performed Kaplan-Meier survival analysis and log-rank tests to assess prognostic value of the features. RESULTS We identified 174 patients who fit our criteria with available MRI images. 122 patients treated in our center were divided into a training set and 52 patients treated in another center were divided into a test set. The intratumoral radiomic signatures(IRS), peritumoral radiomic signatures(PRS) and CRN showed favorable predictive effects for ORR with the area under the receiver operating curve (AUC) of (IRS: 0.845 (95% CI: 0.776-0.914); PRS: 0.799 (95% CI:0.720-0.879); CRN:0.907 (95% CI: 0.855-0.959))in the training set and (IRS: 0.809 (95% CI: 0.693-0.926); PRS: 0.749 (95% CI:0.616-0.883); CRN:0.888(95% CI:0.798-0.979)) in the test set. Kaplan-Meier analyses showed a significantly longer iPFS in the high-CRN group versus the low-CRN group (P < 0.001). The CRNs were also found significantly associated with PFS (P < 0.001), but not OS. CONCLUSION Radiomic biomarkers from pre-treatment MRI images in NSCLC patients with BMs were predictive of iPFS to ICIs. Pre-treatment radiomics may allow early prediction of benefit and expedite more aggressive treatment for high-risk patients. Additional validation of these imaging biomarkers is warranted.
Collapse
Affiliation(s)
- J Xu
- Department of Radiation Oncology and Shandong Provincial Key Laboratory of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China
| | - P Wang
- Shandong Cancer Hospital & Institute, Cheeloo College of Medicine, Shandong University, Jinan, China
| | - Y Li
- Department of Radiation Oncology and Shandong Provincial Key Laboratory of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China
| | - X Shi
- Department of Radiation Oncology and Shandong Provincial Key Laboratory of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China
| | - J Yu
- Department of Radiation Oncology and Shandong Provincial Key Laboratory of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China; Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China
| | - F Teng
- Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China
| |
Collapse
|
162
|
Ding S, Liu H, Zhang L, Chen M, Li Y, Wang B, Liu B, Li R, Huang X. Influence of Eyes Movement on Lens Dose during MR-Guided Radiotherapy for Brain Tumor. Int J Radiat Oncol Biol Phys 2023; 117:e100. [PMID: 37784625 DOI: 10.1016/j.ijrobp.2023.06.868] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/04/2023]
Abstract
PURPOSE/OBJECTIVE(S) Modern radiotherapy techniques achieve highly conformal target doses while avoiding organs at risk such as lens. The magnitude of eyes movement and its influence on lens dose is unclear. The lens dose is relevant for cataract formation. This study aims to evaluate the movement-range of lens and its influence on dose distribution during MR-guided radiotherapy for brain cancer patients. MATERIALS/METHODS Fifty patients with brain cancer who were treated with MR-guided radiotherapy on 1.5 T MR-Linac were included in this study. All patients underwent a pre-treatment MRI and post-treatment MRI for each fraction. The eyes and lens were delineated on each MR image by a radiation oncologist. The reference treatment plans based original CT were recalculated on each MRI by "adapt to position" workflow. Then, we created planning risk volume (PRV) for lens by adding population margin and reoptimized the reference plans to evaluate the dose changes for lens. Inter-fraction and intrafraction variability for eyes and lens were evaluated with the Dice similarity coefficient (DSC), the Hausdorff distance (HD) and mean distance to agreement (MDA). Differences in daily dose (Dmax and Dmean) for eyes and lens were assessed. RESULTS A total of 300 MR images were analyzed in this study. The eyes motion was observed (minimum DSC: 0.57; maximum HD: 10.53; maximum MDA: 3.13). And the obvious lens motion also was found (minimum DSC: 0.01; maximum HD: 10.78; maximum MDA: 5.68). The maximum dose changes for eyes were up to 34.1% and the mean dose changes were up to 18.1%. The maximum dose changes for lens were up to 97.9% and the mean dose changes for eyes were up to 89%. When the reoptimized plans were generated by PRV lens, the dose changes were decreased nearly to 0. CONCLUSION Eyes movements in all radiotherapy fractions result in higher lens doses and potentially increase cataract formation rate. Adding margin expansions in treatment planning, to account for eyes motion, is the feasible approach to limit lens dose.
Collapse
Affiliation(s)
- S Ding
- State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine; Department of Radiation Oncology, Sun Yat-sen University Cancer Center., Guangzhou, Guangdong, China
| | - H Liu
- State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine; Department of Radiation Oncology, Sun Yat-sen University Cancer Center., Guangzhou, China
| | - L Zhang
- Quanzhou First Hospital. Fujian, Quanzhou, China
| | - M Chen
- Department of Radiation Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, China
| | - Y Li
- State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine; Department of Radiation Oncology, Sun Yat-sen University Cancer Center., Guangzhou, China
| | - B Wang
- Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China
| | - B Liu
- State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine; Department of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong 510060, P. R. China, Guangzhou, China, Guangzhou, China
| | - R Li
- State Key Laboratory of Oncology in South China, Guangzhou, China
| | - X Huang
- Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine; Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, Guangdong, 510060, China, Guangzhou, China
| |
Collapse
|
163
|
Zhao X, Li C, Yang H, Wei H, Li Y. Antibacterial Activity of a Lysin LysP53 against Streptococcus mutans. J Dent Res 2023; 102:1231-1240. [PMID: 37698342 DOI: 10.1177/00220345231182675] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 09/13/2023] Open
Abstract
Dental caries is a common disease affecting quality of life globally. In the present study, we found that a bacteriophage lysin LysP53 against Acinetobacter baumannii possesses selective activity on Streptococcus mutans, the main etiological agent of dental caries, even in low pH caries microenvironments, whereas only minor LysP53 activity was detected against Streptococcus sanguinis, Streptococcus oralis, and Streptococcus mitis. Testing activity against S. mutans planktonic cells showed that 4 μM LysP53 could kill more than 84% of S. mutans within 1 min in buffer with optimal pHs ranging from 4.0 to 6.5. Daily application of LysP53 on biofilms formed in BHI medium supplemented or not with sucrose could reduce exopolysaccharides, expression of genes related to acid resistance and adhesion, and the number of live bacteria in the biofilms. LysP53 treatment also showed similar effects as 0.12% chlorhexidine in preventing enamel demineralization due to S. mutans biofilms, as well as effective removal of S. mutans colonization of tooth surfaces in mice without observed toxic effects. Because of its selective activity against main cariogenic bacteria and good activity in low pH caries microenvironments, it is advantageous to use LysP53 as an active agent for preventing caries.
Collapse
Affiliation(s)
- X Zhao
- The State Key Laboratory Breeding Base of Basic Science of Stomatology (Hubei-MOST) & Key Laboratory of Oral Biomedicine, Ministry of Education, School of Stomatology, Wuhan University, Wuhan, Hubei, China
| | - C Li
- CAS Key Laboratory of Special Pathogens and Biosafety, Center for Emerging Infectious Diseases, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, Hubei, China
- University of Chinese Academy of Sciences, Beijing, China
| | - H Yang
- CAS Key Laboratory of Special Pathogens and Biosafety, Center for Emerging Infectious Diseases, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, Hubei, China
- University of Chinese Academy of Sciences, Beijing, China
| | - H Wei
- CAS Key Laboratory of Special Pathogens and Biosafety, Center for Emerging Infectious Diseases, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, Hubei, China
- University of Chinese Academy of Sciences, Beijing, China
| | - Y Li
- The State Key Laboratory Breeding Base of Basic Science of Stomatology (Hubei-MOST) & Key Laboratory of Oral Biomedicine, Ministry of Education, School of Stomatology, Wuhan University, Wuhan, Hubei, China
| |
Collapse
|
164
|
Li Y, Chen L, Li J, Zhao B, Jing T, Wang R. Computational explorations of the interaction between laccase and bisphenol A: influence of surfactant and different organic solvents. SAR QSAR Environ Res 2023; 34:963-981. [PMID: 38009185 DOI: 10.1080/1062936x.2023.2280584] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/08/2023] [Accepted: 10/30/2023] [Indexed: 11/28/2023]
Abstract
Bisphenol A (BPA), as an environmental endocrine disruptor can cause damage to the reproductive, nervous and immune systems. Laccase can be used to degrade BPA. However, laccase is easily deactivated, especially in organic solvents, but the specific details are not clear. Molecular dynamics simulations were used to investigate the reasons for changes in laccase activity in acetonitrile (ACN) and dimethyl formamide (DMF) solutions. In addition, the effects of ACN and DMF on the activity of laccase and surfactant rhamnolipid (RL) on the degradation of BPA by laccase were investigated. Results showed that addition of ACN changed the structure of the laccase, not only decreasing the van der Waals interaction that promoted the binding of laccase with BPA, but also increasing the polar solvation free energy that hindered the binding of laccase with BPA, so it weakened the laccase activity. DMF greatly enhanced the van der Waals interaction between laccase and BPA, and played a positive role in their binding. The addition of surfactant RL alleviated the effect of organic solvent on the activity of laccase by changing the polar solvation energy. The mechanism of surfactant RL affecting laccase activity in ACN and DMF is described, providing support for understanding the effect of organic solvents on laccase.
Collapse
Affiliation(s)
- Y Li
- College of Chemistry and Chemical Engineering, Qiqihar University, Qiqihar, P. R. China
| | - L Chen
- College of Chemistry and Chemical Engineering, Qiqihar University, Qiqihar, P. R. China
| | - J Li
- Transportation Class in the first operation area of the Fourth Oil Production Plant of Daqing Oilfield of CNPC, Daqing, P. R. China
| | - B Zhao
- College of Chemistry and Chemical Engineering, Qiqihar University, Qiqihar, P. R. China
- Heilongjiang Provincial Key Laboratory of Surface Active Agent and Auxiliary, Qiqihar University, Qiqihar, P. R. China
| | - T Jing
- College of Chemistry and Chemical Engineering, Qiqihar University, Qiqihar, P. R. China
| | - R Wang
- College of Chemistry and Chemical Engineering, Qiqihar University, Qiqihar, P. R. China
| |
Collapse
|
165
|
Liu F, Wang H, Jiang C, He L, Xiao S, Yan O, Wu X, Liu W, Ye X, Fan C, Li Y, Zhao Q, Wu W, Tan C. Efficacy and Toxicity of Different Target Volume Delineations of Radiotherapy Based on the Updated RTOG/NRG and EORTC Guidelines in Patients with High Grade Glioma: A Randomized, Controlled Clinical Trial. Int J Radiat Oncol Biol Phys 2023; 117:S84-S85. [PMID: 37784587 DOI: 10.1016/j.ijrobp.2023.06.406] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/04/2023]
Abstract
PURPOSE/OBJECTIVE(S) Postoperative radiotherapy with concomitant and adjuvant temozolomide (TMZ) is the standard of care for newly diagnosed high grade glioma, but the optimal method for target volume delineations for intensity modulated radiation therapy (IMRT) is still unclear. We hypothesized that compared with the EORTC guidelines, IMRT based on the updated RTOG/NRG guidelines was equally effective, without increasing toxicities for patients with high-grade glioma. The purpose of this randomized phase 2 study was to compare the efficacy and toxicity of IMRT based on different target volume delineations (updated RTOG/NRG versus EORTC guidelines) with concomitant and adjuvant TMZ for patients with high grade glioma. MATERIALS/METHODS A total of 302 patients with newly diagnosed high-grade glioma (WHO grade 3-4) were randomly assigned (1:1) to receive postoperative IMRT based on either updated RTOG/NRG guidelines (RTOG/NRG group, n = 151) or EORTC guideline (EORTC group, n = 151), with concomitant and adjuvant TMZ. In the RTOG/NRG group, an initial volume consisting of enhancement, postoperative cavity, plus surrounding edema (or fluid-attenuated inversion recovery [FLAIR] abnormality defined by magnetic resonance imaging [MRI]) and a 2-cm margin received 46 Gy in 23 fractions followed by a boost of 14 Gy in 7 fractions to the area of enhancement plus the cavity and a 2-cm margin. In the EORTC group, a single planning volume was used to deliver 60 Gy in 30 fractions to the area of enhancement and the cavity with a 2-cm margin. The primary end point was overall survival (OS). Secondary end points included progression-free survival (PFS) and toxicities associated with each treatment. RESULTS No statistically significant differences were observed between groups for 1-year OS (71.8% for RTOG/NRG group and 69.9% for EORTC group, respectively; P = 0.759) or 1-year PFS (46.7% for RTOG/NRG group and 43.6% for EORTC group, respectively; P = 0.674). Efficacy did not differ by MGMT methylation status. There were no differences in grade 3-4 toxicities (leukopenia, lymphopenia, neutropenia, thrombocytopenia, fatigue, nausea and vomiting) between the two groups. No grade 5 toxicities were observed in both groups. Multivariate analyses showed that tumor MGMT status (methylated vs unmethylated) and WHO grade (grade 3 vs grade 4) were associated with OS and PFS. However, radiation type (RTOG/NRG group vs EORTC), sex, age, and Karnofsky scale did not significantly influence OS or PFS. CONCLUSION Compared with EORTC guidelines for postoperative radiotherapy, IMRT based on RTOG/NRG guidelines was equally effective, without increasing toxicities for patients with high-grade glioma. This trial is registered with chictr.org.cn, number ChiCTR2100046667.
Collapse
Affiliation(s)
- F Liu
- Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China, Changsha, China
| | - H Wang
- Department of Radiation Oncology, Hunan Cancer Hospital & the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China
| | - C Jiang
- Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China, Changsha, China
| | - L He
- Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China
| | - S Xiao
- Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China
| | - O Yan
- Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China
| | - X Wu
- Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China, Changsha, China
| | - W Liu
- Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China, Changsha, China
| | - X Ye
- Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China, Changsha, China
| | - C Fan
- Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China, Changsha, China
| | - Y Li
- Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China
| | - Q Zhao
- Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China, Changsha, China
| | - W Wu
- Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China, Changsha, China
| | - C Tan
- Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China
| |
Collapse
|
166
|
Yu J, Feng Y, Pi S, Li Y. Effects of the PARP Inhibitor Niraparib on the Radiosensitivity of Human Lung and Cervical Cancer Cells. Int J Radiat Oncol Biol Phys 2023; 117:e274. [PMID: 37785032 DOI: 10.1016/j.ijrobp.2023.06.1246] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/04/2023]
Abstract
PURPOSE/OBJECTIVE(S) DNA damage repair (DDR) initiated after DNA damage may lead to a decreased radiosensitivity of tumor cells or even radiation resistance. Previous studies indicate that PARP inhibitors block the repair of DNA single-strand breaks (SSBs), and unrepaired SSBs may continuously accumulate and form double-strand breaks (DSBs) that promotes tumor cell death. Studies have also shown that PARP inhibitors act synergistically with RT to inhibit DDR. In this study, we aim to investigate the effect of Niraparib, a clinically approved PARP inhibitor on the radiosensitivity of human lung and cervical cancer cells, and preliminarily explore the underlying mechanism. MATERIALS/METHODS The human lung cancer cell line A549 and human cervical cancer cell line Siha were both treated with niraparib (for 1h), or X-ray (4Gy), or Niraparib (for 1h) combined with X-ray (4Gy). The effect was examined via measurements of cell proliferation by the cell counting kit-8 assay, and cell viability was detected by clone formation assays. Cell apoptosis and cell cycle distribution were investigated by flow cytometry. RESULTS In human lung and cervical cancer cell lines, Niraparib combined with radiation therapy significantly inhibited cell proliferation. The proportion of apoptotic cells in cell lines treated with Niraparib plus radiation (the combination group) was significantly higher compared with control, radiation-only, and Niraparib-only groups. Additionally, the proportion of A549 cells in the G2/M phase was significantly increased in the combination group compared with the radiation-only group. CONCLUSION The results support that PARP inhibitor Niraparib increases the radiosensitivity of tumor cells, promotes their apoptosis, and induces cell cycle redistribution. The possible mechanism is associated with the inhibition of radiation-induced DNA damage repair.
Collapse
Affiliation(s)
- J Yu
- Department of Radiation Oncology, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, China
| | - Y Feng
- Shanghai University of Traditional Chinese Medicine affiliated Shuguang Hospital, Shanghai, China
| | - S Pi
- Chengdu Women's and Children's Central Hospital, Chengdu, China
| | - Y Li
- Puyang People's Hospital, Puyang, China
| |
Collapse
|
167
|
Zhang W, Tang Y, Chen W, Gao Y, Wang W, Liu S, Wei L, Cai Y, Zhu Y, Cheng G, Zhang H, Wang X, Zhu S, Wang J, Li G, Yang J, Zhang K, Li N, Li Y, Jin J. Cost-Effectiveness of Short-Course Radiotherapy Based Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer in China. Int J Radiat Oncol Biol Phys 2023; 117:e356-e357. [PMID: 37785230 DOI: 10.1016/j.ijrobp.2023.06.2439] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/04/2023]
Abstract
PURPOSE/OBJECTIVE(S) The phase III STELLAR (NCT02533271) trial demonstrated that four cycles of chemotherapy after short-course radiotherapy (SCRT-TNT) were not inferior to the standard care of long-course concurrent radiotherapy (LCRT) in patients with locally advanced rectal cancer (LARC). This study assessed the cost-effectiveness of SCRT-TNT versus LCRT in locally advanced rectal cancer in China on the basis of the STELLAR trial. MATERIALS/METHODS A Markov model was used to synthesize the healthcare costs and benefits of LARC patients based on results from the STELLAR trial. The model assumes that LARC who meet the inclusion criteria of the STELLAR trial experience four possible states: No Evidence of Disease (NED), locally recurrence, distant metastases, or any death from rectal cancer or other unrelated causes, where local recurrence continues to be classified as resectable and unresectable. The transition status period is 3 month, and 5 years is used to calculate direct medical costs and health benefits. The probabilities of states transition after SCRT-TNT or LCRT were derived from the results of the STELLAR trial and previous published article (Table.1). Costs were evaluated from the Chinese payer's perspective reported in early 2022 US dollars (US$1 = 6.78 Chinese Yuan). Sensitivity analyses were performed for key variables. Cost-effectiveness was evaluated using the incremental cost-effectiveness ratio and net monetary benefits. Effectiveness was defined as quality-adjusted life-years (QALYs). Willingness-to-pay (WTP) threshold was set at $43500/QALY. Data were collected from October 3, 2020, to September 20, 2021, and analyzed from November 15, 2020, to October 25, 2021. RESULTS During the 5-year horizon, for the base case scenario, SCRT-TNT incurred a lower total cost and higher QALYs compared with LCCRT. The total cost was $65767 and QALYs were 1.77 for SCRT-TNT; for LCCRT, the total cost was $72802 and QALYs were 1.64. This resulted in an ICER of -$ 55470.69 per QALY. Therefore, SCRT-TNT was a cost-saving and dominating treatment strategy compared with LCRT. Sensitivity analysis showed that ICERs were most sensitive to the parameters of distant metastases risk after treatment. CONCLUSION SCRT-TNT in locally advanced rectal cancer can be a cost-effective alternative to LCRT in China, and should be considered in appropriately selected patients.
Collapse
Affiliation(s)
- W Zhang
- Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, China
| | - Y Tang
- Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
| | - W Chen
- Office of Cancer Screening, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
| | - Y Gao
- Department of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China
| | - W Wang
- Guizhou Provincial Cancer Hospital, GUIZHOU, China
| | - S Liu
- Jilin Provincial Cancer Hospital, Changchun, China
| | - L Wei
- Department of Radiation Oncology, First Affiliated Hospital of Air Force Medical University, Xi'an, China
| | - Y Cai
- Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Radiation Oncology, Peking University Cancer Hospital and Institute, Beijing, China
| | - Y Zhu
- Zhejiang Cancer Hospital, Hangzhou, China
| | - G Cheng
- Department of Radiation Oncology, China-Japan Union Hospital of Jilin University, Changchun 130033, China
| | - H Zhang
- Department of Radiation and Medical Oncology, Hubei Key Laboratory of Tumor Biological Behaviors, Hubei Cancer Clinical Study Center, Zhongnan Hospital of Wuhan University, Wuhan, China, Wuhan, China
| | - X Wang
- Department of Radiation Oncology/Abdominal Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, China
| | - S Zhu
- Hunan Cancer Hospital, Changsha, Hunan province, China
| | - J Wang
- Fourth Hospital of Hebei Medical University, Shijiazhuang, China
| | - G Li
- Department of Radiation Oncology, National Geriatrics Center, Beijing Hospital of the Ministry of Health, Beijing, China
| | - J Yang
- Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China
| | - K Zhang
- Qinghai Red Cross Hospital, XINING, China
| | - N Li
- Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
| | - Y Li
- Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
| | - J Jin
- Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, China; Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China, Beijing, China
| |
Collapse
|
168
|
Wang HZ, Zheng X, Sun J, Zhu X, Dong D, Du Y, Feng Z, Gong J, Wu H, Geng J, Li S, Song M, Zhang Y, Liu Z, Cai Y, Li Y, Wang W. 4D-MRI Guided Stereotactic Body Radiation Therapy for Unresectable Colorectal Liver Metastases. Int J Radiat Oncol Biol Phys 2023; 117:e359. [PMID: 37785235 DOI: 10.1016/j.ijrobp.2023.06.2445] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/04/2023]
Abstract
PURPOSE/OBJECTIVE(S) This study evaluated the feasibilities and outcomes following four-dimensional magnetic resonance imaging (4D-MRI) guided stereotactic body radiation therapy (SBRT) for unresectable colorectal liver metastases (CRLM). MATERIALS/METHODS From March 2018 to January 2022, we identified 76 unresectable CRLM patients with 123 lesions who received 4D-MRI guided SBRT in our institution. 4D-MRI simulation with or without abdominal compression was conducted for all patients. The prescription dose was 50-65 Gy in 5-12 fractions. The image quality of computed tomography (CT) and MRI were compared using the Clarity Score. Clinical outcomes and toxicity profiles were evaluated. RESULTS The 4D-MRI significantly improved the image quality compared with CT images (mean Clarity Score: 1.67 vs 2.88, P < 0.001). The abdominal compression significantly reduced motions in cranial-caudal direction (P = 0.03) with 2 phase T2 weighted images assessing tumor motion. The median follow-up time was 12.5 months. For 98 lesions assessed for best response, the complete response, partial response and stable disease rate were 57.1 %, 30.6 % and 12.2 %, respectively. The local control (LC) rate at 2 year was 97.3%. 46.1% of patients experienced grade 1-2 toxicities and only 2.6% patients experienced grade 3 hematologic toxicities. CONCLUSION The 4D-MRI technique allowed precise target delineation and motion tracking in unresectable CRLM patients. High LC rate and mild toxicities were achieved. This study provided evidence for using 4D-MRI guided SBRT as an alternative treatment in unresectable CRLM.
Collapse
Affiliation(s)
- H Z Wang
- Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Radiation Oncology, Peking University Cancer Hospital and Institute, Beijing, China
| | - X Zheng
- Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Radiation Oncology, Peking University Cancer Hospital and Institute, Beijing, Beijing, China
| | - J Sun
- Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Radiation Oncology, Peking University Cancer Hospital and Institute, Beijing, Beijing, China
| | - X Zhu
- Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Radiation Oncology, Peking University Cancer Hospital and Institute, Beijing, China
| | - D Dong
- Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Radiation Oncology, Peking University Cancer Hospital and Institute, Beijing, Beijing, China
| | - Y Du
- Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Radiation Oncology, Peking University Cancer Hospital and Institute, Beijing, Beijing, China
| | - Z Feng
- Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Radiation Oncology, Peking University Cancer Hospital and Institute, Beijing, Beijing, China
| | - J Gong
- Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Radiation Oncology, Peking University Cancer Hospital and Institute, Beijing, Beijing, China
| | - H Wu
- Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Radiation Oncology, Peking University Cancer Hospital and Institute, Beijing, Beijing, China
| | - J Geng
- Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Radiation Oncology, Peking University Cancer Hospital and Institute, Beijing, China
| | - S Li
- Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Radiation Oncology, Peking University Cancer Hospital and Institute, Beijing, China
| | - M Song
- Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Radiation Oncology, Peking University Cancer Hospital and Institute, Beijing, China
| | - Y Zhang
- Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Radiation Oncology, Peking University Cancer Hospital and Institute, Beijing, China
| | - Z Liu
- Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Radiation Oncology, Peking University Cancer Hospital and Institute, Beijing, China
| | - Y Cai
- Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Radiation Oncology, Peking University Cancer Hospital and Institute, Beijing, China
| | - Y Li
- Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Radiation Oncology, Peking University Cancer Hospital and Institute, Beijing, China
| | - W Wang
- Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Radiation Oncology, Peking University Cancer Hospital and Institute, Beijing, China
| |
Collapse
|
169
|
Shi X, Wang P, Li Y, Xu J, Yu J, Teng F. Using MRI Radiomics to Predict the Efficacy of Immunotherapy for Brain Metastasis in Patients with Small Cell Lung Cancer. Int J Radiat Oncol Biol Phys 2023; 117:e65-e66. [PMID: 37785933 DOI: 10.1016/j.ijrobp.2023.06.791] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/04/2023]
Abstract
PURPOSE/OBJECTIVE(S) Immune-checkpoint inhibitors (ICIs) combined with chemotherapy has been widely used in the first-line treatment of small cell lung cancer (SCLC) patients. However, the efficacy of ICIs for patients with brain metastases (BMs) of SCLC is limited. There are no effective factors to predict the efficacy. We developed and validate a model to predict intracranial efficacy for ICIs in patients with BMs from SCLC by using MRI radiomics. MATERIALS/METHODS In this study, we collected 101 SCLC patients with BMs treated with ICIs. They clinical characteristics and pre-treatment Magnetic Resonance Imaging (MRI) were collected. Seventy cases collected from our hospital as training cohort and 31 cases collected from another hospital as an independent validation cohort. Brain metastatic lesions were contoured on ITK-SNAP software and 3748 radiomic features capturing both intra- and peritumoral texture patterns were extracted. The primary endpoint of this study was intracranial overall response rate (ORR). Intraclass correlation coefficient (ICC) and random forest (RF) model were used to select radiomic features. The top 10 selected radiomic features were adopted to build prognostic models by using logistic regression. Area Under the Curve (AUC) of the Receiver Operating Characteristic (ROC) was chosen as the metric to assess model performances. We also performed a nomogram based on a multivariate logistic regression model includes radiomic and clinical features to predict ICIs intracranial efficacy. RESULTS The clinical characteristics including number of treatment lines and concurrent brain radiotherapy, ten intratumoral signatures and one peritumoral signatures were found significantly associated with ICIs intracranial efficacy. Predictors contained in the individualized prediction nomogram included the radiomics signature, and clinical features. The model showed favorable discrimination with a C-index of 0.861[95% CI: 0.779-0.943] and AUC of 0.861[95% CI: 0.778- 0.944] in training cohort and with a C-index of 0.812[95% CI: 0.647-0.978] and AUC of 0.812[95% CI:0.646-0.979] in the test cohort. CONCLUSION Radiomic features from pre-treatment MRI images were predictive for intracranial efficacy in SCLC patients with BMs. Pre-treatment radiomics may allow early prediction of benefit and expedite more aggressive treatment for high-risk patients and it has to be further explored as predictor of outcome in a larger series of patients.
Collapse
Affiliation(s)
- X Shi
- Department of Radiation Oncology and Shandong Provincial Key Laboratory of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China
| | - P Wang
- Shandong Cancer Hospital & Institute, Cheeloo College of Medicine, Shandong University, Jinan, China
| | - Y Li
- Department of Radiation Oncology and Shandong Provincial Key Laboratory of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China
| | - J Xu
- Department of Radiation Oncology and Shandong Provincial Key Laboratory of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China
| | - J Yu
- Shandong Cancer Hospital, Shandong University, Jinan, Shandong, China
| | - F Teng
- Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China
| |
Collapse
|
170
|
Yu N, Li J, Chen X, Wang Z, Kang X, Zhang R, Qin J, Zheng Q, Feng G, Deng L, Zhang T, Wang W, Liu W, Wang J, Feng Q, Lv J, Chen D, Zhou Z, Xiao Z, Li Y, Bi N, Li Y, Wang X. Chemoradiotherapy Combined with Nab-Paclitaxel plus Cisplatin in Patients with Locally Advanced Borderline Resectable or Unresectable Esophageal Squamous Cell Carcinoma: A Phase I/II Study. Int J Radiat Oncol Biol Phys 2023; 117:e354. [PMID: 37785224 DOI: 10.1016/j.ijrobp.2023.06.2433] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/04/2023]
Abstract
PURPOSE/OBJECTIVE(S) To evaluate the efficacy and safety of nanoparticle albumin-bound paclitaxel (nab-PTX) plus cisplatin as the regimen of conversional chemoradiotherapy (cCRT) in locally advanced borderline resectable or unresectable esophageal squamous cell carcinoma (ESCC). MATERIALS/METHODS Patients with locally advanced ESCC (cT3-4, Nany, M0-1, M1 was limited to lymph node metastasis in the supraclavicular area) were enrolled. All the patients received the cCRT of nab-PTX plus cisplatin. After the cCRT, those resectable patients received esophagectomy; those unresectable patients continued to receive the definitive chemoradiotherapy (dCRT). The locoregional control (LRC), overall survival (OS), progression-free survival (PFS), distant metastasis free survival (DMFS), pathological complete response (pCR), R0 resection rate and adverse events (AEs) were calculated. RESULTS A total of 45 patients with ESCC treated from October 2019 to May 2021 were finally included. The median follow-up time was 30.3 months. The LRC, OS, EFS, DMFS at 1and 2 years were 81.5%, 86.6%, 64.3%, 73.2% and 72.4%, 68.8%, 44.8%, 52.7% respectively. 21 patients (46.7%) received conversional chemoradiotherapy plus surgery (cCRT+S). The pCR rate and R0 resection rate were 47.6% and 84.0%. The LRC rate at 1 and 2 years were 95.0%, 87.1% in cCRT+S patients and 69.3%, 58.7% in dCRT patients respectively (HR, 5.14; 95% CI, 1.10-23.94; P = 0.021). The OS rate at 1 and 2 years were 95.2% and 84.2% in resectable patients compared to 78.8% and 54.4% in unresectable patients (HR, 3.41; 95% CI, 1.10-10.61; P = 0.024). The toxicities during chemoradiotherapy were tolerated, the most common grade 3-4 toxicities were radiation esophagitis (15.6%). CONCLUSION Nab-PTX plus cisplatin were effective and safe as the regimen of conversional chemoradiotherapy of ESCC. The patients receiving conversional chemoradiotherapy plus surgery (cCRT+S) were prone to have a better survival.
Collapse
Affiliation(s)
- N Yu
- Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
| | - J Li
- Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
| | - X Chen
- Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
| | - Z Wang
- Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
| | - X Kang
- Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
| | - R Zhang
- Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
| | - J Qin
- Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
| | - Q Zheng
- Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
| | - G Feng
- Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
| | - L Deng
- Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
| | - T Zhang
- Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC), Beijing, China
| | - W Wang
- Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
| | - W Liu
- Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
| | - J Wang
- Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC), Beijing, China
| | - Q Feng
- Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
| | - J Lv
- Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
| | - D Chen
- Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
| | - Z Zhou
- Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC), Beijing, China
| | - Z Xiao
- Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
| | - Y Li
- Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
| | - N Bi
- Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
| | - Y Li
- Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
| | - X Wang
- Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
| |
Collapse
|
171
|
Li Y, Zhang J, Cai W, Wang C, Yu Z, Jiang Z, Lai K, Wang Y, Yang G. CREB3L2 Regulates Hemidesmosome Formation during Epithelial Sealing. J Dent Res 2023; 102:1199-1209. [PMID: 37555472 DOI: 10.1177/00220345231176520] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 08/10/2023] Open
Abstract
The long-term success rate of dental implants can be improved by establishing a favorable biological sealing with a high-quality epithelial attachment. The application of mesenchymal stem cells (MSCs) holds promise for facilitating the soft tissue integration around implants, but the molecular mechanism is still unclear and the general application of MSC sheet for soft tissue integration is also relatively unexplored. We found that gingival tissue-derived MSC (GMSC) sheet treatment significantly promoted the expression of hemidesmosome (HD)-related genes and proteins in gingival epithelial cells (GECs). The formation of HDs played a key role in strengthening peri-implant epithelium (PIE) sealing. Further, high-throughput transcriptome sequencing showed that GMSC sheet significantly upregulated the PI3K/AKT pathway, confirming that cell adhesion and HD expression in GECs were regulated by GMSC sheet. We observed that the expression of transcription factor CREB3L2 in GECs was downregulated. After treatment with PI3K pathway inhibitor LY294002, CREB3L2 messenger RNA and protein expression levels were upregulated. Further experiments showed that overexpression or knockdown of CREB3L2 could significantly inhibit or promote HD-related genes and proteins, respectively. We confirmed that CREB3L2 was a transcription factor downstream of the PI3K/AKT pathway and participated in the formation of HDs regulated by GMSC sheet. Finally, through the establishment of early implant placement model in rats, we clarified the molecular function of CREB3L2 in PIE sealing as a mechanical transmission molecule in GECs. The application of GMSC sheet-implant complex could enhance the formation of HDs at the implant-PIE interface and decrease the penetration distance of horseradish peroxidase between the implant and PIE. Meanwhile, GMSC sheet reduced the length of CREB3L2 protein expression on PIE. These findings elucidate the potential function and molecular mechanism of MSC sheet regulating the epithelial sealing around implants, providing new insights and ideas for the application of stem cell therapy in regenerative medicine.
Collapse
Affiliation(s)
- Y Li
- Stomatology Hospital, School of Stomatology, Zhejiang University School of Medicine, Zhejiang Provincial Clinical Research Center of Oral Diseases, Key Laboratory of Oral Biomedical Research of Zhejiang Province, Cancer Center of Zhejiang University, Hangzhou, China
| | - J Zhang
- Stomatology Hospital, School of Stomatology, Zhejiang University School of Medicine, Zhejiang Provincial Clinical Research Center of Oral Diseases, Key Laboratory of Oral Biomedical Research of Zhejiang Province, Cancer Center of Zhejiang University, Hangzhou, China
| | - W Cai
- Stomatology Hospital, School of Stomatology, Zhejiang University School of Medicine, Zhejiang Provincial Clinical Research Center of Oral Diseases, Key Laboratory of Oral Biomedical Research of Zhejiang Province, Cancer Center of Zhejiang University, Hangzhou, China
| | - C Wang
- Stomatology Hospital, School of Stomatology, Zhejiang University School of Medicine, Zhejiang Provincial Clinical Research Center of Oral Diseases, Key Laboratory of Oral Biomedical Research of Zhejiang Province, Cancer Center of Zhejiang University, Hangzhou, China
| | - Z Yu
- Stomatology Hospital, School of Stomatology, Zhejiang University School of Medicine, Zhejiang Provincial Clinical Research Center of Oral Diseases, Key Laboratory of Oral Biomedical Research of Zhejiang Province, Cancer Center of Zhejiang University, Hangzhou, China
| | - Z Jiang
- Stomatology Hospital, School of Stomatology, Zhejiang University School of Medicine, Zhejiang Provincial Clinical Research Center of Oral Diseases, Key Laboratory of Oral Biomedical Research of Zhejiang Province, Cancer Center of Zhejiang University, Hangzhou, China
| | - K Lai
- Stomatology Hospital, School of Stomatology, Zhejiang University School of Medicine, Zhejiang Provincial Clinical Research Center of Oral Diseases, Key Laboratory of Oral Biomedical Research of Zhejiang Province, Cancer Center of Zhejiang University, Hangzhou, China
| | - Y Wang
- Stomatology Hospital, School of Stomatology, Zhejiang University School of Medicine, Zhejiang Provincial Clinical Research Center of Oral Diseases, Key Laboratory of Oral Biomedical Research of Zhejiang Province, Cancer Center of Zhejiang University, Hangzhou, China
| | - G Yang
- Stomatology Hospital, School of Stomatology, Zhejiang University School of Medicine, Zhejiang Provincial Clinical Research Center of Oral Diseases, Key Laboratory of Oral Biomedical Research of Zhejiang Province, Cancer Center of Zhejiang University, Hangzhou, China
| |
Collapse
|
172
|
Fan X, Li Y, Pei Y, Wu K. Recovery Characteristics of Lymphocyte Subsets after Thoracic Radiotherapy: A Single Center Clinical Study. Int J Radiat Oncol Biol Phys 2023; 117:e18. [PMID: 37784799 DOI: 10.1016/j.ijrobp.2023.06.686] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/04/2023]
Abstract
PURPOSE/OBJECTIVE(S) Lymphocytes play a critical role in anti-tumor, and are highly sensitive to radiation. However, the dynamic changes of lymphocytes subsets after receiving thoracic radiotherapy have rarely been investigated. This study was to explore the recovery characteristics of each subset, and the role of thymosin α1 after thoracic radiotherapy. MATERIALS/METHODS A total of 252 patients receiving chest radiotherapy included in this study. Blood was harvested before, at the end of radiotherapy, 1 month, 4 months, 7 months, 10 months, 13 months, and 19 months after radiotherapy for lymphocyte subsets detection by performing flow cytometry. In addition, a total of 26 patients with thoracic malignancy were treated with thymosin α1 after radiotherapy for one month. The number of lymphocyte subsets at the end of 1 month after radiotherapy were compared with control group. Absolute counts method was used in flow cytometry. RESULTS At the end of radiotherapy, nearly all of the subsets decreased significantly (T cell: 65.4%, Tc cell: 64.8%, Th cell: 66.1%, B cell: 88.7%, NK cell: 68.8%), except Treg cell. Tc cells recovered rapidly to baseline level at 1 month. The number of NK cells increased by 1.95 times at 1 month, and recovered to baseline level at 7th month. The number of B cell at 1 month was still 19.2% compared baseline, and recovered slowly to baseline at 7th month. The number of Th cells were nearly no recovery, and were 44.1% compared with baseline even at 19th month. For patients with thymosin α1 injection, all of the lymphocyte subsets had no significant difference compared those without thymosin α1 injection. In addition, younger patients were with better recovery in Th cells (p = 0.011) and B cells (p < 0.001) than elder patients at 1 month. CONCLUSION B cell was the most radiosensitive lymphocyte, and Th cell was continuous exhaustion after thoracic radiation. Thymosin α1 had no effect on lymphocyte subpopulation recovery, and new drugs are urgently needed to explore in the future.
Collapse
Affiliation(s)
- X Fan
- Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China
| | - Y Li
- Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China; Department of Radiation Oncology, Shanghai Proton and Heavy Ion Center, Fudan University Cancer Hospital, Shanghai, China
| | - Y Pei
- Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China
| | - K Wu
- Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China; Department of Radiation Oncology, Shanghai Proton and Heavy Ion Center, Fudan University Cancer Hospital, Shanghai, China
| |
Collapse
|
173
|
Lee SL, Ruggles C, Yadav P, Bassetti MF, Li Y. Crowdsourcing Deep Learning Algorithms to Automatically Contour GI Luminal Organs on Serial MRIs. Int J Radiat Oncol Biol Phys 2023; 117:S116-S117. [PMID: 37784303 DOI: 10.1016/j.ijrobp.2023.06.449] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/04/2023]
Abstract
PURPOSE/OBJECTIVE(S) A major barrier to a sustainable real-time adaptive MR-guided radiotherapy workflow is the time-consuming process of contouring the target and organs-at-risk (OARs) before the delivery of each fraction. While auto-contouring algorithms perform relatively well for many solid organs, the performance on luminal organs in the abdomen remain difficult due to the variability between patients and variability in daily shape and position. The purpose of this study is to evaluate the performance of crowdsourced deep learning algorithms to automatically contour GI luminal organs on serial MRIs. MATERIALS/METHODS The stomach, small intestines, and large intestines were manually contoured on MRIs from patients who had undergone radiotherapy on an MR-Linac by a team of radiation therapists and medical physicists and were verified by a board-certified radiation oncologist. The MRIs and the contours were de-identified and uploaded to Kaggle, an online machine learning competition platform with portion of the data open to the public as training data and the remaining data hidden as a test set. Prize money was offered to teams submitting the best auto-contouring algorithms based on the Dice coefficient and Hausdorff distance evaluation metrics. The average performance of the winning algorithm and of manual contours were compared using unpaired t-test. RESULTS Four hundred sixty-seven MRIs were collected from 107 patients who underwent 1-5 serial MRI sessions between 2015 and 2019. The most common anatomic site of treatment was the pancreas with 41 patients, followed by the liver with 38 patients. The manual contours of the stomach, small intestines, and large intestines on 4 representative MRIs had mean and standard deviation Dice coefficient of 0.90 +/- 0.02, 0.76 +/- 0.04, and 0.85 +/- 0.03 respectively and Hausdorff distance of 18.0 +/- 6.9, 35.5 +/- 12.6, and 32.3 +/- 12.3 mm respectively. The Kaggle competition was held from April to July 2022 and 1548 teams submitted algorithms for evaluation. The auto-contouring performance of the winning solution on the stomach, small intestines, and large intestines, when evaluated on a hold-out test set with 188 MRIs, had mean and standard deviation Dice coefficient of 0.92 +/- 0.04, 0.80 +/- 0.09, 0.85 +/- 0.08 respectively and Hausdorff distance of 15.2 +/- 11.2, 33.9 +/- 15.2, 34.8 +/- 20.3 mm respectively. Unpaired t-test was performed to compare the average performance across three organs of the human (N = 120) and of the algorithm (N = 564). The results suggest that average algorithm performance was statistically superior to manual contours for Dice (p = 0.01), yet not for Hausdorff (p = 0.64). CONCLUSION Crowdsourced deep learning algorithms to auto-contour GI luminal organs on serial MRIs perform superiorly compared to manual contours when using a Dice coefficient metric but not when using a Haudorff distance metric. These auto-contouring algorithms may be used to efficiently adapt radiotherapy plans according to the anatomy of the day for patients with abdominal tumors on MR-Linacs.
Collapse
Affiliation(s)
- S L Lee
- Division of Radiation Oncology, Tom Baker Cancer Centre, Calgary, AB, Canada
| | - C Ruggles
- Department of Biostatistics and Medical Informatics and Department of Computer Sciences, University of Wisconsin - Madison, Madison, WI
| | - P Yadav
- Department of Radiation Oncology, Northwestern University Feinberg School of Medicine, Chicago, IL
| | - M F Bassetti
- Department of Human Oncology, University of Wisconsin Hospitals and Clinics, Madison, WI
| | - Y Li
- Department of Biostatistics and Medical Informatics and Department of Computer Sciences, University of Wisconsin - Madison, Madison, WI
| |
Collapse
|
174
|
Liang WR, Kang R, Zhao X, Zhang L, Jing LP, Yang WR, Li Y, Ye L, Zhou K, Li JP, Fan HH, Yang Y, Xiong YZ, Zhang FK. [Clinical characteristics of aplastic anemia patients with abnormal autoantibodies and the impact of autoantibodies on immunosuppressive therapy response]. Zhonghua Nei Ke Za Zhi 2023; 62:1200-1208. [PMID: 37766439 DOI: 10.3760/cma.j.cn112138-20230201-00045] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Subscribe] [Scholar Register] [Indexed: 09/29/2023]
Abstract
Objective: To investigate the clinical characteristics of patients with acquired aplastic anemia (AA) accompanied by abnormal antinuclear antibody (ANA) and autoantibodies and their effects on the efficacy of immunosuppressive therapy (IST). Method: A retrospective case-control study was conducted, analyzing the clinical data of 291 patients with AA who underwent IST and were screened for autoantibodies at initial diagnosis between January 2018 and December 2019 at Blood Diseases Hospital, Chinese Academy of Medical Sciences. According to the titer of ANA at the initial diagnosis, extracted nuclear antigen antibodies (ENAs) abnormality and the change of ANA titer after treatment, the treatment responses of 3 months and 6 months after IST were compared. The correlation between clinical features and ANA abnormality was analyzed by univariate and multivariate logistic regression analysis. The parameters of univariate analysis P<0.1 were included in multivariate analysis, stepwise regression analysis and subgroup analysis. Results: A total of 291 patients were included in the study, of which 145 (49.83%) were male. Among all patients, 147 (50.52%) tested positive for ANA at initial diagnosis, with titers of 1∶100, 1∶320, and 1∶1 000 observed in 94, 47, and 6 cases, respectively. Female gender, older age, presence of paroxysmal nocturnal hemoglobinuria (PNH) clone, and higher levels of IgG, IgA, and thyroid hormone were significantly associated with ANA positivity at initial diagnosis, while white cell counts, reticulocytes, and free triiodothyronine were significantly lower than that of ANA-negatively patients (all P<0.05). Furthermore, logistic regression analyses revealed that female gender (OR=1.980, 95%CI 1.206-3.277), older age (OR=1.017, 95%CI 1.003-1.032), and presence of PNH clone (OR=1.875, 95%CI 1.049-3.408) were independent risk factors for ANA positivity at initial diagnosis. Subgroup analysis indicated that the risk of ANA positivity at initial diagnosis was even higher in PNH clone-positive patients in the subgroups of females (OR=1.24, 95%CI 1.02-1.51), severe AA (OR=1.26, 95%CI 1.07-1.47), and age≥40 years (OR=1.26, 95%CI 1.05-1.52) (all P<0.05). However, ANA titers at initial diagnosis, presence of other abnormal ENAs, and changes in ANA titers after treatment with IST were not correlated with treatment response (all P>0.05). Conclusions: Approximately 50% of patients with AA had abnormal ANA, and their presence was significantly associated with female gender, older age, and presence of PNH clone at initial diagnosis. However, the presence of abnormal ANA and changes in ANA titers after treatment did not affect the efficacy of IST in patients with AA.
Collapse
Affiliation(s)
- W R Liang
- Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Tianjin 300020, China
| | - R Kang
- Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Tianjin 300020, China
| | - X Zhao
- Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Tianjin 300020, China
| | - L Zhang
- Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Tianjin 300020, China
| | - L P Jing
- Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Tianjin 300020, China
| | - W R Yang
- Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Tianjin 300020, China
| | - Y Li
- Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Tianjin 300020, China
| | - L Ye
- Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Tianjin 300020, China
| | - K Zhou
- Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Tianjin 300020, China
| | - J P Li
- Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Tianjin 300020, China
| | - H H Fan
- Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Tianjin 300020, China
| | - Y Yang
- Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Tianjin 300020, China
| | - Y Z Xiong
- Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Tianjin 300020, China
| | - F K Zhang
- Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Tianjin 300020, China
| |
Collapse
|
175
|
Wang J, Liu X, Luo F, Wang X, Liu Y, Hu C, Qi S, Li Y. Association of Overall Survival Benefit Profile of Radiotherapy with Progression-Free Survival after Chemotherapy for Diffuse Large B-Cell Lymphoma. Int J Radiat Oncol Biol Phys 2023; 117:S63-S64. [PMID: 37784543 DOI: 10.1016/j.ijrobp.2023.06.364] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/04/2023]
Abstract
PURPOSE/OBJECTIVE(S) Benefit of radiotherapy (RT) after chemotherapy (CT) of diffuse large B-cell lymphoma (DLBCL) remains controversial. It is unknown whether improved progression-free survival (PFS) by RT translate into an overall survival (OS) benefit. To address this question, our research comprehensively evaluated the risk-benefit assessment of RT in DLBCL through an in-depth examination of previously reported data from randomized controlled trials (RCTs) and retrospective comparative studies. MATERIALS/METHODS After screening and quality control, this study included 7 randomized controlled trials and 52 retrospective studies of combined-modality therapy (CMT) versus CT alone. The correlation between PFS and OS was evaluated using the Pearson linear correlation coefficient at trial- and study arm-level. A risk-benefit assessment to describe the OS benefit of RT was performed in meta-analyses of pooled HROS with PFS patterns. RESULTS In RCTs, strong correlations were found between HRPFS and HROS at trial-level (r = 0.876), and PFS and OS at treatment arm-level, regardless of treatments (r = 0.945-0.964 for all, CMT or CT). In retrospective studies, similar correlations between HRPFS and HROS (r = 0.639-0.650), and PFS and OS rates (r = 0.882-0.910) were observed, independent of treatments or rituximab. Adding RT into rituximab-based CT increased the average PFS rate from 63.6 ± 18.9% to 81.5 ± 10.6% (P<0.001), with differential OS benefits of RT between studies. Patients can be stratified into four PFS patterns (>80%, >60-80%, >40-60%, and ≤40%); absolute gain in OS from RT ranged from ≤5% at PFS >80% to ∼21% at PFS ≤40%, with pooled-HROS from 0.70 (95% CI, 0.51-0.97) to 0.48 (95% CI, 0.36-0.63) after rituximab-based CT. Linear analysis revealed an OS advantage of CMT over CT alone in a PFS-dependent manner. CONCLUSION We demonstrate a varied OS benefit profile of RT upon different PFS patterns, and provide valuable evidence for making treatment decisions and designing clinical trials. Future strategies to select the use of RT will need careful tailoring in clinical practice or within RCT to optimize outcome.
Collapse
Affiliation(s)
- J Wang
- Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC), Beijing, China; Department of Oncology, Central hospital affiliated to Shandong First Medical University, Jinan, Shandong, China
| | - X Liu
- Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC), Beijing, China
| | - F Luo
- Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC), Beijing, China
| | - X Wang
- Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC), Beijing, China
| | - Y Liu
- Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC), Beijing, China
| | - C Hu
- Johns Hopkins Medicine Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD
| | - S Qi
- Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
| | - Y Li
- Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
| |
Collapse
|
176
|
Zeng SN, Li Y, Li YMQ, Wang SR. Weighted gene co-expression network analysis of key targets and interventional mechanism of Milkvetch root in diabetic nephropathy. Eur Rev Med Pharmacol Sci 2023; 27:9614-9627. [PMID: 37916327 DOI: 10.26355/eurrev_202310_34133] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 11/03/2023]
Abstract
OBJECTIVE This work aimed to explore the key targets and intervention mechanisms of Huangqi (Astragalus membranaceus) in diabetic nephropathy using weighted gene co-expression network analysis (WGCNA). The findings will provide references for identifying critical therapeutic targets for diabetic nephropathy. MATERIALS AND METHODS The GSE1009 dataset was selected from the Gene Expression Omnibus (GEO) database of the National Center for Biotechnology Information (NCBI) for analysis. WGCNA network was constructed to identify differentially expressed genes (DEGs). Gene ontology (GO) and pathway enrichment analysis were performed on the DEGs. RESULTS There were 752 downregulated DEGs and 1,547 upregulated DEGs in the diabetic nephropathy samples. Genes such as PLCE1, CLIC5, PTPRO, HSPA12A, AIF1, GMDS, and SEMA5A were significantly suppressed in the diabetic nephropathy samples, while genes such as CEP152, LUNAR1, and SLC9A1 were significantly upregulated. The optimal soft threshold for the WGCNA network was determined as 12. Hierarchical clustering analysis was conducted to detect co-expression modules with corresponding color assignments, and a total of 9 modules were identified. Clinical characteristics showed a high correlation with the gray, blue, green, and brown modules of the WGCNA. GO analysis and KEGG pathway enrichment analysis revealed that the blue module DEGs were mainly enriched in immune response, inflammatory response, signal transduction, plasma membrane, extracellular region, cell surface, extracellular matrix, and proteinaceous extracellular matrix. The green module DEGs were mainly enriched in mitochondrial elongation, mitochondrial mutation termination, translation, mitochondrial inner membrane, mitochondrion, ATP biosynthetic process, mitochondrial large ribosomal subunit, mitochondrial intermembrane space, nucleolus, and ribosome. Visualization analysis of the bioactive components of Huangqi showed compounds such as quercetin, resveratrol, 7-O-methylisomucronulatol, and isoquercetin, which had more targets. CONCLUSIONS Differentially expressed genes in diabetic nephropathy were mainly enriched in immune response and inflammatory response. Various components of Huangqi have positive application value in the treatment of diabetic nephropathy and can be considered for clinical promotion.
Collapse
Affiliation(s)
- S-N Zeng
- Department of Nephrology, The Third Hospital of Hebei Medical University, Shijiazhuang, China.
| | | | | | | |
Collapse
|
177
|
Zhao X, Fang H, Jing H, Zhang N, Zhang J, Jin J, Zhong Q, Yang WF, Zhong Y, Dong L, Tie J, Wu HF, Wang XH, Lu Y, Hou X, Zhao L, Qi S, Song Y, Liu Y, Tang Y, Lu N, Chen B, Tang Y, Li Y, Wang S. Lymphocyte Count Kinetics and the Effect of Different Radiotherapy Techniques on Radiation-Induced Lymphopenia in Patients with Breast Cancer Receiving Hypofractionated Postmastectomy Radiotherapy. Int J Radiat Oncol Biol Phys 2023; 117:e216-e217. [PMID: 37784888 DOI: 10.1016/j.ijrobp.2023.06.1112] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/04/2023]
Abstract
PURPOSE/OBJECTIVE(S) Radiation-induced lymphopenia (RIL) is associated with poor prognosis in solid tumors. This study aimed to describe the lymphocyte kinetics in patients with breast cancer receiving hypofractionated postmastectomy radiotherapy (RT) and to investigate the association of different RT techniques with RIL. MATERIALS/METHODS We assessed 607 patients who received hypofractionated postmastectomy RT for breast cancer in our prospective clinical database from 8 hospitals. All patients received irradiation to the chest wall and supraclavicular fossa. RT techniques included integrated RT with the photon-based intensity modulated techniques to irradiate all target volumes (integrated RT) and a hybrid approach combining photon irradiation to supraclavicular nodes and electron irradiation to the chest wall (hybrid RT). Peripheral lymphocyte counts (PLC) were tested prior to RT (baseline), weekly during RT, at 1, 2 weeks, 3, 6 months after RT, and then every 6 months. Grade 3+ RIL was defined as PLC nadir during RT of <0.5 ×103/ml. Mean PLC was compared by the t test. Univariate, multivariate, and propensity score matching (PSM) analyses were used to evaluate the effect of different RT techniques on grade 3+ RIL. RESULTS During RT, 121 (19.9%) of patients had grade 3+ RIL. The PLC started to recover at 1 week and reached baseline levels 1 year after RT. A greater proportion of the patients treated with the integrated RT (90/269, 33.5%) developed grade 3+ PLC compared with those receiving hybrid RT (31/338, 9.2%, P < 0.001). After conducting PSM, multivariate analyses showed lower baseline PLC (HR = 0.15, P<0.001) and RT technique (the integrated RT vs. hybrid RT, HR = 4.76, P<0.001) were independent risk factors for grade 3+ RIL. The PLC in patients receiving the integrated RT after RT were higher than that in those receiving hybrid RT (p<0.05). CONCLUSION RT technique affect the risk of and recovery from RIL, which may impact survival. Choosing appropriate RT technique to minimize RIL might be considered to benefit their outcomes.
Collapse
Affiliation(s)
- X Zhao
- Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
| | - H Fang
- Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
| | - H Jing
- Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
| | - N Zhang
- Department of Radiation Oncology, Cancer Hospital of China Medical University, Liaoning Cancer Hospital & Institute, Shenyang, China
| | - J Zhang
- Department of Radiation Oncology, Forth Hospital of Hebei Medical University, Shijiazhuang, China
| | - J Jin
- Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
| | - Q Zhong
- Department of Radiation Oncology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China
| | - W F Yang
- Department of Radiation Oncology, Affiliated Taizhou hospital of Wenzhou Medical University, Taizhou, China
| | - Y Zhong
- Department of Radiation and Medical Oncology, Zhongnan Hospital of Wuhan University, Wuhan, China
| | - L Dong
- Department of Radiation Oncology, The First Hospital, Jilin University, Changchun, China
| | - J Tie
- Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Radiation Oncology, Peking University Cancer Hospital and Institute, Beijing, China
| | - H F Wu
- Department of Radiation Oncology, Jilin Cancer Hospital, Changchun, China
| | - X H Wang
- Department of Radiochemotherapy, People's Hospital of Tangshan City, Tangshan, China
| | - Y Lu
- Department of Radiation Oncology, Cancer Hospital of Henan Province, Zhengzhou, Henan, China
| | - X Hou
- Department of Radiation Oncology, Peking Union Medical College Hospital, Chinese Academy of medical Sciences & Peking Union Medical College, Beijing, China
| | - L Zhao
- Department of Radiation Oncology, Xijing Hospital, Fourth Military Medical University, Xi'an, China
| | - S Qi
- Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
| | - Y Song
- Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
| | - Y Liu
- Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
| | - Y Tang
- Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
| | - N Lu
- Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
| | - B Chen
- Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
| | - Y Tang
- GCP center/Clinical research center, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
| | - Y Li
- Department of Radiation Oncology, National Cancer Center/ National Clinical Research Center for Cancer/ Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
| | - S Wang
- Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
| |
Collapse
|
178
|
Wang L, Wu Z, He Q, Li Y, Wang S, Li F, Wang H, Li W, Han YQ. Distribution Pattern of Metastatic Lymph Nodes in 870 Cases of Nasopharyngeal Carcinoma: A Clue for Individualized Elective Prophylactic Neck Irradiation. Int J Radiat Oncol Biol Phys 2023; 117:e632. [PMID: 37785888 DOI: 10.1016/j.ijrobp.2023.06.2030] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/04/2023]
Abstract
PURPOSE/OBJECTIVE(S) We aimed to explore a potential individualized elective prophylactic neck irradiation (iEPNI) to optimize the current strategy by investigating the distribution of metastatic lymph nodes (LNs) in nasopharyngeal carcinoma (NPC). MATERIALS/METHODS Magnetic resonance imaging (MRI) and clinical data of 870 non-distant metastatic NPC patients admitted to the Hunan Cancer Hospital between January 2019 and December 2019 were reviewed. All patients were staged using the 8th TNM staging system, and the LNs location was assigned based on the 2013 guidelines. According to the distribution patterns of the LNs in NPC, the intra-regional lymphatic drainage levels were categorized into the following three stations: Station 1st of level VIIa and II; Station 2nd of level III and Va; and Station 3rd of level IV, Vb, and Vc. Other levels were defined as extra-regional areas. RESULTS The incidence of LNs metastasis was 822/870 (94.5%), including 198 cases of unilateral metastasis and 624 cases of bilateral metastasis. Among the 870 patients, the most frequently involved intra-regional lymphatic drainage was level IIb (87.1%), followed by level VIIa (80.0%), IIa (61.8%), Va (30.6%), IV (21.4%), Vb (8.9%), and Vc (1.1%). In the extra-regional areas, the detailed LNs distribution was: level Ia (0.2%), level Ib (7.7%), level VI (0.1%), level VIIb (5.6%), level VIII (5.5%), level IX (0.3%), and level X (0.2%). The rates of LNs metastasis in Station 1st, Station 2nd, and Station 3rd were 820/870 (94.3%), 532/870 (61.1%), and 199/870 (22.9%), respectively. Only 4 patients were considered to be skipping metastasis among the three stations (4/870, 0.5%). Additionally, in 203 patients with unilateral Station 1st LNs metastasis, there were 86 (42.4%) and 37 (18.2%) patients with ipsilateral Station 2nd and Station 3rd metastasis, respectively, and 3 (1.5%) and 1 (0.5%) patients with contralateral Station 2nd and Station 3rd LNs metastasis, respectively. CONCLUSION LNs spread from Station 1st to Station 3rd successively with rare skipping metastasis. A potential iEPNI strategy of prophylactical neck irradiation to the ipsilateral latter node-negative station might be feasible, which is detailed as follows: irradiation to Station 1st in patients with no LNs metastasis, irradiation to Station 2nd in patients with only Station 1st metastasis, and irradiation to Station 3rd in patients with Station 2nd metastasis but without Station 3rd metastasis. Further prospective investigations are expected to validate the strategy.
Collapse
Affiliation(s)
- L Wang
- Department of Radiotherapy, the Third Affiliated Hospital of Kunming Medical University, Yunnan Cancer Hospital, Yunnan Cancer Center, Kunming, China
| | - Z Wu
- Department of Radiation Oncology, Hunan Cancer Hospital & the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China
| | - Q He
- Department of Radiation Oncology, Hunan Cancer Hospital & the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China
| | - Y Li
- Department of Radiation Oncology, Hunan Cancer Hospital & the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China
| | - S Wang
- Department of Radiation Oncology, Hunan Cancer Hospital & the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China
| | - F Li
- Department of Imaging, Hunan Cancer Hospital & the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China
| | - H Wang
- Department of Radiation Oncology, Hunan Cancer Hospital & the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China
| | - W Li
- Department of Radiotherapy, the Third Affiliated Hospital of Kunming Medical University, Yunnan Cancer Hospital, Yunnan Cancer Center, Kunming, China
| | - Y Q Han
- Department of Radiation Oncology, Hunan Cancer Hospital & the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China
| |
Collapse
|
179
|
Song Y, Dai J, Liu Q, Wang J, Wang H, Gou X, Xiao Q, Wang H, Zhong R, Xu F, Li Y, Tian R, Yan D. Tumor Treatment Response Assessed During the Chemo-Radiotherapy for Locally Advanced NSCLC. Int J Radiat Oncol Biol Phys 2023; 117:e720. [PMID: 37786103 DOI: 10.1016/j.ijrobp.2023.06.2227] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/04/2023]
Abstract
PURPOSE/OBJECTIVE(S) To evaluate the capability of assessing intratumoral treatment response distribution with using FDG-PET/CT during the chemoradiotherapy of locally advanced NSCLC. MATERIALS/METHODS Twelve of total 50 patients with stage III NSCLC were enrolled in the institutional protocol for concurrent chemoradiotherapy with treatment dose of 54-60 Gy in 27-30 fractions. For each patient, a pre-treatment FDG-PET/CT image (SUV0) and a mid-treatment image (SUVm) obtained within the treatment dose of 24 ∼ 46 Gy were obtained. Followed by deformable PET/CT registration between SUV0 and SUVm, the tumor voxel SUV reduction ratio was obtained to construct a tumor dose response matrix (DRM). Tumor SUVavid was also constructed by limiting tumor voxel SUVm > a given value. Spatial correlations of the tumor SUV0, SUVm, SUVavid and DRM were determined. RESULTS The mean and coefficient variation (CV) of the SUV0, SUVm and DRM for all tumors were 6.56(64%), 2.82(59%) and 0.52(70%) (Table contains the individual data), which were like those on the SUVs and the mean DRM of head-neck HPV- patients reported previously, but much larger on the DRM variation. The inter-tumoral CVs of SUV0 and DRM were 17% and 43%, which were much smaller than those of the intra-tumoral CVs 61% and 55%. Meanwhile, the intra-tumoral variations on both SUV0 and DRM were much larger than those of head-neck HPV- patients. There was a weak correlation between SUV0 and SUVm with the correlation coefficient 0.32, a medium correlation of -0.51 between SUV0 and DRM; 0.58 between SUVm and DRM. It implies that the rule of tumor dose response DRM on treatment modification decision cannot be fully replaced by either SUV0 or SUVm. The spatial correlation between tumor DRM and SUVavid was 0.23 with SUVavid value > 3, which was getting weaker when increasing SUVavid value. CONCLUSION Spatial dose response for NSCLC assessed using FDG-PET/CT feedback demonstrated high treatment resistant patterns, which had a large intra-tumoral variation. In addition, the medium correlations of DRM vs SUV0 and DRM vs SUVm imply that all these factors could be used to guide adaptive modification of NSCLC treatment.
Collapse
Affiliation(s)
- Y Song
- Radiotherapy Physics and Technology Center, Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China
| | - J Dai
- Department of Nuclear Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan, China
| | - Q Liu
- Department of Radiotherapy, Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China
| | - J Wang
- Lung cancer center, West China Hospital, Sichuan University, Chengdu, Sichuan, China
| | - H Wang
- Department of Nuclear Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan, China
| | - X Gou
- Radiotherapy Physics and Technology Center, Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China
| | - Q Xiao
- Radiotherapy Physics and Technology Center, Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China
| | - H Wang
- Department of Nuclear Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan, China
| | - R Zhong
- Radiotherapy Physics and Technology Center, Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China
| | - F Xu
- Lung cancer center, West China Hospital, Sichuan University, Chengdu, Sichuan, China
| | - Y Li
- Lung cancer center, West China Hospital, Sichuan University, Chengdu, Sichuan, China
| | - R Tian
- Department of Nuclear Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan, China
| | - D Yan
- Tumor Adaptive Treatment Research Group, West China Hospital, Sichuan University, Chengdu, China
| |
Collapse
|
180
|
Luo R, Su Z, Kang K, Yu M, Zhou X, Wu Y, Yao Z, Xiu W, Zhang X, Yu Y, Zhou L, Na F, Li Y, Xu Y, Liu Y, Zou B, Peng F, Wang J, Zhong R, Gong Y, Huang M, Bai S, Xue J, Yan D, Lu Y. Hybrid Immuno-RT for Bulky Tumors: Standard Fractionation with Partial Tumor SBRT. Int J Radiat Oncol Biol Phys 2023; 117:S166. [PMID: 37784416 DOI: 10.1016/j.ijrobp.2023.06.264] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/04/2023]
Abstract
PURPOSE/OBJECTIVE(S) Bulky tumors remain challenging to be treated. Stereotactic body radiation therapy (SBRT) is effective against radioresistant tumor cells and can induce immunogenic cell death (ICD) that leads to T-cell-mediated antitumor effects. Low-dose radiation (LDRT) can inflame the tumor microenvironment (TME) by recruiting T cells. We designed a novel radiotherapy technique (RT, ERT) whose dose distribution map resembles the "eclipse" by concurrently delivering LDRT to the whole tumor, meanwhile SBRT to only a part of the same tumor. This study examined the safety and efficacy of ERT to bulky lesions with PD-1 inhibitors in mice and patients. MATERIALS/METHODS In mice with CT26 colon or LLC1 lung bulky tumors (400 - 500 cm3), the whole tumor was irradiated by LDRT (2 Gy x 3), meanwhile the tumor center was irradiated by SBRT (10 Gy x 3); αPD-1 was given weekly. The dependence of therapeutic effects on CD8+ T cells was determined using depleting antibodies. Frequencies of CD8+ T cells and M1 macrophages (Mφ) were determined by flow cytometry. Multiplex Immunohistochemistry (mIHC) was applied to analyze the number and the location of CD8+ T cells and their subpopulations, as well as the phospho-eIF2α level (the ICD marker) of tumor cells in TME. Patients with advanced lung or liver bulky tumors who failed standard treatment or with oncologic emergencies were treated. Kaplan-Meier method was applied to estimate patients' progression-free survival (PFS) and overall survival (OS). RESULTS ERT/αPD-1 is superior to SBRT/αPD-1 or LDRT/αPD-1 in controlling bulky tumors in both mouse models in a CD8+ T-cell dependent manner. In the CT26 model, ERT/αPD-1 resulted in complete tumor regression in 3/11 mice and induced more CD8+ T cells and M1 Mφ in TME compared to other groups. mIHC analysis showed that ERT/αPD-1 induced higher bulk, stem-like (TCF1+ TIM3- PD-1+), and more differentiated (TCF1- TIM3+ PD-1+) CD8+ T cells infiltration into the tumor center and periphery compared to other groups. Compared to untreated or LDRT-treated tumor centers, tumor centers irradiated with ERT or SBRT showed elevated phospho-eIF2α accompanied by higher dendritic cell infiltration. In total, 39 advanced cancer patients were treated with ERT/αPD-1 or plus chemotherapy. Radiation-induced pneumonitis occurred in 1 of 26 patients receiving thoracic ERT. There were two cases of grade III toxicity associated with PD-1 inhibitors. No toxicity above grade III was observed. The objective response rate was 38.5%. The median PFS was 5.6 months and median OS was not reached at a median follow-up of 11.7 months. CONCLUSION ERT/αPD-1 showed superior efficacy in controlling bulky tumor in two mouse models. The hybrid immuno-RT (ERT) combing PD-1 inhibitors was safe and effective in patients with bulky tumors. Further clinical trials in combination with bioimaging to identify the optimal SBRT target region for the bulky tumor are warranted.
Collapse
Affiliation(s)
- R Luo
- Thoracic Oncology Ward, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China; Department of Radiotherapy, Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China
| | - Z Su
- Thoracic Oncology Ward, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China
| | - K Kang
- Thoracic Oncology Ward, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China; Laboratory of Clinical Cell Therapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China
| | - M Yu
- Thoracic Oncology Ward, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China
| | - X Zhou
- Thoracic Oncology Ward, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China; Department of Radiotherapy, Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China
| | - Y Wu
- Thoracic Oncology Ward, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China; Laboratory of Clinical Cell Therapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China
| | - Z Yao
- Thoracic Oncology Ward, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China; Laboratory of Clinical Cell Therapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China
| | - W Xiu
- Thoracic Oncology Ward, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China
| | - X Zhang
- Thoracic Oncology Ward, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China; Department of Radiotherapy, Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China
| | - Y Yu
- Thoracic Oncology Ward, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China
| | - L Zhou
- Thoracic Oncology Ward, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China; Department of Radiotherapy, Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China
| | - F Na
- Thoracic Oncology Ward, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China
| | - Y Li
- Thoracic Oncology Ward, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China
| | - Y Xu
- Thoracic Oncology Ward, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China; Department of Radiotherapy, Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China
| | - Y Liu
- Thoracic Oncology Ward, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China; Department of Radiotherapy, Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China
| | - B Zou
- Thoracic Oncology Ward, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China; Department of Radiotherapy, Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China
| | - F Peng
- Thoracic Oncology Ward, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China
| | - J Wang
- Thoracic Oncology Ward, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China; Department of Radiotherapy, Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China
| | - R Zhong
- Division of Radiation Physics, Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China
| | - Y Gong
- Thoracic Oncology Ward, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China; Department of Radiotherapy, Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China
| | - M Huang
- Thoracic Oncology Ward, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China
| | - S Bai
- Division of Radiation Physics, Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China
| | - J Xue
- Thoracic Oncology Ward, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China; Laboratory of Clinical Cell Therapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China
| | - D Yan
- Division of Radiation Physics, Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China
| | - Y Lu
- Thoracic Oncology Ward, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China; Department of Radiotherapy, Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China
| |
Collapse
|
181
|
Li Y, Jing W, Jing X, Sun Y, Tang X, Guo J, Zhang Y, Zhu H. Outcomes of Consolidative Thoracic Radiation within First-Line Chemoimmunotherapy in Extensive-Stage Small-Cell Lung Cancer: Results from a Single Cancer Center. Int J Radiat Oncol Biol Phys 2023; 117:e37-e38. [PMID: 37785262 DOI: 10.1016/j.ijrobp.2023.06.730] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/04/2023]
Abstract
PURPOSE/OBJECTIVE(S) Thoracic radiation (TRT) benefits local control undoubtedly and survival with some minor controversy in extensive-stage small-cell lung cancer (ES-SCLC) patients undergoing radiotherapy in the chemoradiotherapy era. However, whether TRT could further enhance the benefit of immune checkpoint inhibitors (ICIs) maintenance on outcomes in the immunotherapy era is still unclear. This study aims to investigate the role of consolidative TRT in ES-SCLC patients receiving first-line chemoimmunotherapy followed by immunotherapy maintenance. MATERIALS/METHODS Outcomes of patients who were treated with first-line chemo-immunotherapy followed by ICIs maintenance for ES-SCLC were reviewed. Based on TRT or not, patients were allocated to TRT group or non-TRT group. Progression-free survival (PFS), overall survival (OS) and local-recurrence free survival (LRFS) were calculated by the Kaplan-Meier method and compared by log-rank test. RESULTS A total of 100 patients with no progressive disease after 4 cycles of chemotherapy were retrospectively analyzed between January 2020 and December 2021 and were allocated into TRT group (n = 47) and non-TRT group (n = 53). The median follow-up time was 20.3 months. The median PFS and OS in TRT were 9.1 months and 21.8 months, versus 8.8 months (p = 0.93) and 24.3 months (p = 0.63), respectively, in non-TRT. ICIs agents consisted of Durvalumab (59.0%) and Atezolizumab (41.0%). The median dose of TRT is 50 Gy (IQR: 45 - 54), while the median interval time from chemotherapy completion to TRT was 31 days (IQR: 12 - 44.5). Only 10 (21.3%) patients terminated ICIs in the period of TRT. The rate of intrathoracic progression after the first-line therapy in TRT significantly decreased compared to that with non-TRT (20.0% versus 55.9%, p = 0.003). The median LRFS time in TRT was not reached, but significantly longer than 10.8 months in non-TRT (HR = 0.27, p < 0.01). Second-line chemotherapy significantly prolonged survival compared to that with chemo-free patients (mOS: 24.5 vs. 21.4 months, p = 0.026). The subgroup analysis showed a trend of patients with brain metastases benefit from TRT (21.8 versus 13.7 months, HR 0.61, p = 0.38) while liver metastases did not (13.3 versus 15.0 months, HR 1.80, p = 0.21). Of 47 patients with TRT, only 10.6% of patients experienced grade 3 radiation-induced pneumonitis, while no grade 4 or 5 adverse events occurred. None of patients experienced grade ≥ 3 treatment-related cardiac events. CONCLUSION Consolidative TRT in the period of immunotherapy maintenance followed first-line chemo-immunotherapy did not prolong OS and PFS but increased LRFS in ES-SCLC.
Collapse
Affiliation(s)
- Y Li
- Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Science, Jinan 250117, Shandong Province, China, Jinan, China
| | - W Jing
- Shandong First Medical University and Shandong Academy of Medical Science, Jinan 250021, Shandong Province, China, Jinan, China; Department of Radiation Oncology, Shandong Provincial Hospital to Shandong First Medical University, Jinan 250021, Shandong Province, China, Jinan, China
| | - X Jing
- Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Science, Jinan 250117, Shandong Province, China, Jinan, China
| | - Y Sun
- Department of Medical Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Science, Jinan 250117, Shandong Province, China, Jinan, China
| | - X Tang
- Department of Medical Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Science, Jinan 250117, Shandong Province, China, Jinan, China
| | - J Guo
- Department of Medical Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Science, Jinan 250117, Shandong Province, China, Jinan, China
| | - Y Zhang
- Department of Medical Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Science, Jinan 250117, Shandong Province, China, Jinan, China
| | - H Zhu
- Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Science, Jinan 250117, Shandong Province, China, Jinan, China
| |
Collapse
|
182
|
Mu X, Li Y. Development and Validation of a Nomogram for Patients with Lung Large Cell Neuroendocrine Carcinoma. Int J Radiat Oncol Biol Phys 2023; 117:e37. [PMID: 37785263 DOI: 10.1016/j.ijrobp.2023.06.729] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/04/2023]
Abstract
PURPOSE/OBJECTIVE(S) Pulmonary large cell neuroendocrine carcinoma (LCNEC) is a rarely high-grade neuroendocrine carcinoma of the lung with features of both small cell and non-small cell lung cancer. We aim to construct a prognostic nomogram combined with the clinical features and treatment options to predict disease-specific survival (DSS), meanwhile, evaluating the role of prophylactic cranial irradiation (PCI) in LCNEC by subgroup analysis. MATERIALS/METHODS A total of 713 patients diagnosed with LCNEC from the US National Cancer Institute's Surveillance Epidemiology and End Results (SEER) registry between 2010 and 2016. Cox proportional hazards analysis was conducted to choose the significant predictors of DSS. External validation was performed using 77 patients with LCNEC in the West China Hospital Sichuan University between 2010 and 2018, subgroup analysis was carried out for the whole brain radiotherapy (WBRT) and PCI population. The predictive accuracy and discriminative capability were estimated by the concordance index (C-index), calibration curve and receiver operating characteristic (ROC) curve. The clinical applicability of the nomogram was verified through the decision curve analysis (DCA). RESULTS Six independent risk factors for DSS were identified and integrated into the nomogram. The nomogram achieved good C- indexes of 0.803 and 0.767 in the training and validation group respectively. Moreover, the calibration curves of both cohorts for the probability of survival showed good agreement between prediction by nomogram and actual observation in 1-, 3- and 5-year DSS. The ROC curves demonstrated the prediction accuracy of the established nomogram (all AUC>0.8). DCA confirmed the better potential clinical practicality of the nomogram in the prediction of LCNEC survival than AJCC staging. A risk classification system was built which could perfectly classify LCNEC patients into high- and low-risk groups(p<0.001). Subgroup analysis showed that WBRT did not bring survival benefits, PCI appeared to have survival benefits in LCNEC patients without brain metastases (p>0.05). CONCLUSION The prognostic nomogram developed in this study has certain prognostic value and clinical practicality for LCNEC patients. PCI might be investigated as a means of improving prognosis.
Collapse
Affiliation(s)
- X Mu
- The department of biotherapy, Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China
| | - Y Li
- Lung cancer center, West China Hospital, Sichuan University, Chengdu, Sichuan, China
| |
Collapse
|
183
|
Duan C, Li N, Li Y, Cui J, Xu W, Liu X. Prediction of progesterone receptor expression in high-grade meningioma by using radiomics based on enhanced T1WI. Clin Radiol 2023; 78:e752-e757. [PMID: 37487839 DOI: 10.1016/j.crad.2023.06.006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/03/2023] [Revised: 04/13/2023] [Accepted: 06/03/2023] [Indexed: 07/26/2023]
Abstract
AIM To predict progesterone receptor (PR) expression of high-grade meningioma using radiomics based on enhanced T1-weighted imaging (WI). MATERIALS AND METHODS There were 157 cases of high-grade meningioma in the study. Seventy-eight cases had negative expression and 79 cases had positive expression. Spearman's rank correlation coefficient and least absolute shrinkage and selection operator (LASSO) regression were used to select the valuable features. The models were developed by naive Bayes (NB), random forest (RF), and support vector machine (SVM). Receiver operating characteristic (ROC) and decision curve analysis (DCA) analysis were used to assess the models. RESULTS Nine features were selected as the valuable features using Spearman's analysis and LASSO regression. The RF and NB models achieved the same area under the ROC curve (AUC) of 0.75, which was higher than that of SVM (0.74). There was no significant difference among the AUCs of the three models (p>0.05). There was a larger net benefit in the RF model than the SVM and NB models across all threshold probabilities in the DCA analysis. CONCLUSION The RF model had good performance in predicting PR expression of high-grade meningioma. PR expression evaluation for high-grade meningioma would be helpful in clinical practice.
Collapse
Affiliation(s)
- C Duan
- Department of Radiology, The Affiliated Hospital of Qingdao University, Qingdao City, Shandong Province, China
| | - N Li
- Department of Information Management, The Affiliated Hospital of Qingdao University, Qingdao City, Shandong Province, China
| | - Y Li
- Department of Radiology, Qingdao Women and Children's Hospital, Qingdao City, Shandong Province, China
| | - J Cui
- Department of Radiology, The Affiliated Hospital of Qingdao University, Qingdao City, Shandong Province, China
| | - W Xu
- Department of Radiology, The Affiliated Hospital of Qingdao University, Qingdao City, Shandong Province, China
| | - X Liu
- Department of Radiology, The Affiliated Hospital of Qingdao University, Qingdao City, Shandong Province, China.
| |
Collapse
|
184
|
Ma J, Liu K, Chen W, Wang T, Xu Z, Li Y, Zhao B, Zhou L, Wang F, Li C. A dual-centre study on the radioprotective effect of a novel X-ray protection device during coronary intervention. Clin Radiol 2023; 78:e758-e763. [PMID: 37419771 DOI: 10.1016/j.crad.2023.06.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/14/2023] [Revised: 05/04/2023] [Accepted: 06/04/2023] [Indexed: 07/09/2023]
Abstract
AIM To investigate the shielding efficiency of a novel X-ray protection device (NPD) compared with the traditional lead clothing (TLC) during coronary intervention. MATERIALS AND METHODS This study was performed prospectively in two centres. A total of 200 coronary interventions were included and assigned equally into the NPD or TLC group. The NPD is a floor-standing X-ray protection device, which mainly composes of a barrel-like frame and two layers of lead rubber. Thermoluminescent dosimeters (TLDs) were adopted to detect the cumulative absorbed doses, and were attached outside the NPD or TLC or body of the first operator at four different height levels in four directions during the procedure. RESULTS The cumulative doses outside the NPD were comparable to that of the TLC (2,398.33 ± 2,341.64 versus 1,624.09 ± 1,732.20 μSv, p=0.366), and the cumulative doses inside the NPD were significantly lower than those inside the TLC (40 ± 0 versus 732.28 ± 919.83 μSv, p<0.001). As the TLC did not cover the calf segment of the operator, the area at 50 cm height from the floor in the TLC group was unshielded. The shielding efficiency of NPD was significantly higher than that of the TLC (98.2 ± 0.63% versus 52.11 ± 38.97%, p=0.021). CONCLUSION The NPD has a significantly higher shielding efficacy than that of the TLC, in particular, it protects the operators' lower limb, liberates their lower body from wearing heavy lead apron, and may consequently reduce the radiation or body-load associated complications.
Collapse
Affiliation(s)
- J Ma
- Department of Cardiology, First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China
| | - K Liu
- Department of Cardiology, First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China; Department of Cardiology, The First People's Hospital of Lianyungang, Lianyungang, Jiangsu, China
| | - W Chen
- Jiangsu Provincial Center for Disease Prevention and Control, Nanjing, Jiangsu, China
| | - T Wang
- Department of Cardiology, First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China; Department of Cardiology, The First People's Hospital of Yancheng, Yancheng, Jiangsu, China
| | - Z Xu
- Department of Cardiology, First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China
| | - Y Li
- Department of Cardiology, First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China
| | - B Zhao
- Department of Cardiology, The First People's Hospital of Lianyungang, Lianyungang, Jiangsu, China
| | - L Zhou
- Department of Cardiology, First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
| | - F Wang
- Jiangsu Provincial Center for Disease Prevention and Control, Nanjing, Jiangsu, China.
| | - C Li
- Department of Cardiology, First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
| |
Collapse
|
185
|
Shao HC, Li Y, Wang J, Jiang SB, Zhang Y. Real-Time 3D Liver Tumor Localization via Combined Optical Surface Imaging and an X-Ray Projection from Arbitrary Imaging Angles. Int J Radiat Oncol Biol Phys 2023; 117:S177-S178. [PMID: 37784439 DOI: 10.1016/j.ijrobp.2023.06.2520] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/04/2023]
Abstract
PURPOSE/OBJECTIVE(S) A deep learning (DL)-based, deformable registration-driven liver tumor localization technique was developed for onboard deformable motion tracking. The technique (Surf-X360-Bio) uses in-room optical surface imaging and an x-ray projection at an arbitrary scan angle to solve volumetric liver and liver tumor motion in real-time. MATERIALS/METHODS Surf-X360-Bio solves the volumetric motion of the liver and localizes the liver tumor, through deforming liver and liver tumor meshes segmented on prior 4D-CTs/CBCTs. It uses real-time onboard information from an optical surface image and a simultaneously-acquired x-ray projection (from an arbitrary scan angle). Surf-X360-Bio localizes tumors via two steps: liver boundary motion estimation and intra-liver motion derivation. Surf-X360-Bio first estimates liver boundary motion by a patient-specific surface imaging model (Surf), utilizing the correlation between the external body surface motion and the internal liver boundary motion. As the correlation can be imperfect, the residual motion estimation errors were corrected by a patient-specific, angle-agnostic x-ray imaging model (X360). X360 deformed the liver boundary to match motion-related imaging features encoded in an arbitrarily-angled x-ray projection, using the Surf output for initialization. X360 adopted a geometry-aware learning module to extract and adapt to angle-varying features of arbitrarily-angled x-ray images, by calculating the projection system matrix of each x-ray image on-the-fly during model training and inference. After the liver boundary motion estimation by Surf and X360, intra-liver deformation was solved by a biomechanical model (Bio) to propagate the liver boundary motion inside to localize the tumors. The DL-based Bio model used domain knowledge of tissue biomechanics and finite element analysis (FEA) to solve intra-liver motion, with a much faster speed than conventional FEA methods to meet the real-time constraint. Surf-X360-Bio was evaluated using a dataset of 34 liver patients. Liver tumor localization accuracy was evaluated by the Dice similarity coefficient (DSC), the 95-percentile Hausdorff distance (HD95), and the center-of-mass error (COME). RESULTS Using 3,306 motion scenarios spanning the 360 degree x-ray scan angles for each testing patient, Surf-X360-Bio localized the liver tumors to 0.81 (mean) ± 0.16 (s.d.) in DSC, 2.5 ± 1.7 mm in HD95, and 2.1 ± 1.8 mm in COME. In comparison, the prior reference image without deformable registration-driven localization yielded 0.42 ± 0.29 in DSC, 8.1 ± 5.2 mm in HD95, and 8.5 ± 5.2 mm in COME. Via Surf-X360-Bio, the overall inference time was below 230 ms for each case. CONCLUSION Combining optical surface imaging and x-ray imaging, Surf-X360-Bio achieved fast (<250 ms inference time), accurate (mean error < 2.1 mm), and robust liver tumor localizations at arbitrary x-ray scan angles for real-time, marker-less 3D deformable motion tracking.
Collapse
Affiliation(s)
- H C Shao
- UT Southwestern Medical Center, Dallas, TX
| | - Y Li
- UT Southwestern Medical Center, Dallas, TX
| | - J Wang
- UT Southwestern Medical Center, Dallas, TX
| | - S B Jiang
- Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX
| | - Y Zhang
- University of Texas Southwestern Department of Radiation Oncology, Dallas, TX
| |
Collapse
|
186
|
Li Y, Liu J, Wang GZ, Yu W, Cai X, Li H, Cheng Y, Song XY, Fu XL. Exploration of Multiomic Profiles and Biomarkers as Predictors of Neoadjuvant Chemoradiotherapy Responsiveness in Esophageal Squamous Cell Carcinoma. Int J Radiat Oncol Biol Phys 2023; 117:e315. [PMID: 37785133 DOI: 10.1016/j.ijrobp.2023.06.2347] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/04/2023]
Abstract
PURPOSE/OBJECTIVE(S) The current gold standard of care for resectable locally advanced esophageal cancer is neoadjuvant chemoradiotherapy (NCRT) followed by surgery. Given that only 30-40% of patients with esophageal squamous cell carcinoma (ESCC) achieved a pathologic complete response (pCR) following neoadjuvant chemoradiotherapy, it is critical to understand the biological basis of NCRT resistance in esophageal cancer and identify biomarkers for these patients in order to further personalize treatment plans. We aim to depict the biological landscape of ESCC responsiveness and resistance to neoadjuvant chemoradiotherapy. MATERIALS/METHODS Endoscopic biopsied specimens of the primary tumors and paired peripheral blood samples were obtained from 24 patients before neoadjuvant chemoradiotherapy and tested for whole exosome sequencing, RNA sequencing, and DIA mass spectrometry. Genomic data were analyzed for significantly mutated genes, copy number alterations, MSI, TMB, and mutational signatures. Transcriptomics and proteomics data were used to examine differentially activated pathways. GSEA and ActivePathways were used for the single omics level and joint multi-omics analysis, respectively. Tumor microenvironment (TME) characteristics were deconvoluted by xCell upon RNA-seq data. Treatment resistance biomarkers were identified and validated in a separate cohort using mIHC. RESULTS In the study cohort, 54% (13/24) of the patients achieved pCR. WES data suggested that FBXW7 was more frequently mutated in the pCR group (fisher test p-value = 0.029), and the most significant cytoband loss in the pCR group was 9p21.3 (qval = 0.001). Differences in TMB, MSI, and mutational signatures were not significant between groups. Combined transcriptomics and proteomics analysis revealed that type I interferon signaling pathways and RIG-I-like receptor signaling pathways(p<0.05) were enriched in non-pCR tumors. Esophageal cancer cohort RNA-seq data from TCGA verified the correlation between the genetic variances (FBXW7 mutation and 9p21.3 loss) and the decreased expression of type I interferon signaling pathway genes. In TME analysis, tolerogenic dendritic cells and exhausted T cell signatures were significantly enriched in non-pCR tumors, indicating an immunosuppressive status in treatment resistant patients. Based on proteomics PPI network and differential expression genes from RNA-seq data, a biomarker panel consisted of 12 proteins predictive of non-pCR tumors was identified: STAT1, EIF2AK2, MX1, BST2, TRIM21, SAMHD1, IFI44L, GBP1, PARP14, ISG15, IFIT3, and HLA-B. The expression of selected genes was validated by mIHC in an independent cohort. CONCLUSION Through a multiomics approach, we described the biological characteristics of ESCC with distinct responses to neoadjuvant chemoradiotherapy and proposed a panel of 12 proteins as predictive biomarkers for non-pCR patients.
Collapse
Affiliation(s)
- Y Li
- Department of Radiation Oncology, Shanghai Chest Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China
| | - J Liu
- Department of Radiation Oncology, Shanghai Chest Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China
| | - G Z Wang
- CAS Key Laboratory of Computational Biology, Shanghai Institute of Nutrition and Health, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai, China
| | - W Yu
- Department of Radiation Oncology, Shanghai Chest Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China
| | - X Cai
- Department of Radiation Oncology, Shanghai Chest Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China
| | - H Li
- Department of Radiation Oncology, Shanghai Chest Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China
| | - Y Cheng
- Department of Radiation Oncology, Shanghai Chest Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China
| | - X Y Song
- Department of Radiation Oncology, Shanghai Chest Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China
| | - X L Fu
- Department of Radiation Oncology, Shanghai Chest Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China
| |
Collapse
|
187
|
Zhong S, Liu Y, Fang H, Tang P, Dai J, Shou J, Li Y. Ten-Year Outcomes of Hypofractionated (45 Gy in 9 Fractions) Intensity Modulated Radiotherapy for Localized Prostate Cancer. Int J Radiat Oncol Biol Phys 2023; 117:e455-e456. [PMID: 37785461 DOI: 10.1016/j.ijrobp.2023.06.1645] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/04/2023]
Abstract
PURPOSE/OBJECTIVE(S) We reported 10-year outcomes of localized prostate cancers treated with hypofractionated intensity-modulated radiotherapy of 45 Gy in 9 consecutive fractions. MATERIALS/METHODS From October 2011 to April 2017, thirty patients with localized prostate cancer were enrolled in this prospective trial. The median age of the patients was 72.5 years. According to NCCN recurrence risk criteria, eight patients were at low-risk group, 17 at intermediate risk group, 5 at high-risk group. All patients were treated with hypofractionated intensity-modulated radiotherapy (IMRT) of 45 Gy in 9 consecutive fractions to their prostate with or without seminal vesicles. Before radiotherapy, three gold fiducials were implanted into the prostate. In order to reduce the rectal high dose irradiation volume, an inflated rectal balloon was placed in the rectum at simulation and every treatment and patients were treated with comfortable full bladder. Static Intensity-modulated radiotherapy (SIMRT) was applied in 1 patient, Volumetric Modulated Arc Therapy (VMAT) in 27 patients, and tomotherapy in 2 patients. Image guided radiotherapy (IGRT) with gold fiducial registration was adopted. Twenty-six patients also received androgen deprivation therapy (ADT). The median time of ADT was 6 months. Progression⁃free survival (PFS) and overall survival (OS) were analyzed using Kaplan-Meier analysis. All grade ≥1 genitourinary (GU) and gastrointestinal (GI) toxicities were recorded using Common Terminology Criteria for Adverse Event version 5.0 (CTCAE 5.0) and Radiation Therapy Oncology Group (RTOG) late morbidity criteria, and GU and GI toxicities were cumulatively calculated. RESULTS After a median follow-up of 102 months (65∼131 months), the 10-year OS was 90.0% (95% confidence interval, 83.3%-96.7%), and the 10-year PFS was 86.5% (95% confidence interval, 79.1%-93.9%). According to CTCAE 5.0, grade 1 acute gastrointestinal (GI) toxicity developed in 12 patients, grade 2 in 2 patients, grade 3 in 2 patients, and grade 1 acute genitourinary (GU) toxicity developed in 12 patients, grade 2 in 2 patients, and no grade 3 or higher toxicity occurred. According to RTOG late morbidity criteria, late (≥3 months after radiotherapy) grade 1 GI toxicity developed in 4 patients (13.3%), grade 2 in 1 (3.3%), grade 3 in 1 (3.3%), and late grade 1 GU toxicity occurred in 1 patient (3.3%), grade 2 in 1 (3.3%), grade 3 in 1 (3.3%). No grade 4 or higher GI and GU toxicities developed. Only one grade 3 GI and one grade 2 GU toxicities were observed for the maximum toxicity at the last follow-up. The potency was not evaluated. CONCLUSION The 10-year oncologic outcomes of this shortened hypofractionated IMRT regimen for mainly low/intermediate risk prostate cancer patients is favorable with acceptable acute and late toxicities.
Collapse
Affiliation(s)
- S Zhong
- Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
| | - Y Liu
- Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
| | - H Fang
- Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
| | - P Tang
- Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
| | - J Dai
- Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
| | - J Shou
- Department of Urology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
| | - Y Li
- Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
| |
Collapse
|
188
|
Zhu Y, Zhou Y, Li Y. Value of Baseline Metabolic Tumor Volume for Survival Prognosis and Optimization of Risk-Adapted Treatment Therapy in Patients with Extranodal Nasal-Type Natural Killer/T-Cell Lymphoma. Int J Radiat Oncol Biol Phys 2023; 117:e500-e501. [PMID: 37785575 DOI: 10.1016/j.ijrobp.2023.06.1745] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/04/2023]
Abstract
PURPOSE/OBJECTIVE(S) To assess the association of baseline metabolic tumor volume (MTV) with overall survival (OS) and to explore its potential role in optimization of existing risk-adapted therapy in ENKTCL. MATERIALS/METHODS A total of 133 ENKTCL patients mainly treated by radiotherapy (RT) alone (33.8%) or RT combined with chemotherapy (combined-modality therapy [CMT]) (60.9%) were prospectively included. The impacts of MTV, SUVmax derived from 18F-FDG PET/CT image and clinical factors on OS were investigated. Survival analyses were conducted using Kaplan-Meier method with log-rank tests. Cox proportional hazards regression analysis was used to identify multivariate predictors of OS. Regression-based mediation analysis estimated the hazard ratio (HR) of death for direct effect (not through distant metastasis or locoregional recurrence) and indirect effect (through distant metastasis or locoregional recurrence) of the pathway MTV→distant metastasis→OS and pathway MTV→locoregional recurrence→OS. Inverse probability of treatment weighting (IPTW) analysis was employed to make covariate adjustments. RESULTS MTV and SUVmax were correlated with LDH, PTI, Ann Arbor stage, and NRI score. In univariable analysis, SUVmax, MTV, ECOG PS, PTI and Ann Arbor stage were statistically significantly prognostic factors for OS. Multivariate analysis showed that MTV was the only independent factor of short OS (HR 4.98, 95% CI (1.85 - 13.42), p = 0.002). Mediation analysis showed that distant metastasis played a complete mediating role in the increased death caused by higher MTV (HR of indirect effect 3.15, 95% CI (1.34 - 7.41), p = 0.009; HR of direct effect 2.88, 95% CI (0.80 - 10.32), p = 0.767), with proportion of mediation 76.7%, while locoregional recurrence was not a mediating factor (HR of indirect effect 1.16, 95% CI (0.90 - 1.48), p = 0.255; HR of direct effect 4.48, 95% CI (1.30 - 15.44), p = 0.017) . After adjusting the clinical factors by IPTW between RT alone group and CMT group in early intermediate and high risk ENKTCL, CMT had no PFS and OS benefits compared with RT alone in the low-MTV group (MTV < 49.6ml), while in the high-MTV group (MTV ≥ 49.6ml), the use of CMT compared with RT alone prolonged PFS and OS. CONCLUSION Baseline metabolic tumor volume is an independent prognostic factor for overall survival and distant metastasis rather than locoregional recurrence mediated increased risk of death in patients with MTV higher than 49.6ml. For early-stage intermediate and risk ENKTCL patients with MTV lower than 49.6ml, omission of chemotherapy may not result in loss of PFS and OS.
Collapse
Affiliation(s)
- Y Zhu
- Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC), Beijing, China
| | - Y Zhou
- Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC), Beijing, China
| | - Y Li
- Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
| |
Collapse
|
189
|
Wang X, Qi S, Liu X, Wu Y, Wang J, Luo F, Liu Y, Li Y. Radiotherapy Effect on Long-Term Net Survival Benefit for Early-Stage Diffuse Large B-Cell Lymphoma in the Rituximab Era. Int J Radiat Oncol Biol Phys 2023; 117:e492. [PMID: 37785553 DOI: 10.1016/j.ijrobp.2023.06.1724] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/04/2023]
Abstract
PURPOSE/OBJECTIVE(S) It is controversial whether to add consolidative radiotherapy (RT) after chemoimmunotherapy in the first-line treatment for diffuse large B-cell lymphoma (DLBCL). This study aimed to investigate the long-term net survival benefit of RT for early-stage DLBCL in the rituximab era. MATERIALS/METHODS The data of 10,841 adult patients with early-stage DLBCL from the Surveillance, Epidemiology, and End Results (SEER) database between 2002 and 2015 were extracted and analyzed. The patients had received combined modality treatment (CMT, chemotherapy plus RT) or chemotherapy alone. Linear regression analysis was performed for RT utilization by year of diagnosis. Competing risk analysis was used to evaluate the cumulative incidence of mortality according to the cause of death. Inverse probability of treatment weighting (IPTW) was used to balance the distribution of covariates between treatment arms. Relative survival (RS), standardized mortality ratio (SMR), and transformed Cox regression were performed to estimate the net survival benefit of RT by controlling for background mortality. RESULTS Linear regression revealed that the slope of the best-fit line for RT utilization over time was negative between 2002 and 2015 (m = -0.006, P = 0.003). A total of 4,648 deaths were recorded among 10,841 patients; 55.6% were lymphoma-related death (LRD), and 44.4% were attributed to other causes. Patients initially treated with CMT had a lower cumulative incidence of LRD than chemotherapy alone (HR 0.63, 95% CI: 0.57-0.69; P < 0.001). The 10-year overall survival (OS) rate of 66.1%, RS rate of 85.0%, and SMR of 1.71 achieved with CMT were significantly better than chemotherapy alone (OS, 53.0%; RS, 69.8%; SMR, 2.62; P < 0.001). By IPTW and multivariable analysis, the addition of RT remained associated with better OS (HR 0.67, 95% CI: 0.62-0.71; P < 0.001) and RS (HR 0.69, 95% CI: 0.65-0.74; P < 0.001). CONCLUSION RT was associated with better long-term net survival in patients with early-stage DLBCL in the rituximab era.
Collapse
Affiliation(s)
- X Wang
- Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
| | - S Qi
- Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
| | - X Liu
- Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
| | - Y Wu
- Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
| | - J Wang
- Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
| | - F Luo
- Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
| | - Y Liu
- Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
| | - Y Li
- Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
| |
Collapse
|
190
|
Zhou Z, Tong C, Tian L, Zhang X, Li Y, Xiao Y, Yan L. Retrospective study of preservation and transection of the round ligament of uterus during laparoscopic transabdominal preperitoneal inguinal hernia repair in adult women. Hernia 2023; 27:1195-1202. [PMID: 36949269 PMCID: PMC10533639 DOI: 10.1007/s10029-023-02765-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/12/2022] [Accepted: 03/01/2023] [Indexed: 03/24/2023]
Abstract
PURPOSE The processing of the round ligament of uterus in laparoscopic transabdominal preperitoneal (TAPP) repair of inguinal hernia in women has contended. This study aimed to explore whether there is any difference in the surgical outcome and postoperative complications between the two processing modalities, preservation, and transection of the round ligament of uterus, in adult female inguinal hernia patients undergoing TAPP. METHODS Retrospective analysis of 84 female patients (117 sides) who underwent TAPP in XXX Hospital from July 2013 to August 2022. Patient characteristics and technical details of the surgical procedure were collected and divided into two groups according to whether the round ligament of uterus was severed intraoperatively or not. There were 52 cases (77 sides) in the group with preservation of the round ligament of uterus and 32 cases (40 sides) in the group with transection of the round ligament of uterus, comparing the general condition, surgical condition, and the occurrence of postoperative related complications between the 2 groups. RESULTS The operative time for unilateral primary inguinal hernia was (129.2 ± 35.1) and (89.5 ± 42.6) minutes in the preservation and transection groups, respectively. There were no statistical differences between the two groups in terms of age, length of hospital stay, ASA, BMI, history of lower abdominal surgery, type and side of hernia, intraoperative bleeding, and time to surgery for primary bilateral hernia (P > 0.05). In addition, there was likewise no statistical difference in the occurrence of postoperative Clavien-Dindo classification, VAS, seroma, mesh infection, labia majora edema, chronic pain or abnormal sensation in the inguinal region, and hernia recurrence in the two groups as well (P > 0.05). CONCLUSION There is no evidence that the transection of the round ligament of the uterus during TAPP has an impact on postoperative complications in patients. However, given the important role of the uterine round ligament in the surgical management of patients with uterine prolapse and the high incidence of uterine prolapse in older women, hernia surgeons should also be aware of the need to protect the round ligament of uterus in older women.
Collapse
Affiliation(s)
- Z Zhou
- Department of General Surgery, Shaanxi Provincial People's Hospital, Xi'an, 710068, China
- Yan'an University, Yan'an, China
| | - C Tong
- Department of General Surgery, Shaanxi Provincial People's Hospital, Xi'an, 710068, China
| | - L Tian
- Department of General Surgery, Shaanxi Provincial People's Hospital, Xi'an, 710068, China
| | - X Zhang
- Department of General Surgery, Shaanxi Provincial People's Hospital, Xi'an, 710068, China
| | - Y Li
- Department of General Surgery, Shaanxi Provincial People's Hospital, Xi'an, 710068, China
| | - Y Xiao
- Department of General Surgery, Shaanxi Provincial People's Hospital, Xi'an, 710068, China
| | - L Yan
- Department of General Surgery, Shaanxi Provincial People's Hospital, Xi'an, 710068, China.
| |
Collapse
|
191
|
Li Y, Pavanram P, Bühring J, Rütten S, Schröder KU, Zhou J, Pufe T, Wang LN, Zadpoor AA, Jahr H. Physiomimetic biocompatibility evaluation of directly printed degradable porous iron implants using various cell types. Acta Biomater 2023; 169:589-604. [PMID: 37536493 DOI: 10.1016/j.actbio.2023.07.056] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/04/2023] [Revised: 07/04/2023] [Accepted: 07/27/2023] [Indexed: 08/05/2023]
Abstract
Additively manufactured (AM) degradable porous metallic biomaterials offer unique opportunities for satisfying the design requirements of an ideal bone substitute. Among the currently available biodegradable metals, iron has the highest elastic modulus, meaning that it would benefit the most from porous design. Given the successful preclinical applications of such biomaterials for the treatment of cardiovascular diseases, the moderate compatibility of AM porous iron with osteoblast-like cells, reported in earlier studies, has been surprising. This may be because, as opposed to static in vitro conditions, the biodegradation products of iron in vivo are transported away and excreted. To better mimic the in situ situations of biodegradable biomaterials after implantation, we compared the biodegradation behavior and cytocompatibility of AM porous iron under static conditions to the conditions with dynamic in situ-like fluid flow perfusion in a bioreactor. Furthermore, the compatibility of these scaffolds with four different cell types was evaluated to better understand the implications of these implants for the complex process of natural wound healing. These included endothelial cells, L929 fibroblasts, RAW264.7 macrophage-like cells, and osteoblastic MG-63 cells. The biodegradation rate of the scaffolds was significantly increased in the perfusion bioreactor as compared to static immersion. Under either condition, the compatibility with L929 cells was the best. Moreover, the compatibility with all the cell types was much enhanced under physiomimetic dynamic flow conditions as compared to static biodegradation. Our study highlights the importance of physiomimetic culture conditions and cell type selection when evaluating the cytocompatibility of degradable biomaterials in vitro. STATEMENT OF SIGNIFICANCE: Additively manufactured (AM) degradable porous metals offer unique opportunities for the treatment of large bony defects. Despite the successful preclinical applications of biodegradable iron in the cardiovascular field, the moderate compatibility of AM porous iron with osteoblast-like cells was reported. To better mimic the in vivo condition, we compared the biodegradation behavior and cytocompatibility of AM porous iron under static condition to dynamic perfusion. Furthermore, the compatibility of these scaffolds with various cell types was evaluated to better simulate the process of natural wound healing. Our study suggests that AM porous iron holds great promise for orthopedic applications, while also highlighting the importance of physio-mimetic culture conditions and cell type selection when evaluating the cytocompatibility of degradable biomaterials in vitro.
Collapse
Affiliation(s)
- Y Li
- Beijing Advanced Innovation Center for Materials Genome Engineering, School of Materials Science and Engineering, University of Science and Technology Beijing, Beijing, 100083, China; Department of Biomechanical Engineering, Delft University of Technology, Delft 2628CD, the Netherlands.
| | - P Pavanram
- Institute of Anatomy and Cell Biology, University Hospital RWTH Aachen, Aachen 52074, Germany
| | - J Bühring
- Institute of Structural Mechanics and Lightweight Design, RWTH Aachen University, 52062 Aachen, Germany
| | - S Rütten
- Institute of Pathology, Electron Microscopy Unit, University Hospital RWTH Aachen, Aachen 52074, Germany
| | - K-U Schröder
- Institute of Structural Mechanics and Lightweight Design, RWTH Aachen University, 52062 Aachen, Germany
| | - J Zhou
- Department of Biomechanical Engineering, Delft University of Technology, Delft 2628CD, the Netherlands
| | - T Pufe
- Institute of Anatomy and Cell Biology, University Hospital RWTH Aachen, Aachen 52074, Germany
| | - L-N Wang
- Beijing Advanced Innovation Center for Materials Genome Engineering, School of Materials Science and Engineering, University of Science and Technology Beijing, Beijing, 100083, China.
| | - A A Zadpoor
- Department of Biomechanical Engineering, Delft University of Technology, Delft 2628CD, the Netherlands
| | - H Jahr
- Institute of Anatomy and Cell Biology, University Hospital RWTH Aachen, Aachen 52074, Germany.; Institute of Structural Mechanics and Lightweight Design, RWTH Aachen University, 52062 Aachen, Germany.
| |
Collapse
|
192
|
Aaij R, Abdelmotteleb ASW, Abellan Beteta C, Abudinén F, Ackernley T, Adeva B, Adinolfi M, Adlarson P, Afsharnia H, Agapopoulou C, Aidala CA, Ajaltouni Z, Akar S, Akiba K, Albicocco P, Albrecht J, Alessio F, Alexander M, Alfonso Albero A, Aliouche Z, Alvarez Cartelle P, Amalric R, Amato S, Amey JL, Amhis Y, An L, Anderlini L, Andersson M, Andreianov A, Andreotti M, Andreou D, Ao D, Archilli F, Artamonov A, Artuso M, Aslanides E, Atzeni M, Audurier B, Bachiller Perea IB, Bachmann S, Bachmayer M, Back JJ, Bailly-Reyre A, Baladron Rodriguez P, Balagura V, Baldini W, Baptista de Souza Leite J, Barbetti M, Barlow RJ, Barsuk S, Barter W, Bartolini M, Baryshnikov F, Basels JM, Bassi G, Batsukh B, Battig A, Bay A, Beck A, Becker M, Bedeschi F, Bediaga IB, Beiter A, Belin S, Bellee V, Belous K, Belov I, Belyaev I, Benane G, Bencivenni G, Ben-Haim E, Berezhnoy A, Bernet R, Bernet Andres S, Berninghoff D, Bernstein HC, Bertella C, Bertolin A, Betancourt C, Betti F, Bezshyiko I, Bhom J, Bian L, Bieker MS, Biesuz NV, Billoir P, Biolchini A, Birch M, Bishop FCR, Bitadze A, Bizzeti A, Blago MP, Blake T, Blanc F, Blank JE, Blusk S, Bobulska D, Boelhauve JA, Boente Garcia O, Boettcher T, Boldyrev A, Bolognani CS, Bolzonella R, Bondar N, Borgato F, Borghi S, Borsato M, Borsuk JT, Bouchiba SA, Bowcock TJV, Boyer A, Bozzi C, Bradley MJ, Braun S, Brea Rodriguez A, Brodzicka J, Brossa Gonzalo A, Brown J, Brundu D, Buonaura A, Buonincontri L, Burke AT, Burr C, Bursche A, Butkevich A, Butter JS, Buytaert J, Byczynski W, Cadeddu S, Cai H, Calabrese R, Calefice L, Cali S, Calvi M, Calvo Gomez M, Campana P, Campora Perez DH, Campoverde Quezada AF, Capelli S, Capriotti L, Carbone A, Cardinale R, Cardini A, Carniti P, Carus L, Casais Vidal A, Caspary R, Casse G, Cattaneo M, Cavallero G, Cavallini V, Celani S, Cerasoli J, Cervenkov D, Chadwick AJ, Chahrour I, Chapman MG, Charles M, Charpentier P, Chavez Barajas CA, Chefdeville M, Chen C, Chen S, Chernov A, Chernyshenko S, Chobanova V, Cholak S, Chrzaszcz M, Chubykin A, Chulikov V, Ciambrone P, Cicala MF, Cid Vidal X, Ciezarek G, Cifra P, Ciullo G, Clarke PEL, Clemencic M, Cliff HV, Closier J, Cobbledick JL, Coco V, Cogan J, Cogneras E, Cojocariu L, Collins P, Colombo T, Congedo L, Contu A, Cooke N, Corredoira I, Corti G, Couturier B, Craik DC, Cruz Torres M, Currie R, Da Silva CL, Dadabaev S, Dai L, Dai X, Dall'Occo E, Dalseno J, D'Ambrosio C, Daniel J, Danilina A, d'Argent P, Davies JE, Davis A, De Aguiar Francisco O, de Boer J, De Bruyn K, De Capua S, De Cian M, De Freitas Carneiro Da Graca U, De Lucia E, De Miranda JM, De Paula L, De Serio M, De Simone D, De Simone P, De Vellis F, de Vries JA, Dean CT, Debernardis F, Decamp D, Dedu V, Del Buono L, Delaney B, Dembinski HP, Denysenko V, Deschamps O, Dettori F, Dey B, Di Nezza P, Diachkov I, Didenko S, Dieste Maronas L, Ding S, Dobishuk V, Dolmatov A, Dong C, Donohoe AM, Dordei F, Dos Reis AC, Douglas L, Downes AG, Duda P, Dudek MW, Dufour L, Duk V, Durante P, Duras MM, Durham JM, Dutta D, Dziurda A, Dzyuba A, Easo S, Egede U, Egorychev V, Eirea Orro C, Eisenhardt S, Ejopu E, Ek-In S, Eklund L, Elashri ME, Ellbracht J, Ely S, Ene A, Epple E, Escher S, Eschle J, Esen S, Evans T, Fabiano F, Falcao LN, Fan Y, Fang B, Fantini L, Faria M, Farry S, Fazzini D, Felkowski LF, Feo M, Fernandez Gomez M, Fernez AD, Ferrari F, Ferreira Lopes L, Ferreira Rodrigues F, Ferreres Sole S, Ferrillo M, Ferro-Luzzi M, Filippov S, Fini RA, Fiorini M, Firlej M, Fischer KM, Fitzgerald DS, Fitzpatrick C, Fiutowski T, Fleuret F, Fontana M, Fontanelli F, Forty R, Foulds-Holt D, Franco Lima V, Franco Sevilla M, Frank M, Franzoso E, Frau G, Frei C, Friday DA, Frontini L, Fu J, Fuehring Q, Fulghesu T, Gabriel E, Galati G, Galati MD, Gallas Torreira A, Galli D, Gambetta S, Gandelman M, Gandini P, Gao HG, Gao Y, Gao Y, Garau M, Garcia Martin LM, Garcia Moreno P, García Pardiñas J, Garcia Plana B, Garcia Rosales FA, Garrido L, Gaspar C, Geertsema RE, Gerick D, Gerken LL, Gersabeck E, Gersabeck M, Gershon T, Giambastiani L, Gibson V, Giemza HK, Gilman AL, Giovannetti M, Gioventù A, Gironella Gironell P, Giugliano C, Giza MA, Gizdov K, Gkougkousis EL, Gligorov VV, Göbel C, Golobardes E, Golubkov D, Golutvin A, Gomes A, Gomez Fernandez S, Goncalves Abrantes F, Goncerz M, Gong G, Gorelov IV, Gotti C, Grabowski JP, Grammatico T, Granado Cardoso LA, Graugés E, Graverini E, Graziani G, Grecu AT, Greeven LM, Grieser NA, Grillo L, Gromov S, Gruberg Cazon BR, Gu C, Guarise M, Guittiere M, Günther PA, Gushchin E, Guth A, Guz Y, Gys T, Hadavizadeh T, Hadjivasiliou C, Haefeli G, Haen C, Haimberger J, Haines SC, Halewood-Leagas T, Halvorsen MM, Hamilton PM, Hammerich J, Han Q, Han X, Hansmann-Menzemer S, Hao L, Harnew N, Harrison T, Hasse C, Hatch M, He J, Heijhoff K, Hemmer FH, Henderson C, Henderson RDL, Hennequin AM, Hennessy K, Henry L, Herd J, Heuel J, Hicheur A, Hill D, Hilton M, Hollitt SE, Horswill J, Hou R, Hou Y, Hu J, Hu J, Hu W, Hu X, Huang W, Huang X, Hulsbergen W, Hunter RJ, Hushchyn M, Hutchcroft D, Ibis P, Idzik M, Ilin D, Ilten P, Inglessi A, Iniukhin A, Ishteev A, Ivshin K, Jacobsson R, Jage H, Jaimes Elles SJ, Jakobsen S, Jans E, Jashal BK, Jawahery A, Jevtic V, Jiang E, Jiang X, Jiang Y, John M, Johnson D, Jones CR, Jones TP, Joshi SJ, Jost B, Jurik N, Juszczak I, Kandybei S, Kang Y, Karacson M, Karpenkov D, Karpov M, Kautz JW, Keizer F, Keller DM, Kenzie M, Ketel T, Khanji B, Kharisova A, Kholodenko S, Khreich G, Kirn T, Kirsebom VS, Kitouni O, Klaver S, Kleijne N, Klimaszewski K, Kmiec MR, Koliiev S, Kolk L, Kondybayeva A, Konoplyannikov A, Kopciewicz P, Kopecna R, Koppenburg P, Korolev M, Kostiuk I, Kot O, Kotriakhova S, Kozachuk A, Kravchenko P, Kravchuk L, Krawczyk RD, Kreps M, Kretzschmar S, Krokovny P, Krupa W, Krzemien W, Kubat J, Kubis S, Kucewicz W, Kucharczyk M, Kudryavtsev V, Kulikova EK, Kupsc A, Lacarrere D, Lafferty G, Lai A, Lampis A, Lancierini D, Landesa Gomez C, Lane JJ, Lane R, Langenbruch C, Langer J, Lantwin O, Latham T, Lazzari F, Lazzaroni M, Lazzeroni C, Le Gac R, Lee SH, Lefèvre R, Leflat A, Legotin S, Lenisa P, Leroy O, Lesiak T, Leverington B, Li A, Li H, Li K, Li P, Li PR, Li S, Li T, Li T, Li Y, Li Z, Liang X, Lin C, Lin T, Lindner R, Lisovskyi V, Litvinov R, Liu G, Liu H, Liu K, Liu Q, Liu S, Lobo Salvia A, Loi A, Lollini R, Lomba Castro J, Longstaff I, Lopes JH, Lopez Huertas A, López Soliño S, Lovell GH, Lu Y, Lucarelli C, Lucchesi D, Luchuk S, Lucio Martinez M, Lukashenko V, Luo Y, Lupato A, Luppi E, Lusiani A, Lynch K, Lyu XR, Ma R, Maccolini S, Machefert F, Maciuc F, Mackay I, Macko V, Madhan Mohan LR, Maevskiy A, Maisuzenko D, Majewski MW, Malczewski JJ, Malde S, Malecki B, Malinin A, Maltsev T, Manca G, Mancinelli G, Mancuso C, Manera Escalero R, Manuzzi D, Manzari CA, Marangotto D, Marchand JF, Marconi U, Mariani S, Marin Benito C, Marks J, Marshall AM, Marshall PJ, Martelli G, Martellotti G, Martinazzoli L, Martinelli M, Martinez Santos D, Martinez Vidal F, Massafferri A, Materok M, Matev R, Mathad A, Matiunin V, Matteuzzi C, Mattioli KR, Mauri A, Maurice E, Mauricio J, Mazurek M, McCann M, Mcconnell L, McGrath TH, McHugh NT, McNab A, McNulty R, Meadows B, Meier G, Melnychuk D, Meloni S, Merk M, Merli A, Meyer Garcia L, Miao D, Mikhasenko M, Milanes DA, Millard E, Milovanovic M, Minard MN, Minotti A, Miralles T, Mitchell SE, Mitreska B, Mitzel DS, Modak A, Mödden A, Mohammed RA, Moise RD, Mokhnenko S, Mombächer T, Monk M, Monroy IA, Monteil S, Morello G, Morello MJ, Morgenthaler MP, Moron J, Morris AB, Morris AG, Mountain R, Mu H, Muhammad E, Muheim F, Mulder M, Müller K, Murphy CH, Murray D, Murta R, Muzzetto P, Naik P, Nakada T, Nandakumar R, Nanut T, Nasteva I, Needham M, Neri N, Neubert S, Neufeld N, Neustroev P, Newcombe R, Nicolini J, Nicotra D, Niel EM, Nieswand S, Nikitin N, Nolte NS, Normand C, Novoa Fernandez J, Nowak GN, Nunez C, Oblakowska-Mucha A, Obraztsov V, Oeser T, Okamura S, Oldeman R, Oliva F, Onderwater CJG, O'Neil RH, Otalora Goicochea JM, Ovsiannikova T, Owen P, Oyanguren A, Ozcelik O, Padeken KO, Pagare B, Pais PR, Pajero T, Palano A, Palutan M, Panshin G, Paolucci L, Papanestis A, Pappagallo M, Pappalardo LL, Pappenheimer C, Parker W, Parkes C, Passalacqua B, Passaleva G, Pastore A, Patel M, Patrignani C, Pawley CJ, Pellegrino A, Pepe Altarelli M, Perazzini S, Pereima D, Pereiro Castro A, Perret P, Petridis K, Petrolini A, Petrucci S, Petruzzo M, Pham H, Philippov A, Piandani R, Pica L, Piccini M, Pietrzyk B, Pietrzyk G, Pili M, Pinci D, Pisani F, Pizzichemi M, Placinta V, Plews J, Plo Casasus M, Polci F, Poli Lener M, Poluektov A, Polukhina N, Polyakov I, Polycarpo E, Ponce S, Popov D, Poslavskii S, Prasanth K, Promberger L, Prouve C, Pugatch V, Puill V, Punzi G, Qi HR, Qian W, Qin N, Qu S, Quagliani R, Raab NV, Rachwal B, Rademacker JH, Rajagopalan R, Rama M, Ramos Pernas M, Rangel MS, Ratnikov F, Raven G, Rebollo De Miguel M, Redi F, Reich J, Reiss F, Remon Alepuz C, Ren Z, Resmi PK, Ribatti R, Ricci AM, Ricciardi S, Richardson K, Richardson-Slipper M, Rinnert K, Robbe P, Robertson G, Rodrigues E, Rodriguez Fernandez E, Rodriguez Lopez JA, Rodriguez Rodriguez E, Rolf DL, Rollings A, Roloff P, Romanovskiy V, Romero Lamas M, Romero Vidal A, Roth JD, Rotondo M, Rudolph MS, Ruf T, Ruiz Fernandez RA, Ruiz Vidal J, Ryzhikov A, Ryzka J, Saborido Silva JJ, Sagidova N, Sahoo N, Saitta B, Salomoni M, Sanchez Gras C, Sanderswood I, Santacesaria R, Santamarina Rios C, Santimaria M, Santovetti E, Saranin D, Sarpis G, Sarpis M, Sarti A, Satriano C, Satta A, Saur M, Savrina D, Sazak H, Scantlebury Smead LG, Scarabotto A, Schael S, Scherl S, Schiller M, Schindler H, Schmelling M, Schmidt B, Schmitt S, Schneider O, Schopper A, Schubiger M, Schulte S, Schune MH, Schwemmer R, Sciascia B, Sciuccati A, Sellam S, Semennikov A, Senghi Soares M, Sergi A, Serra N, Sestini L, Seuthe A, Shang Y, Shangase DM, Shapkin M, Shchemerov I, Shchutska L, Shears T, Shekhtman L, Shen Z, Sheng S, Shevchenko V, Shi B, Shields EB, Shimizu Y, Shmanin E, Shorkin R, Shupperd JD, Siddi BG, Silva Coutinho R, Simi G, Simone S, Singla M, Skidmore N, Skuza R, Skwarnicki T, Slater MW, Smallwood JC, Smeaton JG, Smith E, Smith K, Smith M, Snoch A, Soares Lavra L, Sokoloff MD, Soler FJP, Solomin A, Solovev A, Solovyev I, Song R, Souza De Almeida FL, Souza De Paula B, Spaan B, Spadaro Norella E, Spedicato E, Spiridenkov E, Spradlin P, Sriskaran V, Stagni F, Stahl M, Stahl S, Stanislaus S, Stein EN, Steinkamp O, Stenyakin O, Stevens H, Strekalina D, Su YS, Suljik F, Sun J, Sun L, Sun Y, Swallow PN, Swientek K, Szabelski A, Szumlak T, Szymanski M, Tan Y, Taneja S, Tat MD, Terentev A, Teubert F, Thomas E, Thompson DJD, Thomson KA, Tilquin H, Tisserand V, T'Jampens S, Tobin M, Tomassetti L, Tonani G, Tong X, Torres Machado D, Tou DY, Trippl C, Tuci G, Tuning N, Ukleja A, Unverzagt DJ, Usachov A, Ustyuzhanin A, Uwer U, Vagner A, Vagnoni V, Valassi A, Valenti G, Valls Canudas N, Van Dijk M, Van Hecke H, van Herwijnen E, Van Hulse CB, van Veghel M, Vazquez Gomez R, Vazquez Regueiro P, Vázquez Sierra C, Vecchi S, Velthuis JJ, Veltri M, Venkateswaran A, Veronesi M, Vesterinen M, Vieira D, Vieites Diaz M, Vilasis-Cardona X, Vilella Figueras E, Villa A, Vincent P, Volle FC, Vom Bruch D, Vorobyev A, Vorobyev V, Voropaev N, Vos K, Vrahas C, Walsh J, Walton EJ, Wan G, Wang C, Wang G, Wang J, Wang J, Wang J, Wang J, Wang M, Wang R, Wang X, Wang Y, Wang Z, Wang Z, Wang Z, Ward JA, Watson NK, Websdale D, Wei Y, Westhenry BDC, White DJ, Whitehead M, Wiederhold AR, Wiedner D, Wilkinson G, Wilkinson MK, Williams I, Williams M, Williams MRJ, Williams R, Wilson FF, Wislicki W, Witek M, Witola L, Wong CP, Wormser G, Wotton SA, Wu H, Wu J, Wyllie K, Xiang Z, Xie Y, Xu A, Xu J, Xu L, Xu L, Xu M, Xu Q, Xu Z, Xu Z, Yang D, Yang S, Yang X, Yang Y, Yang Z, Yang Z, Yeomans LE, Yeroshenko V, Yeung H, Yin H, Yu J, Yuan X, Zaffaroni E, Zavertyaev M, Zdybal M, Zeng M, Zhang C, Zhang D, Zhang L, Zhang S, Zhang S, Zhang Y, Zhang Y, Zhao Y, Zharkova A, Zhelezov A, Zheng Y, Zhou T, Zhou X, Zhou Y, Zhovkovska V, Zhu X, Zhu X, Zhu Z, Zhukov V, Zou Q, Zucchelli S, Zuliani D, Zunica G. Observation of New Ω_{c}^{0} States Decaying to the Ξ_{c}^{+}K^{-} Final State. Phys Rev Lett 2023; 131:131902. [PMID: 37831985 DOI: 10.1103/physrevlett.131.131902] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/10/2023] [Revised: 04/26/2023] [Accepted: 06/26/2023] [Indexed: 10/15/2023]
Abstract
Two new excited states, Ω_{c}(3185)^{0} and Ω_{c}(3327)^{0}, are observed in the Ξ_{c}^{+}K^{-} invariant-mass spectrum using proton-proton collision data collected by the LHCb experiment, corresponding to an integrated luminosity of 9 fb^{-1}. Five previously observed excited Ω_{c}^{0} states are confirmed, namely Ω_{c}(3000)^{0}, Ω_{c}(3050)^{0}, Ω_{c}(3065)^{0}, Ω_{c}(3090)^{0}, and Ω_{c}(3119)^{0}. The masses and widths of these seven states are measured with the highest precision to date.
Collapse
Affiliation(s)
- R Aaij
- Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands
| | | | | | - F Abudinén
- Department of Physics, University of Warwick, Coventry, United Kingdom
| | - T Ackernley
- Oliver Lodge Laboratory, University of Liverpool, Liverpool, United Kingdom
| | - B Adeva
- Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
| | - M Adinolfi
- H.H. Wills Physics Laboratory, University of Bristol, Bristol, United Kingdom
| | - P Adlarson
- Department of Physics and Astronomy, Uppsala University, Uppsala, Sweden (associated with School of Physics and Astronomy, University of Glasgow, Glasgow, United Kingdom)
| | - H Afsharnia
- Université Clermont Auvergne, CNRS/IN2P3, LPC, Clermont-Ferrand, France
| | - C Agapopoulou
- LPNHE, Sorbonne Université, Paris Diderot Sorbonne Paris Cité, CNRS/IN2P3, Paris, France
| | - C A Aidala
- University of Michigan, Ann Arbor, MI, United States (associated with Syracuse University, Syracuse, NY, United States)
| | - Z Ajaltouni
- Université Clermont Auvergne, CNRS/IN2P3, LPC, Clermont-Ferrand, France
| | - S Akar
- University of Cincinnati, Cincinnati, OH, United States
| | - K Akiba
- Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands
| | - P Albicocco
- INFN Laboratori Nazionali di Frascati, Frascati, Italy
| | - J Albrecht
- Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
| | - F Alessio
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - M Alexander
- School of Physics and Astronomy, University of Glasgow, Glasgow, United Kingdom
| | | | - Z Aliouche
- Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
| | - P Alvarez Cartelle
- Cavendish Laboratory, University of Cambridge, Cambridge, United Kingdom
| | - R Amalric
- LPNHE, Sorbonne Université, Paris Diderot Sorbonne Paris Cité, CNRS/IN2P3, Paris, France
| | - S Amato
- Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil
| | - J L Amey
- H.H. Wills Physics Laboratory, University of Bristol, Bristol, United Kingdom
| | - Y Amhis
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, Orsay, France
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - L An
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | | | - M Andersson
- Physik-Institut, Universität Zürich, Zürich, Switzerland
| | - A Andreianov
- Affiliated with an institute covered by a cooperation agreement with CERN
| | | | - D Andreou
- Syracuse University, Syracuse, NY, United States
| | - D Ao
- University of Chinese Academy of Sciences, Beijing, China
| | - F Archilli
- INFN Sezione di Roma Tor Vergata, Roma, Italy
| | - A Artamonov
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - M Artuso
- Syracuse University, Syracuse, NY, United States
| | - E Aslanides
- Aix Marseille Univ, CNRS/IN2P3, CPPM, Marseille, France
| | - M Atzeni
- Physik-Institut, Universität Zürich, Zürich, Switzerland
| | - B Audurier
- Laboratoire Leprince-Ringuet, CNRS/IN2P3, Ecole Polytechnique, Institut Polytechnique de Paris, Palaiseau, France
| | | | - S Bachmann
- Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
| | - M Bachmayer
- Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
| | - J J Back
- Department of Physics, University of Warwick, Coventry, United Kingdom
| | - A Bailly-Reyre
- LPNHE, Sorbonne Université, Paris Diderot Sorbonne Paris Cité, CNRS/IN2P3, Paris, France
| | - P Baladron Rodriguez
- Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
| | - V Balagura
- Laboratoire Leprince-Ringuet, CNRS/IN2P3, Ecole Polytechnique, Institut Polytechnique de Paris, Palaiseau, France
| | - W Baldini
- INFN Sezione di Ferrara, Ferrara, Italy
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | | | | | - R J Barlow
- Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
| | - S Barsuk
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, Orsay, France
| | - W Barter
- School of Physics and Astronomy, University of Edinburgh, Edinburgh, United Kingdom
| | - M Bartolini
- Cavendish Laboratory, University of Cambridge, Cambridge, United Kingdom
| | - F Baryshnikov
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - J M Basels
- I. Physikalisches Institut, RWTH Aachen University, Aachen, Germany
| | - G Bassi
- INFN Sezione di Pisa, Pisa, Italy
| | - B Batsukh
- Institute Of High Energy Physics (IHEP), Beijing, China
| | - A Battig
- Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
| | - A Bay
- Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
| | - A Beck
- Department of Physics, University of Warwick, Coventry, United Kingdom
| | - M Becker
- Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
| | | | - I B Bediaga
- Centro Brasileiro de Pesquisas Físicas (CBPF), Rio de Janeiro, Brazil
| | - A Beiter
- Syracuse University, Syracuse, NY, United States
| | - S Belin
- Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
| | - V Bellee
- Physik-Institut, Universität Zürich, Zürich, Switzerland
| | - K Belous
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - I Belov
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - I Belyaev
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - G Benane
- Aix Marseille Univ, CNRS/IN2P3, CPPM, Marseille, France
| | - G Bencivenni
- INFN Laboratori Nazionali di Frascati, Frascati, Italy
| | - E Ben-Haim
- LPNHE, Sorbonne Université, Paris Diderot Sorbonne Paris Cité, CNRS/IN2P3, Paris, France
| | - A Berezhnoy
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - R Bernet
- Physik-Institut, Universität Zürich, Zürich, Switzerland
| | - S Bernet Andres
- DS4DS, La Salle, Universitat Ramon Llull, Barcelona, Spain (associated with ICCUB, Universitat de Barcelona, Barcelona, Spain)
| | - D Berninghoff
- Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
| | | | - C Bertella
- Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
| | - A Bertolin
- Università degli Studi di Padova, Università e INFN, Padova, Padova, Italy
| | - C Betancourt
- Physik-Institut, Universität Zürich, Zürich, Switzerland
| | - F Betti
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - Ia Bezshyiko
- Physik-Institut, Universität Zürich, Zürich, Switzerland
| | - J Bhom
- Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland
| | - L Bian
- School of Physics and Technology, Wuhan University, Wuhan, China (associated with Center for High Energy Physics, Tsinghua University, Beijing, China)
| | - M S Bieker
- Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
| | | | - P Billoir
- LPNHE, Sorbonne Université, Paris Diderot Sorbonne Paris Cité, CNRS/IN2P3, Paris, France
| | - A Biolchini
- Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands
| | - M Birch
- Imperial College London, London, United Kingdom
| | - F C R Bishop
- Cavendish Laboratory, University of Cambridge, Cambridge, United Kingdom
| | - A Bitadze
- Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
| | - A Bizzeti
- Centro Brasileiro de Pesquisas Físicas (CBPF), Rio de Janeiro, Brazil
- Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil
- Center for High Energy Physics, Tsinghua University, Beijing, China
- Institute Of High Energy Physics (IHEP), Beijing, China
- School of Physics State Key Laboratory of Nuclear Physics and Technology, Peking University, Beijing, China
- University of Chinese Academy of Sciences, Beijing, China
- Institute of Particle Physics, Central China Normal University, Wuhan, Hubei, China
- Université Savoie Mont Blanc, CNRS, IN2P3-LAPP, Annecy, France
- Université Clermont Auvergne, CNRS/IN2P3, LPC, Clermont-Ferrand, France
- Aix Marseille Univ, CNRS/IN2P3, CPPM, Marseille, France
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, Orsay, France
- Laboratoire Leprince-Ringuet, CNRS/IN2P3, Ecole Polytechnique, Institut Polytechnique de Paris, Palaiseau, France
- LPNHE, Sorbonne Université, Paris Diderot Sorbonne Paris Cité, CNRS/IN2P3, Paris, France
- I. Physikalisches Institut, RWTH Aachen University, Aachen, Germany
- Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
- Max-Planck-Institut für Kernphysik (MPIK), Heidelberg, Germany
- Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
- School of Physics, University College Dublin, Dublin, Ireland
- INFN Sezione di Bari, Bari, Italy
- INFN Sezione di Bologna, Bologna, Italy
- INFN Sezione di Ferrara, Ferrara, Italy
- INFN Sezione di Firenze, Firenze, Italy
- INFN Laboratori Nazionali di Frascati, Frascati, Italy
- INFN Sezione di Genova, Genova, Italy
- INFN Sezione di Milano, Milano, Italy
- INFN Sezione di Milano-Bicocca, Milano, Italy
- INFN Sezione di Cagliari, Monserrato, Italy
- Università degli Studi di Padova, Università e INFN, Padova, Padova, Italy
- INFN Sezione di Pisa, Pisa, Italy
- INFN Sezione di Roma La Sapienza, Roma, Italy
- INFN Sezione di Roma Tor Vergata, Roma, Italy
- Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands
- Nikhef National Institute for Subatomic Physics and VU University Amsterdam, Amsterdam, Netherlands
- AGH - University of Science and Technology, Faculty of Physics and Applied Computer Science, Kraków, Poland
- Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland
- National Center for Nuclear Research (NCBJ), Warsaw, Poland
- Horia Hulubei National Institute of Physics and Nuclear Engineering, Bucharest-Magurele, Romania
- Affiliated with an institute covered by a cooperation agreement with CERN
- ICCUB, Universitat de Barcelona, Barcelona, Spain
- Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
- Instituto de Fisica Corpuscular, Centro Mixto Universidad de Valencia - CSIC, Valencia, Spain
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
- Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
- Physik-Institut, Universität Zürich, Zürich, Switzerland
- NSC Kharkiv Institute of Physics and Technology (NSC KIPT), Kharkiv, Ukraine
- Institute for Nuclear Research of the National Academy of Sciences (KINR), Kyiv, Ukraine
- University of Birmingham, Birmingham, United Kingdom
- H.H. Wills Physics Laboratory, University of Bristol, Bristol, United Kingdom
- Cavendish Laboratory, University of Cambridge, Cambridge, United Kingdom
- Department of Physics, University of Warwick, Coventry, United Kingdom
- STFC Rutherford Appleton Laboratory, Didcot, United Kingdom
- School of Physics and Astronomy, University of Edinburgh, Edinburgh, United Kingdom
- School of Physics and Astronomy, University of Glasgow, Glasgow, United Kingdom
- Oliver Lodge Laboratory, University of Liverpool, Liverpool, United Kingdom
- Imperial College London, London, United Kingdom
- Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
- Department of Physics, University of Oxford, Oxford, United Kingdom
- Massachusetts Institute of Technology, Cambridge, MA, United States
- University of Cincinnati, Cincinnati, OH, United States
- University of Maryland, College Park, MD, United States
- Los Alamos National Laboratory (LANL), Los Alamos, NM, United States
- Syracuse University, Syracuse, NY, United States
- School of Physics and Astronomy, Monash University, Melbourne, Australia (associated with Department of Physics, University of Warwick, Coventry, United Kingdom)
- Pontifícia Universidade Católica do Rio de Janeiro (PUC-Rio), Rio de Janeiro, Brazil (associated with Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil)
- Physics and Micro Electronic College, Hunan University, Changsha City, China (associated with Institute of Particle Physics, Central China Normal University, Wuhan, Hubei, China)
- Guangdong Provincial Key Laboratory of Nuclear Science, Guangdong-Hong Kong Joint Laboratory of Quantum Matter, Institute of Quantum Matter, South China Normal University, Guangzhou, China (associated with Center for High Energy Physics, Tsinghua University, Beijing, China)
- Lanzhou University, Lanzhou, China (associated with Institute Of High Energy Physics (IHEP), Beijing, China)
- School of Physics and Technology, Wuhan University, Wuhan, China (associated with Center for High Energy Physics, Tsinghua University, Beijing, China)
- Departamento de Fisica, Universidad Nacional de Colombia, Bogota, Colombia (associated with LPNHE, Sorbonne Université, Paris Diderot Sorbonne Paris Cité, CNRS/IN2P3, Paris, France)
- Universität Bonn - Helmholtz-Institut für Strahlen und Kernphysik, Bonn, Germany (associated with Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany)
- Eotvos Lorand University, Budapest, Hungary (associated with European Organization for Nuclear Research (CERN), Geneva, Switzerland)
- INFN Sezione di Perugia, Perugia, Italy (associated with INFN Sezione di Ferrara, Ferrara, Italy)
- Van Swinderen Institute, University of Groningen, Groningen, Netherlands (associated with Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands)
- Universiteit Maastricht, Maastricht, Netherlands (associated with Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands)
- Tadeusz Kosciuszko Cracow University of Technology, Cracow, Poland (associated with Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland)
- DS4DS, La Salle, Universitat Ramon Llull, Barcelona, Spain (associated with ICCUB, Universitat de Barcelona, Barcelona, Spain)
- Department of Physics and Astronomy, Uppsala University, Uppsala, Sweden (associated with School of Physics and Astronomy, University of Glasgow, Glasgow, United Kingdom)
- University of Michigan, Ann Arbor, MI, United States (associated with Syracuse University, Syracuse, NY, United States)
| | - M P Blago
- Cavendish Laboratory, University of Cambridge, Cambridge, United Kingdom
| | - T Blake
- Department of Physics, University of Warwick, Coventry, United Kingdom
| | - F Blanc
- Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
| | - J E Blank
- Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
| | - S Blusk
- Syracuse University, Syracuse, NY, United States
| | - D Bobulska
- School of Physics and Astronomy, University of Glasgow, Glasgow, United Kingdom
| | - J A Boelhauve
- Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
| | - O Boente Garcia
- Laboratoire Leprince-Ringuet, CNRS/IN2P3, Ecole Polytechnique, Institut Polytechnique de Paris, Palaiseau, France
| | - T Boettcher
- University of Cincinnati, Cincinnati, OH, United States
| | - A Boldyrev
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - C S Bolognani
- Universiteit Maastricht, Maastricht, Netherlands (associated with Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands)
| | | | - N Bondar
- Affiliated with an institute covered by a cooperation agreement with CERN
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - F Borgato
- Università degli Studi di Padova, Università e INFN, Padova, Padova, Italy
| | - S Borghi
- Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
| | - M Borsato
- Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
| | - J T Borsuk
- Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland
| | - S A Bouchiba
- Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
| | - T J V Bowcock
- Oliver Lodge Laboratory, University of Liverpool, Liverpool, United Kingdom
| | - A Boyer
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - C Bozzi
- INFN Sezione di Ferrara, Ferrara, Italy
| | - M J Bradley
- Imperial College London, London, United Kingdom
| | - S Braun
- University of Maryland, College Park, MD, United States
| | - A Brea Rodriguez
- Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
| | - J Brodzicka
- Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland
| | - A Brossa Gonzalo
- Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
| | - J Brown
- Oliver Lodge Laboratory, University of Liverpool, Liverpool, United Kingdom
| | - D Brundu
- INFN Sezione di Cagliari, Monserrato, Italy
| | - A Buonaura
- Physik-Institut, Universität Zürich, Zürich, Switzerland
| | - L Buonincontri
- Università degli Studi di Padova, Università e INFN, Padova, Padova, Italy
| | - A T Burke
- Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
| | - C Burr
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - A Bursche
- Guangdong Provincial Key Laboratory of Nuclear Science, Guangdong-Hong Kong Joint Laboratory of Quantum Matter, Institute of Quantum Matter, South China Normal University, Guangzhou, China (associated with Center for High Energy Physics, Tsinghua University, Beijing, China)
| | - A Butkevich
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - J S Butter
- Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands
| | - J Buytaert
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - W Byczynski
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - S Cadeddu
- INFN Sezione di Cagliari, Monserrato, Italy
| | - H Cai
- School of Physics and Technology, Wuhan University, Wuhan, China (associated with Center for High Energy Physics, Tsinghua University, Beijing, China)
| | | | - L Calefice
- Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
| | - S Cali
- INFN Laboratori Nazionali di Frascati, Frascati, Italy
| | - M Calvi
- INFN Sezione di Milano-Bicocca, Milano, Italy
| | - M Calvo Gomez
- DS4DS, La Salle, Universitat Ramon Llull, Barcelona, Spain (associated with ICCUB, Universitat de Barcelona, Barcelona, Spain)
| | - P Campana
- INFN Laboratori Nazionali di Frascati, Frascati, Italy
| | - D H Campora Perez
- Universiteit Maastricht, Maastricht, Netherlands (associated with Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands)
| | | | - S Capelli
- INFN Sezione di Milano-Bicocca, Milano, Italy
| | | | - A Carbone
- INFN Sezione di Bologna, Bologna, Italy
| | | | - A Cardini
- INFN Sezione di Cagliari, Monserrato, Italy
| | - P Carniti
- INFN Sezione di Milano-Bicocca, Milano, Italy
| | - L Carus
- I. Physikalisches Institut, RWTH Aachen University, Aachen, Germany
| | - A Casais Vidal
- Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
| | - R Caspary
- Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
| | - G Casse
- Oliver Lodge Laboratory, University of Liverpool, Liverpool, United Kingdom
| | - M Cattaneo
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - G Cavallero
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
- Imperial College London, London, United Kingdom
| | | | - S Celani
- Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
| | - J Cerasoli
- Aix Marseille Univ, CNRS/IN2P3, CPPM, Marseille, France
| | - D Cervenkov
- Department of Physics, University of Oxford, Oxford, United Kingdom
| | - A J Chadwick
- Oliver Lodge Laboratory, University of Liverpool, Liverpool, United Kingdom
| | - I Chahrour
- University of Michigan, Ann Arbor, MI, United States (associated with Syracuse University, Syracuse, NY, United States)
| | - M G Chapman
- H.H. Wills Physics Laboratory, University of Bristol, Bristol, United Kingdom
| | - M Charles
- LPNHE, Sorbonne Université, Paris Diderot Sorbonne Paris Cité, CNRS/IN2P3, Paris, France
| | - Ph Charpentier
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - C A Chavez Barajas
- Oliver Lodge Laboratory, University of Liverpool, Liverpool, United Kingdom
| | - M Chefdeville
- Université Savoie Mont Blanc, CNRS, IN2P3-LAPP, Annecy, France
| | - C Chen
- Aix Marseille Univ, CNRS/IN2P3, CPPM, Marseille, France
| | - S Chen
- Institute Of High Energy Physics (IHEP), Beijing, China
| | - A Chernov
- Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland
| | - S Chernyshenko
- Institute for Nuclear Research of the National Academy of Sciences (KINR), Kyiv, Ukraine
| | - V Chobanova
- Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
| | - S Cholak
- Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
| | - M Chrzaszcz
- Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland
| | - A Chubykin
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - V Chulikov
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - P Ciambrone
- INFN Laboratori Nazionali di Frascati, Frascati, Italy
| | - M F Cicala
- Department of Physics, University of Warwick, Coventry, United Kingdom
| | - X Cid Vidal
- Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
| | - G Ciezarek
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - P Cifra
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - G Ciullo
- INFN Sezione di Ferrara, Ferrara, Italy
| | - P E L Clarke
- School of Physics and Astronomy, University of Edinburgh, Edinburgh, United Kingdom
| | - M Clemencic
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - H V Cliff
- Cavendish Laboratory, University of Cambridge, Cambridge, United Kingdom
| | - J Closier
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - J L Cobbledick
- Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
| | - V Coco
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - J Cogan
- Aix Marseille Univ, CNRS/IN2P3, CPPM, Marseille, France
| | - E Cogneras
- Université Clermont Auvergne, CNRS/IN2P3, LPC, Clermont-Ferrand, France
| | - L Cojocariu
- Horia Hulubei National Institute of Physics and Nuclear Engineering, Bucharest-Magurele, Romania
| | - P Collins
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - T Colombo
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | | | - A Contu
- INFN Sezione di Cagliari, Monserrato, Italy
| | - N Cooke
- University of Birmingham, Birmingham, United Kingdom
| | - I Corredoira
- Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
| | - G Corti
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - B Couturier
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - D C Craik
- Physik-Institut, Universität Zürich, Zürich, Switzerland
| | - M Cruz Torres
- Centro Brasileiro de Pesquisas Físicas (CBPF), Rio de Janeiro, Brazil
| | - R Currie
- School of Physics and Astronomy, University of Edinburgh, Edinburgh, United Kingdom
| | - C L Da Silva
- Los Alamos National Laboratory (LANL), Los Alamos, NM, United States
| | - S Dadabaev
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - L Dai
- Physics and Micro Electronic College, Hunan University, Changsha City, China (associated with Institute of Particle Physics, Central China Normal University, Wuhan, Hubei, China)
| | - X Dai
- School of Physics State Key Laboratory of Nuclear Physics and Technology, Peking University, Beijing, China
| | - E Dall'Occo
- Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
| | - J Dalseno
- Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
| | - C D'Ambrosio
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - J Daniel
- Université Clermont Auvergne, CNRS/IN2P3, LPC, Clermont-Ferrand, France
| | - A Danilina
- Affiliated with an institute covered by a cooperation agreement with CERN
| | | | - J E Davies
- Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
| | - A Davis
- Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
| | - O De Aguiar Francisco
- Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
| | - J de Boer
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - K De Bruyn
- Van Swinderen Institute, University of Groningen, Groningen, Netherlands (associated with Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands)
| | - S De Capua
- Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
| | - M De Cian
- Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
| | | | - E De Lucia
- INFN Laboratori Nazionali di Frascati, Frascati, Italy
| | - J M De Miranda
- Centro Brasileiro de Pesquisas Físicas (CBPF), Rio de Janeiro, Brazil
| | - L De Paula
- Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil
| | | | - D De Simone
- Physik-Institut, Universität Zürich, Zürich, Switzerland
| | - P De Simone
- INFN Laboratori Nazionali di Frascati, Frascati, Italy
| | - F De Vellis
- Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
| | - J A de Vries
- Universiteit Maastricht, Maastricht, Netherlands (associated with Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands)
| | - C T Dean
- Los Alamos National Laboratory (LANL), Los Alamos, NM, United States
| | | | - D Decamp
- Université Savoie Mont Blanc, CNRS, IN2P3-LAPP, Annecy, France
| | - V Dedu
- Aix Marseille Univ, CNRS/IN2P3, CPPM, Marseille, France
| | - L Del Buono
- LPNHE, Sorbonne Université, Paris Diderot Sorbonne Paris Cité, CNRS/IN2P3, Paris, France
| | - B Delaney
- Massachusetts Institute of Technology, Cambridge, MA, United States
| | - H-P Dembinski
- Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
| | - V Denysenko
- Physik-Institut, Universität Zürich, Zürich, Switzerland
| | - O Deschamps
- Université Clermont Auvergne, CNRS/IN2P3, LPC, Clermont-Ferrand, France
| | - F Dettori
- INFN Sezione di Cagliari, Monserrato, Italy
| | - B Dey
- Eotvos Lorand University, Budapest, Hungary (associated with European Organization for Nuclear Research (CERN), Geneva, Switzerland)
| | - P Di Nezza
- INFN Laboratori Nazionali di Frascati, Frascati, Italy
| | - I Diachkov
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - S Didenko
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - L Dieste Maronas
- Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
| | - S Ding
- Syracuse University, Syracuse, NY, United States
| | - V Dobishuk
- Institute for Nuclear Research of the National Academy of Sciences (KINR), Kyiv, Ukraine
| | - A Dolmatov
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - C Dong
- Center for High Energy Physics, Tsinghua University, Beijing, China
| | - A M Donohoe
- School of Physics, University College Dublin, Dublin, Ireland
| | - F Dordei
- INFN Sezione di Cagliari, Monserrato, Italy
| | - A C Dos Reis
- Centro Brasileiro de Pesquisas Físicas (CBPF), Rio de Janeiro, Brazil
| | - L Douglas
- School of Physics and Astronomy, University of Glasgow, Glasgow, United Kingdom
| | - A G Downes
- Université Savoie Mont Blanc, CNRS, IN2P3-LAPP, Annecy, France
| | - P Duda
- Tadeusz Kosciuszko Cracow University of Technology, Cracow, Poland (associated with Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland)
| | - M W Dudek
- Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland
| | - L Dufour
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - V Duk
- INFN Sezione di Perugia, Perugia, Italy (associated with INFN Sezione di Ferrara, Ferrara, Italy)
| | - P Durante
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - M M Duras
- Tadeusz Kosciuszko Cracow University of Technology, Cracow, Poland (associated with Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland)
| | - J M Durham
- Los Alamos National Laboratory (LANL), Los Alamos, NM, United States
| | - D Dutta
- Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
| | - A Dziurda
- Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland
| | - A Dzyuba
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - S Easo
- STFC Rutherford Appleton Laboratory, Didcot, United Kingdom
| | - U Egede
- School of Physics and Astronomy, Monash University, Melbourne, Australia (associated with Department of Physics, University of Warwick, Coventry, United Kingdom)
| | - V Egorychev
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - C Eirea Orro
- Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
| | - S Eisenhardt
- School of Physics and Astronomy, University of Edinburgh, Edinburgh, United Kingdom
| | - E Ejopu
- Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
| | - S Ek-In
- Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
| | - L Eklund
- Department of Physics and Astronomy, Uppsala University, Uppsala, Sweden (associated with School of Physics and Astronomy, University of Glasgow, Glasgow, United Kingdom)
| | - M E Elashri
- University of Cincinnati, Cincinnati, OH, United States
| | - J Ellbracht
- Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
| | - S Ely
- Imperial College London, London, United Kingdom
| | - A Ene
- Horia Hulubei National Institute of Physics and Nuclear Engineering, Bucharest-Magurele, Romania
| | - E Epple
- University of Cincinnati, Cincinnati, OH, United States
| | - S Escher
- I. Physikalisches Institut, RWTH Aachen University, Aachen, Germany
| | - J Eschle
- Physik-Institut, Universität Zürich, Zürich, Switzerland
| | - S Esen
- Physik-Institut, Universität Zürich, Zürich, Switzerland
| | - T Evans
- Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
| | - F Fabiano
- INFN Sezione di Cagliari, Monserrato, Italy
| | - L N Falcao
- Centro Brasileiro de Pesquisas Físicas (CBPF), Rio de Janeiro, Brazil
| | - Y Fan
- University of Chinese Academy of Sciences, Beijing, China
| | - B Fang
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, Orsay, France
- School of Physics and Technology, Wuhan University, Wuhan, China (associated with Center for High Energy Physics, Tsinghua University, Beijing, China)
| | - L Fantini
- INFN Sezione di Perugia, Perugia, Italy (associated with INFN Sezione di Ferrara, Ferrara, Italy)
| | - M Faria
- Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
| | - S Farry
- Oliver Lodge Laboratory, University of Liverpool, Liverpool, United Kingdom
| | - D Fazzini
- INFN Sezione di Milano-Bicocca, Milano, Italy
| | - L F Felkowski
- Tadeusz Kosciuszko Cracow University of Technology, Cracow, Poland (associated with Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland)
| | - M Feo
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - M Fernandez Gomez
- Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
| | - A D Fernez
- University of Maryland, College Park, MD, United States
| | - F Ferrari
- INFN Sezione di Bologna, Bologna, Italy
| | - L Ferreira Lopes
- Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
| | | | - S Ferreres Sole
- Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands
| | - M Ferrillo
- Physik-Institut, Universität Zürich, Zürich, Switzerland
| | - M Ferro-Luzzi
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - S Filippov
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - R A Fini
- INFN Sezione di Bari, Bari, Italy
| | - M Fiorini
- INFN Sezione di Ferrara, Ferrara, Italy
| | - M Firlej
- AGH - University of Science and Technology, Faculty of Physics and Applied Computer Science, Kraków, Poland
| | - K M Fischer
- Department of Physics, University of Oxford, Oxford, United Kingdom
| | - D S Fitzgerald
- University of Michigan, Ann Arbor, MI, United States (associated with Syracuse University, Syracuse, NY, United States)
| | - C Fitzpatrick
- Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
| | - T Fiutowski
- AGH - University of Science and Technology, Faculty of Physics and Applied Computer Science, Kraków, Poland
| | - F Fleuret
- Laboratoire Leprince-Ringuet, CNRS/IN2P3, Ecole Polytechnique, Institut Polytechnique de Paris, Palaiseau, France
| | - M Fontana
- LPNHE, Sorbonne Université, Paris Diderot Sorbonne Paris Cité, CNRS/IN2P3, Paris, France
| | | | - R Forty
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - D Foulds-Holt
- Cavendish Laboratory, University of Cambridge, Cambridge, United Kingdom
| | - V Franco Lima
- Oliver Lodge Laboratory, University of Liverpool, Liverpool, United Kingdom
| | | | - M Frank
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | | | - G Frau
- Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
| | - C Frei
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - D A Friday
- Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
| | | | - J Fu
- University of Chinese Academy of Sciences, Beijing, China
| | - Q Fuehring
- Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
| | - T Fulghesu
- LPNHE, Sorbonne Université, Paris Diderot Sorbonne Paris Cité, CNRS/IN2P3, Paris, France
| | - E Gabriel
- Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands
| | - G Galati
- INFN Sezione di Bari, Bari, Italy
| | - M D Galati
- Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands
| | - A Gallas Torreira
- Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
| | - D Galli
- INFN Sezione di Bologna, Bologna, Italy
| | - S Gambetta
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
- School of Physics and Astronomy, University of Edinburgh, Edinburgh, United Kingdom
| | - M Gandelman
- Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil
| | - P Gandini
- INFN Sezione di Milano, Milano, Italy
| | - H G Gao
- University of Chinese Academy of Sciences, Beijing, China
| | - Y Gao
- Institute of Particle Physics, Central China Normal University, Wuhan, Hubei, China
| | - Y Gao
- School of Physics State Key Laboratory of Nuclear Physics and Technology, Peking University, Beijing, China
| | - M Garau
- INFN Sezione di Cagliari, Monserrato, Italy
| | - L M Garcia Martin
- Department of Physics, University of Warwick, Coventry, United Kingdom
| | | | - J García Pardiñas
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - B Garcia Plana
- Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
| | - F A Garcia Rosales
- Laboratoire Leprince-Ringuet, CNRS/IN2P3, Ecole Polytechnique, Institut Polytechnique de Paris, Palaiseau, France
| | - L Garrido
- ICCUB, Universitat de Barcelona, Barcelona, Spain
| | - C Gaspar
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - R E Geertsema
- Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands
| | - D Gerick
- Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
| | - L L Gerken
- Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
| | - E Gersabeck
- Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
| | - M Gersabeck
- Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
| | - T Gershon
- Department of Physics, University of Warwick, Coventry, United Kingdom
| | - L Giambastiani
- Università degli Studi di Padova, Università e INFN, Padova, Padova, Italy
| | - V Gibson
- Cavendish Laboratory, University of Cambridge, Cambridge, United Kingdom
| | - H K Giemza
- National Center for Nuclear Research (NCBJ), Warsaw, Poland
| | - A L Gilman
- Department of Physics, University of Oxford, Oxford, United Kingdom
| | - M Giovannetti
- INFN Laboratori Nazionali di Frascati, Frascati, Italy
| | - A Gioventù
- Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
| | | | | | - M A Giza
- Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland
| | - K Gizdov
- School of Physics and Astronomy, University of Edinburgh, Edinburgh, United Kingdom
| | - E L Gkougkousis
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - V V Gligorov
- LPNHE, Sorbonne Université, Paris Diderot Sorbonne Paris Cité, CNRS/IN2P3, Paris, France
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - C Göbel
- Pontifícia Universidade Católica do Rio de Janeiro (PUC-Rio), Rio de Janeiro, Brazil (associated with Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil)
| | - E Golobardes
- DS4DS, La Salle, Universitat Ramon Llull, Barcelona, Spain (associated with ICCUB, Universitat de Barcelona, Barcelona, Spain)
| | - D Golubkov
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - A Golutvin
- Affiliated with an institute covered by a cooperation agreement with CERN
- Imperial College London, London, United Kingdom
| | - A Gomes
- Centro Brasileiro de Pesquisas Físicas (CBPF), Rio de Janeiro, Brazil
- Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil
| | | | | | - M Goncerz
- Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland
| | - G Gong
- Center for High Energy Physics, Tsinghua University, Beijing, China
| | - I V Gorelov
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - C Gotti
- INFN Sezione di Milano-Bicocca, Milano, Italy
| | - J P Grabowski
- Universität Bonn - Helmholtz-Institut für Strahlen und Kernphysik, Bonn, Germany (associated with Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany)
| | - T Grammatico
- LPNHE, Sorbonne Université, Paris Diderot Sorbonne Paris Cité, CNRS/IN2P3, Paris, France
| | | | - E Graugés
- ICCUB, Universitat de Barcelona, Barcelona, Spain
| | - E Graverini
- Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
| | - G Graziani
- Centro Brasileiro de Pesquisas Físicas (CBPF), Rio de Janeiro, Brazil
- Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil
- Center for High Energy Physics, Tsinghua University, Beijing, China
- Institute Of High Energy Physics (IHEP), Beijing, China
- School of Physics State Key Laboratory of Nuclear Physics and Technology, Peking University, Beijing, China
- University of Chinese Academy of Sciences, Beijing, China
- Institute of Particle Physics, Central China Normal University, Wuhan, Hubei, China
- Université Savoie Mont Blanc, CNRS, IN2P3-LAPP, Annecy, France
- Université Clermont Auvergne, CNRS/IN2P3, LPC, Clermont-Ferrand, France
- Aix Marseille Univ, CNRS/IN2P3, CPPM, Marseille, France
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, Orsay, France
- Laboratoire Leprince-Ringuet, CNRS/IN2P3, Ecole Polytechnique, Institut Polytechnique de Paris, Palaiseau, France
- LPNHE, Sorbonne Université, Paris Diderot Sorbonne Paris Cité, CNRS/IN2P3, Paris, France
- I. Physikalisches Institut, RWTH Aachen University, Aachen, Germany
- Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
- Max-Planck-Institut für Kernphysik (MPIK), Heidelberg, Germany
- Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
- School of Physics, University College Dublin, Dublin, Ireland
- INFN Sezione di Bari, Bari, Italy
- INFN Sezione di Bologna, Bologna, Italy
- INFN Sezione di Ferrara, Ferrara, Italy
- INFN Sezione di Firenze, Firenze, Italy
- INFN Laboratori Nazionali di Frascati, Frascati, Italy
- INFN Sezione di Genova, Genova, Italy
- INFN Sezione di Milano, Milano, Italy
- INFN Sezione di Milano-Bicocca, Milano, Italy
- INFN Sezione di Cagliari, Monserrato, Italy
- Università degli Studi di Padova, Università e INFN, Padova, Padova, Italy
- INFN Sezione di Pisa, Pisa, Italy
- INFN Sezione di Roma La Sapienza, Roma, Italy
- INFN Sezione di Roma Tor Vergata, Roma, Italy
- Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands
- Nikhef National Institute for Subatomic Physics and VU University Amsterdam, Amsterdam, Netherlands
- AGH - University of Science and Technology, Faculty of Physics and Applied Computer Science, Kraków, Poland
- Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland
- National Center for Nuclear Research (NCBJ), Warsaw, Poland
- Horia Hulubei National Institute of Physics and Nuclear Engineering, Bucharest-Magurele, Romania
- Affiliated with an institute covered by a cooperation agreement with CERN
- ICCUB, Universitat de Barcelona, Barcelona, Spain
- Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
- Instituto de Fisica Corpuscular, Centro Mixto Universidad de Valencia - CSIC, Valencia, Spain
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
- Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
- Physik-Institut, Universität Zürich, Zürich, Switzerland
- NSC Kharkiv Institute of Physics and Technology (NSC KIPT), Kharkiv, Ukraine
- Institute for Nuclear Research of the National Academy of Sciences (KINR), Kyiv, Ukraine
- University of Birmingham, Birmingham, United Kingdom
- H.H. Wills Physics Laboratory, University of Bristol, Bristol, United Kingdom
- Cavendish Laboratory, University of Cambridge, Cambridge, United Kingdom
- Department of Physics, University of Warwick, Coventry, United Kingdom
- STFC Rutherford Appleton Laboratory, Didcot, United Kingdom
- School of Physics and Astronomy, University of Edinburgh, Edinburgh, United Kingdom
- School of Physics and Astronomy, University of Glasgow, Glasgow, United Kingdom
- Oliver Lodge Laboratory, University of Liverpool, Liverpool, United Kingdom
- Imperial College London, London, United Kingdom
- Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
- Department of Physics, University of Oxford, Oxford, United Kingdom
- Massachusetts Institute of Technology, Cambridge, MA, United States
- University of Cincinnati, Cincinnati, OH, United States
- University of Maryland, College Park, MD, United States
- Los Alamos National Laboratory (LANL), Los Alamos, NM, United States
- Syracuse University, Syracuse, NY, United States
- School of Physics and Astronomy, Monash University, Melbourne, Australia (associated with Department of Physics, University of Warwick, Coventry, United Kingdom)
- Pontifícia Universidade Católica do Rio de Janeiro (PUC-Rio), Rio de Janeiro, Brazil (associated with Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil)
- Physics and Micro Electronic College, Hunan University, Changsha City, China (associated with Institute of Particle Physics, Central China Normal University, Wuhan, Hubei, China)
- Guangdong Provincial Key Laboratory of Nuclear Science, Guangdong-Hong Kong Joint Laboratory of Quantum Matter, Institute of Quantum Matter, South China Normal University, Guangzhou, China (associated with Center for High Energy Physics, Tsinghua University, Beijing, China)
- Lanzhou University, Lanzhou, China (associated with Institute Of High Energy Physics (IHEP), Beijing, China)
- School of Physics and Technology, Wuhan University, Wuhan, China (associated with Center for High Energy Physics, Tsinghua University, Beijing, China)
- Departamento de Fisica, Universidad Nacional de Colombia, Bogota, Colombia (associated with LPNHE, Sorbonne Université, Paris Diderot Sorbonne Paris Cité, CNRS/IN2P3, Paris, France)
- Universität Bonn - Helmholtz-Institut für Strahlen und Kernphysik, Bonn, Germany (associated with Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany)
- Eotvos Lorand University, Budapest, Hungary (associated with European Organization for Nuclear Research (CERN), Geneva, Switzerland)
- INFN Sezione di Perugia, Perugia, Italy (associated with INFN Sezione di Ferrara, Ferrara, Italy)
- Van Swinderen Institute, University of Groningen, Groningen, Netherlands (associated with Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands)
- Universiteit Maastricht, Maastricht, Netherlands (associated with Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands)
- Tadeusz Kosciuszko Cracow University of Technology, Cracow, Poland (associated with Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland)
- DS4DS, La Salle, Universitat Ramon Llull, Barcelona, Spain (associated with ICCUB, Universitat de Barcelona, Barcelona, Spain)
- Department of Physics and Astronomy, Uppsala University, Uppsala, Sweden (associated with School of Physics and Astronomy, University of Glasgow, Glasgow, United Kingdom)
- University of Michigan, Ann Arbor, MI, United States (associated with Syracuse University, Syracuse, NY, United States)
| | - A T Grecu
- Horia Hulubei National Institute of Physics and Nuclear Engineering, Bucharest-Magurele, Romania
| | - L M Greeven
- Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands
| | - N A Grieser
- University of Cincinnati, Cincinnati, OH, United States
| | - L Grillo
- School of Physics and Astronomy, University of Glasgow, Glasgow, United Kingdom
| | - S Gromov
- Affiliated with an institute covered by a cooperation agreement with CERN
| | | | - C Gu
- Center for High Energy Physics, Tsinghua University, Beijing, China
| | - M Guarise
- INFN Sezione di Ferrara, Ferrara, Italy
| | - M Guittiere
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, Orsay, France
| | - P A Günther
- Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
| | - E Gushchin
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - A Guth
- I. Physikalisches Institut, RWTH Aachen University, Aachen, Germany
| | - Y Guz
- School of Physics State Key Laboratory of Nuclear Physics and Technology, Peking University, Beijing, China
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - T Gys
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - T Hadavizadeh
- School of Physics and Astronomy, Monash University, Melbourne, Australia (associated with Department of Physics, University of Warwick, Coventry, United Kingdom)
| | | | - G Haefeli
- Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
| | - C Haen
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - J Haimberger
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - S C Haines
- Cavendish Laboratory, University of Cambridge, Cambridge, United Kingdom
| | - T Halewood-Leagas
- Oliver Lodge Laboratory, University of Liverpool, Liverpool, United Kingdom
| | - M M Halvorsen
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - P M Hamilton
- University of Maryland, College Park, MD, United States
| | - J Hammerich
- Oliver Lodge Laboratory, University of Liverpool, Liverpool, United Kingdom
| | - Q Han
- Institute of Particle Physics, Central China Normal University, Wuhan, Hubei, China
| | - X Han
- Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
| | - S Hansmann-Menzemer
- Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
| | - L Hao
- University of Chinese Academy of Sciences, Beijing, China
| | - N Harnew
- Department of Physics, University of Oxford, Oxford, United Kingdom
| | - T Harrison
- Oliver Lodge Laboratory, University of Liverpool, Liverpool, United Kingdom
| | - C Hasse
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - M Hatch
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - J He
- University of Chinese Academy of Sciences, Beijing, China
| | - K Heijhoff
- Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands
| | - F H Hemmer
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - C Henderson
- University of Cincinnati, Cincinnati, OH, United States
| | - R D L Henderson
- Department of Physics, University of Warwick, Coventry, United Kingdom
- School of Physics and Astronomy, Monash University, Melbourne, Australia (associated with Department of Physics, University of Warwick, Coventry, United Kingdom)
| | - A M Hennequin
- Massachusetts Institute of Technology, Cambridge, MA, United States
| | - K Hennessy
- Oliver Lodge Laboratory, University of Liverpool, Liverpool, United Kingdom
| | - L Henry
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - J Herd
- Imperial College London, London, United Kingdom
| | - J Heuel
- I. Physikalisches Institut, RWTH Aachen University, Aachen, Germany
| | - A Hicheur
- Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil
| | - D Hill
- Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
| | - M Hilton
- Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
| | - S E Hollitt
- Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
| | - J Horswill
- Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
| | - R Hou
- Institute of Particle Physics, Central China Normal University, Wuhan, Hubei, China
| | - Y Hou
- Université Savoie Mont Blanc, CNRS, IN2P3-LAPP, Annecy, France
| | - J Hu
- Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
| | - J Hu
- Guangdong Provincial Key Laboratory of Nuclear Science, Guangdong-Hong Kong Joint Laboratory of Quantum Matter, Institute of Quantum Matter, South China Normal University, Guangzhou, China (associated with Center for High Energy Physics, Tsinghua University, Beijing, China)
| | - W Hu
- School of Physics State Key Laboratory of Nuclear Physics and Technology, Peking University, Beijing, China
| | - X Hu
- Center for High Energy Physics, Tsinghua University, Beijing, China
| | - W Huang
- University of Chinese Academy of Sciences, Beijing, China
| | - X Huang
- School of Physics and Technology, Wuhan University, Wuhan, China (associated with Center for High Energy Physics, Tsinghua University, Beijing, China)
| | - W Hulsbergen
- Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands
| | - R J Hunter
- Department of Physics, University of Warwick, Coventry, United Kingdom
| | - M Hushchyn
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - D Hutchcroft
- Oliver Lodge Laboratory, University of Liverpool, Liverpool, United Kingdom
| | - P Ibis
- Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
| | - M Idzik
- AGH - University of Science and Technology, Faculty of Physics and Applied Computer Science, Kraków, Poland
| | - D Ilin
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - P Ilten
- University of Cincinnati, Cincinnati, OH, United States
| | - A Inglessi
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - A Iniukhin
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - A Ishteev
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - K Ivshin
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - R Jacobsson
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - H Jage
- I. Physikalisches Institut, RWTH Aachen University, Aachen, Germany
| | - S J Jaimes Elles
- Instituto de Fisica Corpuscular, Centro Mixto Universidad de Valencia - CSIC, Valencia, Spain
| | - S Jakobsen
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - E Jans
- Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands
| | - B K Jashal
- Instituto de Fisica Corpuscular, Centro Mixto Universidad de Valencia - CSIC, Valencia, Spain
| | - A Jawahery
- University of Maryland, College Park, MD, United States
| | - V Jevtic
- Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
| | - E Jiang
- University of Maryland, College Park, MD, United States
| | - X Jiang
- Institute Of High Energy Physics (IHEP), Beijing, China
- University of Chinese Academy of Sciences, Beijing, China
| | - Y Jiang
- University of Chinese Academy of Sciences, Beijing, China
| | - M John
- Department of Physics, University of Oxford, Oxford, United Kingdom
| | - D Johnson
- Massachusetts Institute of Technology, Cambridge, MA, United States
| | - C R Jones
- Cavendish Laboratory, University of Cambridge, Cambridge, United Kingdom
| | - T P Jones
- Department of Physics, University of Warwick, Coventry, United Kingdom
| | - S J Joshi
- National Center for Nuclear Research (NCBJ), Warsaw, Poland
| | - B Jost
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - N Jurik
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - I Juszczak
- Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland
| | - S Kandybei
- NSC Kharkiv Institute of Physics and Technology (NSC KIPT), Kharkiv, Ukraine
| | - Y Kang
- Center for High Energy Physics, Tsinghua University, Beijing, China
| | - M Karacson
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - D Karpenkov
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - M Karpov
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - J W Kautz
- University of Cincinnati, Cincinnati, OH, United States
| | - F Keizer
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - D M Keller
- Syracuse University, Syracuse, NY, United States
| | - M Kenzie
- Department of Physics, University of Warwick, Coventry, United Kingdom
| | - T Ketel
- Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands
| | - B Khanji
- Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
| | - A Kharisova
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - S Kholodenko
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - G Khreich
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, Orsay, France
| | - T Kirn
- I. Physikalisches Institut, RWTH Aachen University, Aachen, Germany
| | - V S Kirsebom
- Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
| | - O Kitouni
- Massachusetts Institute of Technology, Cambridge, MA, United States
| | - S Klaver
- Nikhef National Institute for Subatomic Physics and VU University Amsterdam, Amsterdam, Netherlands
| | | | - K Klimaszewski
- National Center for Nuclear Research (NCBJ), Warsaw, Poland
| | - M R Kmiec
- National Center for Nuclear Research (NCBJ), Warsaw, Poland
| | - S Koliiev
- Institute for Nuclear Research of the National Academy of Sciences (KINR), Kyiv, Ukraine
| | - L Kolk
- Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
| | - A Kondybayeva
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - A Konoplyannikov
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - P Kopciewicz
- AGH - University of Science and Technology, Faculty of Physics and Applied Computer Science, Kraków, Poland
| | - R Kopecna
- Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
| | - P Koppenburg
- Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands
| | - M Korolev
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - I Kostiuk
- Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands
| | - O Kot
- Institute for Nuclear Research of the National Academy of Sciences (KINR), Kyiv, Ukraine
| | - S Kotriakhova
- Centro Brasileiro de Pesquisas Físicas (CBPF), Rio de Janeiro, Brazil
- Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil
- Center for High Energy Physics, Tsinghua University, Beijing, China
- Institute Of High Energy Physics (IHEP), Beijing, China
- School of Physics State Key Laboratory of Nuclear Physics and Technology, Peking University, Beijing, China
- University of Chinese Academy of Sciences, Beijing, China
- Institute of Particle Physics, Central China Normal University, Wuhan, Hubei, China
- Université Savoie Mont Blanc, CNRS, IN2P3-LAPP, Annecy, France
- Université Clermont Auvergne, CNRS/IN2P3, LPC, Clermont-Ferrand, France
- Aix Marseille Univ, CNRS/IN2P3, CPPM, Marseille, France
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, Orsay, France
- Laboratoire Leprince-Ringuet, CNRS/IN2P3, Ecole Polytechnique, Institut Polytechnique de Paris, Palaiseau, France
- LPNHE, Sorbonne Université, Paris Diderot Sorbonne Paris Cité, CNRS/IN2P3, Paris, France
- I. Physikalisches Institut, RWTH Aachen University, Aachen, Germany
- Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
- Max-Planck-Institut für Kernphysik (MPIK), Heidelberg, Germany
- Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
- School of Physics, University College Dublin, Dublin, Ireland
- INFN Sezione di Bari, Bari, Italy
- INFN Sezione di Bologna, Bologna, Italy
- INFN Sezione di Ferrara, Ferrara, Italy
- INFN Sezione di Firenze, Firenze, Italy
- INFN Laboratori Nazionali di Frascati, Frascati, Italy
- INFN Sezione di Genova, Genova, Italy
- INFN Sezione di Milano, Milano, Italy
- INFN Sezione di Milano-Bicocca, Milano, Italy
- INFN Sezione di Cagliari, Monserrato, Italy
- Università degli Studi di Padova, Università e INFN, Padova, Padova, Italy
- INFN Sezione di Pisa, Pisa, Italy
- INFN Sezione di Roma La Sapienza, Roma, Italy
- INFN Sezione di Roma Tor Vergata, Roma, Italy
- Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands
- Nikhef National Institute for Subatomic Physics and VU University Amsterdam, Amsterdam, Netherlands
- AGH - University of Science and Technology, Faculty of Physics and Applied Computer Science, Kraków, Poland
- Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland
- National Center for Nuclear Research (NCBJ), Warsaw, Poland
- Horia Hulubei National Institute of Physics and Nuclear Engineering, Bucharest-Magurele, Romania
- Affiliated with an institute covered by a cooperation agreement with CERN
- ICCUB, Universitat de Barcelona, Barcelona, Spain
- Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
- Instituto de Fisica Corpuscular, Centro Mixto Universidad de Valencia - CSIC, Valencia, Spain
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
- Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
- Physik-Institut, Universität Zürich, Zürich, Switzerland
- NSC Kharkiv Institute of Physics and Technology (NSC KIPT), Kharkiv, Ukraine
- Institute for Nuclear Research of the National Academy of Sciences (KINR), Kyiv, Ukraine
- University of Birmingham, Birmingham, United Kingdom
- H.H. Wills Physics Laboratory, University of Bristol, Bristol, United Kingdom
- Cavendish Laboratory, University of Cambridge, Cambridge, United Kingdom
- Department of Physics, University of Warwick, Coventry, United Kingdom
- STFC Rutherford Appleton Laboratory, Didcot, United Kingdom
- School of Physics and Astronomy, University of Edinburgh, Edinburgh, United Kingdom
- School of Physics and Astronomy, University of Glasgow, Glasgow, United Kingdom
- Oliver Lodge Laboratory, University of Liverpool, Liverpool, United Kingdom
- Imperial College London, London, United Kingdom
- Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
- Department of Physics, University of Oxford, Oxford, United Kingdom
- Massachusetts Institute of Technology, Cambridge, MA, United States
- University of Cincinnati, Cincinnati, OH, United States
- University of Maryland, College Park, MD, United States
- Los Alamos National Laboratory (LANL), Los Alamos, NM, United States
- Syracuse University, Syracuse, NY, United States
- School of Physics and Astronomy, Monash University, Melbourne, Australia (associated with Department of Physics, University of Warwick, Coventry, United Kingdom)
- Pontifícia Universidade Católica do Rio de Janeiro (PUC-Rio), Rio de Janeiro, Brazil (associated with Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil)
- Physics and Micro Electronic College, Hunan University, Changsha City, China (associated with Institute of Particle Physics, Central China Normal University, Wuhan, Hubei, China)
- Guangdong Provincial Key Laboratory of Nuclear Science, Guangdong-Hong Kong Joint Laboratory of Quantum Matter, Institute of Quantum Matter, South China Normal University, Guangzhou, China (associated with Center for High Energy Physics, Tsinghua University, Beijing, China)
- Lanzhou University, Lanzhou, China (associated with Institute Of High Energy Physics (IHEP), Beijing, China)
- School of Physics and Technology, Wuhan University, Wuhan, China (associated with Center for High Energy Physics, Tsinghua University, Beijing, China)
- Departamento de Fisica, Universidad Nacional de Colombia, Bogota, Colombia (associated with LPNHE, Sorbonne Université, Paris Diderot Sorbonne Paris Cité, CNRS/IN2P3, Paris, France)
- Universität Bonn - Helmholtz-Institut für Strahlen und Kernphysik, Bonn, Germany (associated with Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany)
- Eotvos Lorand University, Budapest, Hungary (associated with European Organization for Nuclear Research (CERN), Geneva, Switzerland)
- INFN Sezione di Perugia, Perugia, Italy (associated with INFN Sezione di Ferrara, Ferrara, Italy)
- Van Swinderen Institute, University of Groningen, Groningen, Netherlands (associated with Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands)
- Universiteit Maastricht, Maastricht, Netherlands (associated with Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands)
- Tadeusz Kosciuszko Cracow University of Technology, Cracow, Poland (associated with Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland)
- DS4DS, La Salle, Universitat Ramon Llull, Barcelona, Spain (associated with ICCUB, Universitat de Barcelona, Barcelona, Spain)
- Department of Physics and Astronomy, Uppsala University, Uppsala, Sweden (associated with School of Physics and Astronomy, University of Glasgow, Glasgow, United Kingdom)
- University of Michigan, Ann Arbor, MI, United States (associated with Syracuse University, Syracuse, NY, United States)
| | - A Kozachuk
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - P Kravchenko
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - L Kravchuk
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - R D Krawczyk
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - M Kreps
- Department of Physics, University of Warwick, Coventry, United Kingdom
| | - S Kretzschmar
- I. Physikalisches Institut, RWTH Aachen University, Aachen, Germany
| | - P Krokovny
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - W Krupa
- AGH - University of Science and Technology, Faculty of Physics and Applied Computer Science, Kraków, Poland
| | - W Krzemien
- National Center for Nuclear Research (NCBJ), Warsaw, Poland
| | - J Kubat
- Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
| | - S Kubis
- Tadeusz Kosciuszko Cracow University of Technology, Cracow, Poland (associated with Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland)
| | - W Kucewicz
- Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland
| | - M Kucharczyk
- Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland
| | - V Kudryavtsev
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - E K Kulikova
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - A Kupsc
- Department of Physics and Astronomy, Uppsala University, Uppsala, Sweden (associated with School of Physics and Astronomy, University of Glasgow, Glasgow, United Kingdom)
| | - D Lacarrere
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - G Lafferty
- Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
| | - A Lai
- INFN Sezione di Cagliari, Monserrato, Italy
| | - A Lampis
- INFN Sezione di Cagliari, Monserrato, Italy
| | - D Lancierini
- Physik-Institut, Universität Zürich, Zürich, Switzerland
| | - C Landesa Gomez
- Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
| | - J J Lane
- Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
| | - R Lane
- H.H. Wills Physics Laboratory, University of Bristol, Bristol, United Kingdom
| | - C Langenbruch
- I. Physikalisches Institut, RWTH Aachen University, Aachen, Germany
| | - J Langer
- Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
| | - O Lantwin
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - T Latham
- Department of Physics, University of Warwick, Coventry, United Kingdom
| | | | | | - C Lazzeroni
- University of Birmingham, Birmingham, United Kingdom
| | - R Le Gac
- Aix Marseille Univ, CNRS/IN2P3, CPPM, Marseille, France
| | - S H Lee
- University of Michigan, Ann Arbor, MI, United States (associated with Syracuse University, Syracuse, NY, United States)
| | - R Lefèvre
- Université Clermont Auvergne, CNRS/IN2P3, LPC, Clermont-Ferrand, France
| | - A Leflat
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - S Legotin
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - P Lenisa
- INFN Sezione di Ferrara, Ferrara, Italy
| | - O Leroy
- Aix Marseille Univ, CNRS/IN2P3, CPPM, Marseille, France
| | - T Lesiak
- Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland
| | - B Leverington
- Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
| | - A Li
- Center for High Energy Physics, Tsinghua University, Beijing, China
| | - H Li
- Guangdong Provincial Key Laboratory of Nuclear Science, Guangdong-Hong Kong Joint Laboratory of Quantum Matter, Institute of Quantum Matter, South China Normal University, Guangzhou, China (associated with Center for High Energy Physics, Tsinghua University, Beijing, China)
| | - K Li
- Institute of Particle Physics, Central China Normal University, Wuhan, Hubei, China
| | - P Li
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - P-R Li
- Lanzhou University, Lanzhou, China (associated with Institute Of High Energy Physics (IHEP), Beijing, China)
| | - S Li
- Institute of Particle Physics, Central China Normal University, Wuhan, Hubei, China
| | - T Li
- Institute Of High Energy Physics (IHEP), Beijing, China
| | - T Li
- Guangdong Provincial Key Laboratory of Nuclear Science, Guangdong-Hong Kong Joint Laboratory of Quantum Matter, Institute of Quantum Matter, South China Normal University, Guangzhou, China (associated with Center for High Energy Physics, Tsinghua University, Beijing, China)
| | - Y Li
- Institute Of High Energy Physics (IHEP), Beijing, China
| | - Z Li
- Syracuse University, Syracuse, NY, United States
| | - X Liang
- Syracuse University, Syracuse, NY, United States
| | - C Lin
- University of Chinese Academy of Sciences, Beijing, China
| | - T Lin
- STFC Rutherford Appleton Laboratory, Didcot, United Kingdom
| | - R Lindner
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - V Lisovskyi
- Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
| | - R Litvinov
- INFN Sezione di Cagliari, Monserrato, Italy
| | - G Liu
- Guangdong Provincial Key Laboratory of Nuclear Science, Guangdong-Hong Kong Joint Laboratory of Quantum Matter, Institute of Quantum Matter, South China Normal University, Guangzhou, China (associated with Center for High Energy Physics, Tsinghua University, Beijing, China)
| | - H Liu
- University of Chinese Academy of Sciences, Beijing, China
| | - K Liu
- Lanzhou University, Lanzhou, China (associated with Institute Of High Energy Physics (IHEP), Beijing, China)
| | - Q Liu
- University of Chinese Academy of Sciences, Beijing, China
| | - S Liu
- Institute Of High Energy Physics (IHEP), Beijing, China
- University of Chinese Academy of Sciences, Beijing, China
| | | | - A Loi
- INFN Sezione di Cagliari, Monserrato, Italy
| | - R Lollini
- INFN Sezione di Perugia, Perugia, Italy (associated with INFN Sezione di Ferrara, Ferrara, Italy)
| | - J Lomba Castro
- Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
| | - I Longstaff
- School of Physics and Astronomy, University of Glasgow, Glasgow, United Kingdom
| | - J H Lopes
- Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil
| | | | - S López Soliño
- Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
| | - G H Lovell
- Cavendish Laboratory, University of Cambridge, Cambridge, United Kingdom
| | - Y Lu
- Institute Of High Energy Physics (IHEP), Beijing, China
| | | | - D Lucchesi
- Università degli Studi di Padova, Università e INFN, Padova, Padova, Italy
| | - S Luchuk
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - M Lucio Martinez
- Universiteit Maastricht, Maastricht, Netherlands (associated with Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands)
| | - V Lukashenko
- Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands
- Institute for Nuclear Research of the National Academy of Sciences (KINR), Kyiv, Ukraine
| | - Y Luo
- Center for High Energy Physics, Tsinghua University, Beijing, China
| | - A Lupato
- Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
| | - E Luppi
- INFN Sezione di Ferrara, Ferrara, Italy
| | | | - K Lynch
- School of Physics, University College Dublin, Dublin, Ireland
| | - X-R Lyu
- University of Chinese Academy of Sciences, Beijing, China
| | - R Ma
- University of Chinese Academy of Sciences, Beijing, China
| | - S Maccolini
- Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
| | - F Machefert
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, Orsay, France
| | - F Maciuc
- Horia Hulubei National Institute of Physics and Nuclear Engineering, Bucharest-Magurele, Romania
| | - I Mackay
- Department of Physics, University of Oxford, Oxford, United Kingdom
| | - V Macko
- Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
| | - L R Madhan Mohan
- Cavendish Laboratory, University of Cambridge, Cambridge, United Kingdom
| | - A Maevskiy
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - D Maisuzenko
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - M W Majewski
- AGH - University of Science and Technology, Faculty of Physics and Applied Computer Science, Kraków, Poland
| | - J J Malczewski
- Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland
| | - S Malde
- Department of Physics, University of Oxford, Oxford, United Kingdom
| | - B Malecki
- Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - A Malinin
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - T Maltsev
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - G Manca
- INFN Sezione di Cagliari, Monserrato, Italy
| | - G Mancinelli
- Aix Marseille Univ, CNRS/IN2P3, CPPM, Marseille, France
| | - C Mancuso
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, Orsay, France
- INFN Sezione di Milano, Milano, Italy
| | | | - D Manuzzi
- INFN Sezione di Bologna, Bologna, Italy
| | - C A Manzari
- Physik-Institut, Universität Zürich, Zürich, Switzerland
| | | | - J F Marchand
- Université Savoie Mont Blanc, CNRS, IN2P3-LAPP, Annecy, France
| | - U Marconi
- INFN Sezione di Bologna, Bologna, Italy
| | - S Mariani
- INFN Sezione di Firenze, Firenze, Italy
| | | | - J Marks
- Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
| | - A M Marshall
- H.H. Wills Physics Laboratory, University of Bristol, Bristol, United Kingdom
| | - P J Marshall
- Oliver Lodge Laboratory, University of Liverpool, Liverpool, United Kingdom
| | - G Martelli
- INFN Sezione di Perugia, Perugia, Italy (associated with INFN Sezione di Ferrara, Ferrara, Italy)
| | | | - L Martinazzoli
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | | | - D Martinez Santos
- Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
| | - F Martinez Vidal
- Instituto de Fisica Corpuscular, Centro Mixto Universidad de Valencia - CSIC, Valencia, Spain
| | - A Massafferri
- Centro Brasileiro de Pesquisas Físicas (CBPF), Rio de Janeiro, Brazil
| | - M Materok
- I. Physikalisches Institut, RWTH Aachen University, Aachen, Germany
| | - R Matev
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - A Mathad
- Physik-Institut, Universität Zürich, Zürich, Switzerland
| | - V Matiunin
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - C Matteuzzi
- INFN Sezione di Milano-Bicocca, Milano, Italy
| | - K R Mattioli
- Laboratoire Leprince-Ringuet, CNRS/IN2P3, Ecole Polytechnique, Institut Polytechnique de Paris, Palaiseau, France
| | - A Mauri
- Imperial College London, London, United Kingdom
| | - E Maurice
- Laboratoire Leprince-Ringuet, CNRS/IN2P3, Ecole Polytechnique, Institut Polytechnique de Paris, Palaiseau, France
| | - J Mauricio
- ICCUB, Universitat de Barcelona, Barcelona, Spain
| | - M Mazurek
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - M McCann
- Imperial College London, London, United Kingdom
| | - L Mcconnell
- School of Physics, University College Dublin, Dublin, Ireland
| | - T H McGrath
- Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
| | - N T McHugh
- School of Physics and Astronomy, University of Glasgow, Glasgow, United Kingdom
| | - A McNab
- Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
| | - R McNulty
- School of Physics, University College Dublin, Dublin, Ireland
| | - B Meadows
- University of Cincinnati, Cincinnati, OH, United States
| | - G Meier
- Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
| | - D Melnychuk
- National Center for Nuclear Research (NCBJ), Warsaw, Poland
| | - S Meloni
- INFN Sezione di Milano-Bicocca, Milano, Italy
| | - M Merk
- Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands
- Universiteit Maastricht, Maastricht, Netherlands (associated with Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands)
| | - A Merli
- INFN Sezione di Milano, Milano, Italy
| | - L Meyer Garcia
- Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil
| | - D Miao
- Institute Of High Energy Physics (IHEP), Beijing, China
- University of Chinese Academy of Sciences, Beijing, China
| | - M Mikhasenko
- Universität Bonn - Helmholtz-Institut für Strahlen und Kernphysik, Bonn, Germany (associated with Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany)
| | - D A Milanes
- Departamento de Fisica, Universidad Nacional de Colombia, Bogota, Colombia (associated with LPNHE, Sorbonne Université, Paris Diderot Sorbonne Paris Cité, CNRS/IN2P3, Paris, France)
| | - E Millard
- Department of Physics, University of Warwick, Coventry, United Kingdom
| | - M Milovanovic
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - M-N Minard
- Université Savoie Mont Blanc, CNRS, IN2P3-LAPP, Annecy, France
| | - A Minotti
- INFN Sezione di Milano-Bicocca, Milano, Italy
| | - T Miralles
- Université Clermont Auvergne, CNRS/IN2P3, LPC, Clermont-Ferrand, France
| | - S E Mitchell
- School of Physics and Astronomy, University of Edinburgh, Edinburgh, United Kingdom
| | - B Mitreska
- Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
| | - D S Mitzel
- Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
| | - A Modak
- STFC Rutherford Appleton Laboratory, Didcot, United Kingdom
| | - A Mödden
- Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
| | - R A Mohammed
- Department of Physics, University of Oxford, Oxford, United Kingdom
| | - R D Moise
- I. Physikalisches Institut, RWTH Aachen University, Aachen, Germany
| | - S Mokhnenko
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - T Mombächer
- Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
| | - M Monk
- Department of Physics, University of Warwick, Coventry, United Kingdom
- School of Physics and Astronomy, Monash University, Melbourne, Australia (associated with Department of Physics, University of Warwick, Coventry, United Kingdom)
| | - I A Monroy
- Departamento de Fisica, Universidad Nacional de Colombia, Bogota, Colombia (associated with LPNHE, Sorbonne Université, Paris Diderot Sorbonne Paris Cité, CNRS/IN2P3, Paris, France)
| | - S Monteil
- Université Clermont Auvergne, CNRS/IN2P3, LPC, Clermont-Ferrand, France
| | - G Morello
- INFN Laboratori Nazionali di Frascati, Frascati, Italy
| | | | - M P Morgenthaler
- Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
| | - J Moron
- AGH - University of Science and Technology, Faculty of Physics and Applied Computer Science, Kraków, Poland
| | - A B Morris
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - A G Morris
- Department of Physics, University of Warwick, Coventry, United Kingdom
| | - R Mountain
- Syracuse University, Syracuse, NY, United States
| | - H Mu
- Center for High Energy Physics, Tsinghua University, Beijing, China
| | - E Muhammad
- Department of Physics, University of Warwick, Coventry, United Kingdom
| | - F Muheim
- School of Physics and Astronomy, University of Edinburgh, Edinburgh, United Kingdom
| | - M Mulder
- Van Swinderen Institute, University of Groningen, Groningen, Netherlands (associated with Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands)
| | - K Müller
- Physik-Institut, Universität Zürich, Zürich, Switzerland
| | - C H Murphy
- Department of Physics, University of Oxford, Oxford, United Kingdom
| | - D Murray
- Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
| | - R Murta
- Imperial College London, London, United Kingdom
| | - P Muzzetto
- INFN Sezione di Cagliari, Monserrato, Italy
| | - P Naik
- H.H. Wills Physics Laboratory, University of Bristol, Bristol, United Kingdom
| | - T Nakada
- Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
| | - R Nandakumar
- STFC Rutherford Appleton Laboratory, Didcot, United Kingdom
| | - T Nanut
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - I Nasteva
- Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil
| | - M Needham
- School of Physics and Astronomy, University of Edinburgh, Edinburgh, United Kingdom
| | - N Neri
- INFN Sezione di Milano, Milano, Italy
| | - S Neubert
- Universität Bonn - Helmholtz-Institut für Strahlen und Kernphysik, Bonn, Germany (associated with Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany)
| | - N Neufeld
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - P Neustroev
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - R Newcombe
- Imperial College London, London, United Kingdom
| | - J Nicolini
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, Orsay, France
- Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
| | - D Nicotra
- Universiteit Maastricht, Maastricht, Netherlands (associated with Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands)
| | - E M Niel
- Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
| | - S Nieswand
- I. Physikalisches Institut, RWTH Aachen University, Aachen, Germany
| | - N Nikitin
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - N S Nolte
- Massachusetts Institute of Technology, Cambridge, MA, United States
| | - C Normand
- Université Savoie Mont Blanc, CNRS, IN2P3-LAPP, Annecy, France
- INFN Sezione di Cagliari, Monserrato, Italy
| | - J Novoa Fernandez
- Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
| | - G N Nowak
- University of Cincinnati, Cincinnati, OH, United States
| | - C Nunez
- University of Michigan, Ann Arbor, MI, United States (associated with Syracuse University, Syracuse, NY, United States)
| | - A Oblakowska-Mucha
- AGH - University of Science and Technology, Faculty of Physics and Applied Computer Science, Kraków, Poland
| | - V Obraztsov
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - T Oeser
- I. Physikalisches Institut, RWTH Aachen University, Aachen, Germany
| | - S Okamura
- INFN Sezione di Ferrara, Ferrara, Italy
| | - R Oldeman
- INFN Sezione di Cagliari, Monserrato, Italy
| | - F Oliva
- School of Physics and Astronomy, University of Edinburgh, Edinburgh, United Kingdom
| | - C J G Onderwater
- Van Swinderen Institute, University of Groningen, Groningen, Netherlands (associated with Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands)
| | - R H O'Neil
- School of Physics and Astronomy, University of Edinburgh, Edinburgh, United Kingdom
| | | | - T Ovsiannikova
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - P Owen
- Physik-Institut, Universität Zürich, Zürich, Switzerland
| | - A Oyanguren
- Instituto de Fisica Corpuscular, Centro Mixto Universidad de Valencia - CSIC, Valencia, Spain
| | - O Ozcelik
- School of Physics and Astronomy, University of Edinburgh, Edinburgh, United Kingdom
| | - K O Padeken
- Universität Bonn - Helmholtz-Institut für Strahlen und Kernphysik, Bonn, Germany (associated with Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany)
| | - B Pagare
- Department of Physics, University of Warwick, Coventry, United Kingdom
| | - P R Pais
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - T Pajero
- Department of Physics, University of Oxford, Oxford, United Kingdom
| | - A Palano
- INFN Sezione di Bari, Bari, Italy
| | - M Palutan
- INFN Laboratori Nazionali di Frascati, Frascati, Italy
| | - G Panshin
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - L Paolucci
- Department of Physics, University of Warwick, Coventry, United Kingdom
| | - A Papanestis
- STFC Rutherford Appleton Laboratory, Didcot, United Kingdom
| | | | | | | | - W Parker
- University of Maryland, College Park, MD, United States
| | - C Parkes
- Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
| | | | | | | | - M Patel
- Imperial College London, London, United Kingdom
| | | | - C J Pawley
- Universiteit Maastricht, Maastricht, Netherlands (associated with Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands)
| | - A Pellegrino
- Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands
| | - M Pepe Altarelli
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | | | - D Pereima
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - A Pereiro Castro
- Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
| | - P Perret
- Université Clermont Auvergne, CNRS/IN2P3, LPC, Clermont-Ferrand, France
| | - K Petridis
- H.H. Wills Physics Laboratory, University of Bristol, Bristol, United Kingdom
| | | | - S Petrucci
- School of Physics and Astronomy, University of Edinburgh, Edinburgh, United Kingdom
| | | | - H Pham
- Syracuse University, Syracuse, NY, United States
| | - A Philippov
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - R Piandani
- University of Chinese Academy of Sciences, Beijing, China
| | - L Pica
- INFN Sezione di Pisa, Pisa, Italy
| | - M Piccini
- INFN Sezione di Perugia, Perugia, Italy (associated with INFN Sezione di Ferrara, Ferrara, Italy)
| | - B Pietrzyk
- Université Savoie Mont Blanc, CNRS, IN2P3-LAPP, Annecy, France
| | - G Pietrzyk
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, Orsay, France
| | - M Pili
- Department of Physics, University of Oxford, Oxford, United Kingdom
| | - D Pinci
- INFN Sezione di Roma La Sapienza, Roma, Italy
| | - F Pisani
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - M Pizzichemi
- INFN Sezione di Milano-Bicocca, Milano, Italy
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - V Placinta
- Horia Hulubei National Institute of Physics and Nuclear Engineering, Bucharest-Magurele, Romania
| | - J Plews
- University of Birmingham, Birmingham, United Kingdom
| | - M Plo Casasus
- Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
| | - F Polci
- LPNHE, Sorbonne Université, Paris Diderot Sorbonne Paris Cité, CNRS/IN2P3, Paris, France
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - M Poli Lener
- INFN Laboratori Nazionali di Frascati, Frascati, Italy
| | - A Poluektov
- Aix Marseille Univ, CNRS/IN2P3, CPPM, Marseille, France
| | - N Polukhina
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - I Polyakov
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - E Polycarpo
- Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil
| | - S Ponce
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - D Popov
- University of Chinese Academy of Sciences, Beijing, China
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - S Poslavskii
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - K Prasanth
- Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland
| | - L Promberger
- Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
| | - C Prouve
- Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
| | - V Pugatch
- Institute for Nuclear Research of the National Academy of Sciences (KINR), Kyiv, Ukraine
| | - V Puill
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, Orsay, France
| | - G Punzi
- INFN Sezione di Pisa, Pisa, Italy
| | - H R Qi
- Center for High Energy Physics, Tsinghua University, Beijing, China
| | - W Qian
- University of Chinese Academy of Sciences, Beijing, China
| | - N Qin
- Center for High Energy Physics, Tsinghua University, Beijing, China
| | - S Qu
- Center for High Energy Physics, Tsinghua University, Beijing, China
| | - R Quagliani
- Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
| | - N V Raab
- School of Physics, University College Dublin, Dublin, Ireland
| | - B Rachwal
- AGH - University of Science and Technology, Faculty of Physics and Applied Computer Science, Kraków, Poland
| | - J H Rademacker
- H.H. Wills Physics Laboratory, University of Bristol, Bristol, United Kingdom
| | | | - M Rama
- INFN Sezione di Pisa, Pisa, Italy
| | - M Ramos Pernas
- Department of Physics, University of Warwick, Coventry, United Kingdom
| | - M S Rangel
- Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil
| | - F Ratnikov
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - G Raven
- Nikhef National Institute for Subatomic Physics and VU University Amsterdam, Amsterdam, Netherlands
| | - M Rebollo De Miguel
- Instituto de Fisica Corpuscular, Centro Mixto Universidad de Valencia - CSIC, Valencia, Spain
| | - F Redi
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - J Reich
- H.H. Wills Physics Laboratory, University of Bristol, Bristol, United Kingdom
| | - F Reiss
- Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
| | - C Remon Alepuz
- Instituto de Fisica Corpuscular, Centro Mixto Universidad de Valencia - CSIC, Valencia, Spain
| | - Z Ren
- Center for High Energy Physics, Tsinghua University, Beijing, China
| | - P K Resmi
- Department of Physics, University of Oxford, Oxford, United Kingdom
| | | | - A M Ricci
- INFN Sezione di Cagliari, Monserrato, Italy
| | - S Ricciardi
- STFC Rutherford Appleton Laboratory, Didcot, United Kingdom
| | - K Richardson
- Massachusetts Institute of Technology, Cambridge, MA, United States
| | - M Richardson-Slipper
- School of Physics and Astronomy, University of Edinburgh, Edinburgh, United Kingdom
| | - K Rinnert
- Oliver Lodge Laboratory, University of Liverpool, Liverpool, United Kingdom
| | - P Robbe
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, Orsay, France
| | - G Robertson
- School of Physics and Astronomy, University of Edinburgh, Edinburgh, United Kingdom
| | - E Rodrigues
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
- Oliver Lodge Laboratory, University of Liverpool, Liverpool, United Kingdom
| | - E Rodriguez Fernandez
- Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
| | - J A Rodriguez Lopez
- Departamento de Fisica, Universidad Nacional de Colombia, Bogota, Colombia (associated with LPNHE, Sorbonne Université, Paris Diderot Sorbonne Paris Cité, CNRS/IN2P3, Paris, France)
| | - E Rodriguez Rodriguez
- Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
| | - D L Rolf
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - A Rollings
- Department of Physics, University of Oxford, Oxford, United Kingdom
| | - P Roloff
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - V Romanovskiy
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - M Romero Lamas
- Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
| | - A Romero Vidal
- Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
| | - J D Roth
- University of Michigan, Ann Arbor, MI, United States (associated with Syracuse University, Syracuse, NY, United States)
| | - M Rotondo
- INFN Laboratori Nazionali di Frascati, Frascati, Italy
| | - M S Rudolph
- Syracuse University, Syracuse, NY, United States
| | - T Ruf
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - R A Ruiz Fernandez
- Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
| | - J Ruiz Vidal
- Instituto de Fisica Corpuscular, Centro Mixto Universidad de Valencia - CSIC, Valencia, Spain
| | - A Ryzhikov
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - J Ryzka
- AGH - University of Science and Technology, Faculty of Physics and Applied Computer Science, Kraków, Poland
| | - J J Saborido Silva
- Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
| | - N Sagidova
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - N Sahoo
- University of Birmingham, Birmingham, United Kingdom
| | - B Saitta
- INFN Sezione di Cagliari, Monserrato, Italy
| | - M Salomoni
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - C Sanchez Gras
- Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands
| | - I Sanderswood
- Instituto de Fisica Corpuscular, Centro Mixto Universidad de Valencia - CSIC, Valencia, Spain
| | | | - C Santamarina Rios
- Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
| | - M Santimaria
- INFN Laboratori Nazionali di Frascati, Frascati, Italy
| | | | - D Saranin
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - G Sarpis
- I. Physikalisches Institut, RWTH Aachen University, Aachen, Germany
| | - M Sarpis
- Universität Bonn - Helmholtz-Institut für Strahlen und Kernphysik, Bonn, Germany (associated with Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany)
| | - A Sarti
- INFN Sezione di Roma La Sapienza, Roma, Italy
| | - C Satriano
- INFN Sezione di Roma La Sapienza, Roma, Italy
| | - A Satta
- INFN Sezione di Roma Tor Vergata, Roma, Italy
| | - M Saur
- Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
| | - D Savrina
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - H Sazak
- Université Clermont Auvergne, CNRS/IN2P3, LPC, Clermont-Ferrand, France
| | | | - A Scarabotto
- LPNHE, Sorbonne Université, Paris Diderot Sorbonne Paris Cité, CNRS/IN2P3, Paris, France
| | - S Schael
- I. Physikalisches Institut, RWTH Aachen University, Aachen, Germany
| | - S Scherl
- Oliver Lodge Laboratory, University of Liverpool, Liverpool, United Kingdom
| | - M Schiller
- School of Physics and Astronomy, University of Glasgow, Glasgow, United Kingdom
| | - H Schindler
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - M Schmelling
- Max-Planck-Institut für Kernphysik (MPIK), Heidelberg, Germany
| | - B Schmidt
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - S Schmitt
- I. Physikalisches Institut, RWTH Aachen University, Aachen, Germany
| | - O Schneider
- Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
| | - A Schopper
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - M Schubiger
- Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands
| | - S Schulte
- Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
| | - M H Schune
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, Orsay, France
| | - R Schwemmer
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - B Sciascia
- INFN Laboratori Nazionali di Frascati, Frascati, Italy
| | - A Sciuccati
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - S Sellam
- Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
| | - A Semennikov
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - M Senghi Soares
- Nikhef National Institute for Subatomic Physics and VU University Amsterdam, Amsterdam, Netherlands
| | - A Sergi
- INFN Sezione di Genova, Genova, Italy
| | - N Serra
- Physik-Institut, Universität Zürich, Zürich, Switzerland
| | - L Sestini
- Università degli Studi di Padova, Università e INFN, Padova, Padova, Italy
| | - A Seuthe
- Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
| | - Y Shang
- School of Physics State Key Laboratory of Nuclear Physics and Technology, Peking University, Beijing, China
| | - D M Shangase
- University of Michigan, Ann Arbor, MI, United States (associated with Syracuse University, Syracuse, NY, United States)
| | - M Shapkin
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - I Shchemerov
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - L Shchutska
- Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
| | - T Shears
- Oliver Lodge Laboratory, University of Liverpool, Liverpool, United Kingdom
| | - L Shekhtman
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - Z Shen
- School of Physics State Key Laboratory of Nuclear Physics and Technology, Peking University, Beijing, China
| | - S Sheng
- Institute Of High Energy Physics (IHEP), Beijing, China
- University of Chinese Academy of Sciences, Beijing, China
| | - V Shevchenko
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - B Shi
- University of Chinese Academy of Sciences, Beijing, China
| | - E B Shields
- INFN Sezione di Milano-Bicocca, Milano, Italy
| | - Y Shimizu
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, Orsay, France
| | - E Shmanin
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - R Shorkin
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - J D Shupperd
- Syracuse University, Syracuse, NY, United States
| | - B G Siddi
- INFN Sezione di Ferrara, Ferrara, Italy
| | | | - G Simi
- Università degli Studi di Padova, Università e INFN, Padova, Padova, Italy
| | - S Simone
- INFN Sezione di Bari, Bari, Italy
| | - M Singla
- School of Physics and Astronomy, Monash University, Melbourne, Australia (associated with Department of Physics, University of Warwick, Coventry, United Kingdom)
| | - N Skidmore
- Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
| | - R Skuza
- Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
| | - T Skwarnicki
- Syracuse University, Syracuse, NY, United States
| | - M W Slater
- University of Birmingham, Birmingham, United Kingdom
| | - J C Smallwood
- Department of Physics, University of Oxford, Oxford, United Kingdom
| | - J G Smeaton
- Cavendish Laboratory, University of Cambridge, Cambridge, United Kingdom
| | - E Smith
- Physik-Institut, Universität Zürich, Zürich, Switzerland
| | - K Smith
- Los Alamos National Laboratory (LANL), Los Alamos, NM, United States
| | - M Smith
- Imperial College London, London, United Kingdom
| | - A Snoch
- Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands
| | - L Soares Lavra
- Université Clermont Auvergne, CNRS/IN2P3, LPC, Clermont-Ferrand, France
| | - M D Sokoloff
- University of Cincinnati, Cincinnati, OH, United States
| | - F J P Soler
- School of Physics and Astronomy, University of Glasgow, Glasgow, United Kingdom
| | - A Solomin
- Affiliated with an institute covered by a cooperation agreement with CERN
- H.H. Wills Physics Laboratory, University of Bristol, Bristol, United Kingdom
| | - A Solovev
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - I Solovyev
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - R Song
- School of Physics and Astronomy, Monash University, Melbourne, Australia (associated with Department of Physics, University of Warwick, Coventry, United Kingdom)
| | | | - B Souza De Paula
- Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil
| | - B Spaan
- Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
| | | | | | - E Spiridenkov
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - P Spradlin
- School of Physics and Astronomy, University of Glasgow, Glasgow, United Kingdom
| | - V Sriskaran
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - F Stagni
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - M Stahl
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - S Stahl
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - S Stanislaus
- Department of Physics, University of Oxford, Oxford, United Kingdom
| | - E N Stein
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - O Steinkamp
- Physik-Institut, Universität Zürich, Zürich, Switzerland
| | - O Stenyakin
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - H Stevens
- Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
| | - D Strekalina
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - Y S Su
- University of Chinese Academy of Sciences, Beijing, China
| | - F Suljik
- Department of Physics, University of Oxford, Oxford, United Kingdom
| | - J Sun
- INFN Sezione di Cagliari, Monserrato, Italy
| | - L Sun
- School of Physics and Technology, Wuhan University, Wuhan, China (associated with Center for High Energy Physics, Tsinghua University, Beijing, China)
| | - Y Sun
- University of Maryland, College Park, MD, United States
| | - P N Swallow
- University of Birmingham, Birmingham, United Kingdom
| | - K Swientek
- AGH - University of Science and Technology, Faculty of Physics and Applied Computer Science, Kraków, Poland
| | - A Szabelski
- National Center for Nuclear Research (NCBJ), Warsaw, Poland
| | - T Szumlak
- AGH - University of Science and Technology, Faculty of Physics and Applied Computer Science, Kraków, Poland
| | - M Szymanski
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - Y Tan
- Center for High Energy Physics, Tsinghua University, Beijing, China
| | - S Taneja
- Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
| | - M D Tat
- Department of Physics, University of Oxford, Oxford, United Kingdom
| | - A Terentev
- Physik-Institut, Universität Zürich, Zürich, Switzerland
| | - F Teubert
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - E Thomas
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | | | - K A Thomson
- Oliver Lodge Laboratory, University of Liverpool, Liverpool, United Kingdom
| | - H Tilquin
- Imperial College London, London, United Kingdom
| | - V Tisserand
- Université Clermont Auvergne, CNRS/IN2P3, LPC, Clermont-Ferrand, France
| | - S T'Jampens
- Université Savoie Mont Blanc, CNRS, IN2P3-LAPP, Annecy, France
| | - M Tobin
- Institute Of High Energy Physics (IHEP), Beijing, China
| | | | - G Tonani
- INFN Sezione di Milano, Milano, Italy
| | - X Tong
- School of Physics State Key Laboratory of Nuclear Physics and Technology, Peking University, Beijing, China
| | - D Torres Machado
- Centro Brasileiro de Pesquisas Físicas (CBPF), Rio de Janeiro, Brazil
| | - D Y Tou
- Center for High Energy Physics, Tsinghua University, Beijing, China
| | - C Trippl
- Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
| | - G Tuci
- University of Chinese Academy of Sciences, Beijing, China
| | - N Tuning
- Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands
| | - A Ukleja
- National Center for Nuclear Research (NCBJ), Warsaw, Poland
| | - D J Unverzagt
- Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
| | - A Usachov
- Nikhef National Institute for Subatomic Physics and VU University Amsterdam, Amsterdam, Netherlands
| | - A Ustyuzhanin
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - U Uwer
- Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
| | - A Vagner
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - V Vagnoni
- INFN Sezione di Bologna, Bologna, Italy
| | - A Valassi
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - G Valenti
- INFN Sezione di Bologna, Bologna, Italy
| | - N Valls Canudas
- DS4DS, La Salle, Universitat Ramon Llull, Barcelona, Spain (associated with ICCUB, Universitat de Barcelona, Barcelona, Spain)
| | - M Van Dijk
- Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
| | - H Van Hecke
- Los Alamos National Laboratory (LANL), Los Alamos, NM, United States
| | | | - C B Van Hulse
- Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
| | - M van Veghel
- Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands
| | | | - P Vazquez Regueiro
- Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
| | - C Vázquez Sierra
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - S Vecchi
- INFN Sezione di Ferrara, Ferrara, Italy
| | - J J Velthuis
- H.H. Wills Physics Laboratory, University of Bristol, Bristol, United Kingdom
| | - M Veltri
- INFN Sezione di Firenze, Firenze, Italy
| | - A Venkateswaran
- Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
| | - M Veronesi
- Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands
| | - M Vesterinen
- Department of Physics, University of Warwick, Coventry, United Kingdom
| | - D Vieira
- University of Cincinnati, Cincinnati, OH, United States
| | - M Vieites Diaz
- Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
| | - X Vilasis-Cardona
- DS4DS, La Salle, Universitat Ramon Llull, Barcelona, Spain (associated with ICCUB, Universitat de Barcelona, Barcelona, Spain)
| | - E Vilella Figueras
- Oliver Lodge Laboratory, University of Liverpool, Liverpool, United Kingdom
| | - A Villa
- INFN Sezione di Bologna, Bologna, Italy
| | - P Vincent
- LPNHE, Sorbonne Université, Paris Diderot Sorbonne Paris Cité, CNRS/IN2P3, Paris, France
| | - F C Volle
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, Orsay, France
| | - D Vom Bruch
- Aix Marseille Univ, CNRS/IN2P3, CPPM, Marseille, France
| | - A Vorobyev
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - V Vorobyev
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - N Voropaev
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - K Vos
- Universiteit Maastricht, Maastricht, Netherlands (associated with Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands)
| | - C Vrahas
- School of Physics and Astronomy, University of Edinburgh, Edinburgh, United Kingdom
| | - J Walsh
- INFN Sezione di Pisa, Pisa, Italy
| | - E J Walton
- School of Physics and Astronomy, Monash University, Melbourne, Australia (associated with Department of Physics, University of Warwick, Coventry, United Kingdom)
| | - G Wan
- School of Physics State Key Laboratory of Nuclear Physics and Technology, Peking University, Beijing, China
| | - C Wang
- Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
| | - G Wang
- Institute of Particle Physics, Central China Normal University, Wuhan, Hubei, China
| | - J Wang
- School of Physics State Key Laboratory of Nuclear Physics and Technology, Peking University, Beijing, China
| | - J Wang
- Institute Of High Energy Physics (IHEP), Beijing, China
| | - J Wang
- Center for High Energy Physics, Tsinghua University, Beijing, China
| | - J Wang
- School of Physics and Technology, Wuhan University, Wuhan, China (associated with Center for High Energy Physics, Tsinghua University, Beijing, China)
| | - M Wang
- INFN Sezione di Milano, Milano, Italy
| | - R Wang
- H.H. Wills Physics Laboratory, University of Bristol, Bristol, United Kingdom
| | - X Wang
- Guangdong Provincial Key Laboratory of Nuclear Science, Guangdong-Hong Kong Joint Laboratory of Quantum Matter, Institute of Quantum Matter, South China Normal University, Guangzhou, China (associated with Center for High Energy Physics, Tsinghua University, Beijing, China)
| | - Y Wang
- Institute of Particle Physics, Central China Normal University, Wuhan, Hubei, China
| | - Z Wang
- Physik-Institut, Universität Zürich, Zürich, Switzerland
| | - Z Wang
- Center for High Energy Physics, Tsinghua University, Beijing, China
| | - Z Wang
- University of Chinese Academy of Sciences, Beijing, China
| | - J A Ward
- Department of Physics, University of Warwick, Coventry, United Kingdom
- School of Physics and Astronomy, Monash University, Melbourne, Australia (associated with Department of Physics, University of Warwick, Coventry, United Kingdom)
| | - N K Watson
- University of Birmingham, Birmingham, United Kingdom
| | - D Websdale
- Imperial College London, London, United Kingdom
| | - Y Wei
- School of Physics State Key Laboratory of Nuclear Physics and Technology, Peking University, Beijing, China
| | - B D C Westhenry
- H.H. Wills Physics Laboratory, University of Bristol, Bristol, United Kingdom
| | - D J White
- Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
| | - M Whitehead
- School of Physics and Astronomy, University of Glasgow, Glasgow, United Kingdom
| | - A R Wiederhold
- Department of Physics, University of Warwick, Coventry, United Kingdom
| | - D Wiedner
- Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
| | - G Wilkinson
- Department of Physics, University of Oxford, Oxford, United Kingdom
| | - M K Wilkinson
- University of Cincinnati, Cincinnati, OH, United States
| | - I Williams
- Cavendish Laboratory, University of Cambridge, Cambridge, United Kingdom
| | - M Williams
- Massachusetts Institute of Technology, Cambridge, MA, United States
| | - M R J Williams
- School of Physics and Astronomy, University of Edinburgh, Edinburgh, United Kingdom
| | - R Williams
- Cavendish Laboratory, University of Cambridge, Cambridge, United Kingdom
| | - F F Wilson
- STFC Rutherford Appleton Laboratory, Didcot, United Kingdom
| | - W Wislicki
- National Center for Nuclear Research (NCBJ), Warsaw, Poland
| | - M Witek
- Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland
| | - L Witola
- Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
| | - C P Wong
- Los Alamos National Laboratory (LANL), Los Alamos, NM, United States
| | - G Wormser
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, Orsay, France
| | - S A Wotton
- Cavendish Laboratory, University of Cambridge, Cambridge, United Kingdom
| | - H Wu
- Syracuse University, Syracuse, NY, United States
| | - J Wu
- Institute of Particle Physics, Central China Normal University, Wuhan, Hubei, China
| | - K Wyllie
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - Z Xiang
- University of Chinese Academy of Sciences, Beijing, China
| | - Y Xie
- Institute of Particle Physics, Central China Normal University, Wuhan, Hubei, China
| | - A Xu
- School of Physics State Key Laboratory of Nuclear Physics and Technology, Peking University, Beijing, China
| | - J Xu
- University of Chinese Academy of Sciences, Beijing, China
| | - L Xu
- Center for High Energy Physics, Tsinghua University, Beijing, China
| | - L Xu
- Center for High Energy Physics, Tsinghua University, Beijing, China
| | - M Xu
- Department of Physics, University of Warwick, Coventry, United Kingdom
| | - Q Xu
- University of Chinese Academy of Sciences, Beijing, China
| | - Z Xu
- Université Clermont Auvergne, CNRS/IN2P3, LPC, Clermont-Ferrand, France
| | - Z Xu
- University of Chinese Academy of Sciences, Beijing, China
| | - D Yang
- Center for High Energy Physics, Tsinghua University, Beijing, China
| | - S Yang
- University of Chinese Academy of Sciences, Beijing, China
| | - X Yang
- School of Physics State Key Laboratory of Nuclear Physics and Technology, Peking University, Beijing, China
| | - Y Yang
- University of Chinese Academy of Sciences, Beijing, China
| | - Z Yang
- School of Physics State Key Laboratory of Nuclear Physics and Technology, Peking University, Beijing, China
| | - Z Yang
- University of Maryland, College Park, MD, United States
| | - L E Yeomans
- Oliver Lodge Laboratory, University of Liverpool, Liverpool, United Kingdom
| | - V Yeroshenko
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, Orsay, France
| | - H Yeung
- Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
| | - H Yin
- Institute of Particle Physics, Central China Normal University, Wuhan, Hubei, China
| | - J Yu
- Physics and Micro Electronic College, Hunan University, Changsha City, China (associated with Institute of Particle Physics, Central China Normal University, Wuhan, Hubei, China)
| | - X Yuan
- Syracuse University, Syracuse, NY, United States
| | - E Zaffaroni
- Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
| | - M Zavertyaev
- Max-Planck-Institut für Kernphysik (MPIK), Heidelberg, Germany
| | - M Zdybal
- Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland
| | - M Zeng
- Center for High Energy Physics, Tsinghua University, Beijing, China
| | - C Zhang
- School of Physics State Key Laboratory of Nuclear Physics and Technology, Peking University, Beijing, China
| | - D Zhang
- Institute of Particle Physics, Central China Normal University, Wuhan, Hubei, China
| | - L Zhang
- Center for High Energy Physics, Tsinghua University, Beijing, China
| | - S Zhang
- Physics and Micro Electronic College, Hunan University, Changsha City, China (associated with Institute of Particle Physics, Central China Normal University, Wuhan, Hubei, China)
| | - S Zhang
- School of Physics State Key Laboratory of Nuclear Physics and Technology, Peking University, Beijing, China
| | - Y Zhang
- School of Physics State Key Laboratory of Nuclear Physics and Technology, Peking University, Beijing, China
| | - Y Zhang
- Department of Physics, University of Oxford, Oxford, United Kingdom
| | - Y Zhao
- Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
| | - A Zharkova
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - A Zhelezov
- Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
| | - Y Zheng
- University of Chinese Academy of Sciences, Beijing, China
| | - T Zhou
- School of Physics State Key Laboratory of Nuclear Physics and Technology, Peking University, Beijing, China
| | - X Zhou
- Institute of Particle Physics, Central China Normal University, Wuhan, Hubei, China
| | - Y Zhou
- University of Chinese Academy of Sciences, Beijing, China
| | - V Zhovkovska
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, Orsay, France
| | - X Zhu
- Center for High Energy Physics, Tsinghua University, Beijing, China
| | - X Zhu
- Institute of Particle Physics, Central China Normal University, Wuhan, Hubei, China
| | - Z Zhu
- University of Chinese Academy of Sciences, Beijing, China
| | - V Zhukov
- I. Physikalisches Institut, RWTH Aachen University, Aachen, Germany
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - Q Zou
- Institute Of High Energy Physics (IHEP), Beijing, China
- University of Chinese Academy of Sciences, Beijing, China
| | | | - D Zuliani
- Università degli Studi di Padova, Università e INFN, Padova, Padova, Italy
| | - G Zunica
- Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
| |
Collapse
|
193
|
Aaij R, Abdelmotteleb ASW, Abellan Beteta C, Abudinén F, Ackernley T, Adeva B, Adinolfi M, Adlarson P, Afsharnia H, Agapopoulou C, Aidala CA, Ajaltouni Z, Akar S, Akiba K, Albicocco P, Albrecht J, Alessio F, Alexander M, Alfonso Albero A, Aliouche Z, Alvarez Cartelle P, Amalric R, Amato S, Amey JL, Amhis Y, An L, Anderlini L, Andersson M, Andreianov A, Andreotti M, Andreou D, Ao D, Archilli F, Artamonov A, Artuso M, Aslanides E, Atzeni M, Audurier B, Bachiller Perea I, Bachmann S, Bachmayer M, Back JJ, Bailly-Reyre A, Baladron Rodriguez P, Balagura V, Baldini W, Baptista de Souza Leite J, Barbetti M, Barlow RJ, Barsuk S, Barter W, Bartolini M, Baryshnikov F, Basels JM, Bassi G, Batsukh B, Battig A, Bay A, Beck A, Becker M, Bedeschi F, Bediaga IB, Beiter A, Belin S, Bellee V, Belous K, Belov I, Belyaev I, Benane G, Bencivenni G, Ben-Haim E, Berezhnoy A, Bernet R, Bernet Andres S, Berninghoff D, Bernstein HC, Bertella C, Bertolin A, Betancourt C, Betti F, Bezshyiko I, Bhasin S, Bhom J, Bian L, Bieker MS, Biesuz NV, Billoir P, Biolchini A, Birch M, Bishop FCR, Bitadze A, Bizzeti A, Blago MP, Blake T, Blanc F, Blank JE, Blusk S, Bobulska D, Boelhauve JA, Boente Garcia O, Boettcher T, Boldyrev A, Bolognani CS, Bolzonella R, Bondar N, Borgato F, Borghi S, Borsato M, Borsuk JT, Bouchiba SA, Bowcock TJV, Boyer A, Bozzi C, Bradley MJ, Braun S, Brea Rodriguez A, Brodzicka J, Brossa Gonzalo A, Brown J, Brundu D, Buonaura A, Buonincontri L, Burke AT, Burr C, Bursche A, Butkevich A, Butter JS, Buytaert J, Byczynski W, Cadeddu S, Cai H, Calabrese R, Calefice L, Cali S, Calvi M, Calvo Gomez M, Campana P, Campora Perez DH, Campoverde Quezada AF, Capelli S, Capriotti L, Carbone A, Cardinale R, Cardini A, Carniti P, Carus L, Casais Vidal A, Caspary R, Casse G, Cattaneo M, Cavallero G, Cavallini V, Celani S, Cerasoli J, Cervenkov D, Chadwick AJ, Chahrour I, Chapman MG, Charles M, Charpentier P, Chavez Barajas CA, Chefdeville M, Chen C, Chen S, Chernov A, Chernyshenko S, Chobanova V, Cholak S, Chrzaszcz M, Chubykin A, Chulikov V, Ciambrone P, Cicala MF, Cid Vidal X, Ciezarek G, Cifra P, Ciullo G, Clarke PEL, Clemencic M, Cliff HV, Closier J, Cobbledick JL, Coco V, Cogan J, Cogneras E, Cojocariu L, Collins P, Colombo T, Congedo L, Contu A, Cooke N, Corredoira I, Corti G, Couturier B, Craik DC, Cruz Torres M, Currie R, Da Silva CL, Dadabaev S, Dai L, Dai X, Dall'Occo E, Dalseno J, D'Ambrosio C, Daniel J, Danilina A, d'Argent P, Davies JE, Davis A, De Aguiar Francisco O, de Boer J, De Bruyn K, De Capua S, De Cian M, De Freitas Carneiro Da Graca U, De Lucia E, De Miranda JM, De Paula L, De Serio M, De Simone D, De Simone P, De Vellis F, de Vries JA, Dean CT, Debernardis F, Decamp D, Dedu V, Del Buono L, Delaney B, Dembinski HP, Denysenko V, Deschamps O, Dettori F, Dey B, Di Nezza P, Diachkov I, Didenko S, Dieste Maronas L, Ding S, Dobishuk V, Dolmatov A, Dong C, Donohoe AM, Dordei F, Dos Reis AC, Douglas L, Downes AG, Duda P, Dudek MW, Dufour L, Duk V, Durante P, Duras MM, Durham JM, Dutta D, Dziurda A, Dzyuba A, Easo S, Egede U, Egorychev V, Eirea Orro C, Eisenhardt S, Ejopu E, Ek-In S, Eklund L, Elashri M, Ellbracht J, Ely S, Ene A, Epple E, Escher S, Eschle J, Esen S, Evans T, Fabiano F, Falcao LN, Fan Y, Fang B, Fantini L, Faria M, Farry S, Fazzini D, Felkowski L, Feo M, Fernandez Gomez M, Fernez AD, Ferrari F, Ferreira Lopes L, Ferreira Rodrigues F, Ferreres Sole S, Ferrillo M, Ferro-Luzzi M, Filippov S, Fini RA, Fiorini M, Firlej M, Fischer KM, Fitzgerald DS, Fitzpatrick C, Fiutowski T, Fleuret F, Fontana M, Fontanelli F, Forty R, Foulds-Holt D, Franco Lima V, Franco Sevilla M, Frank M, Franzoso E, Frau G, Frei C, Friday DA, Frontini L, Fu J, Fuehring Q, Fulghesu T, Gabriel E, Galati G, Galati MD, Gallas Torreira A, Galli D, Gambetta S, Gandelman M, Gandini P, Gao Y, Gao Y, Garau M, Garcia Martin LM, Garcia Moreno P, García Pardiñas J, Garcia Plana B, Garcia Rosales FA, Garrido L, Gaspar C, Geertsema RE, Gerick D, Gerken LL, Gersabeck E, Gersabeck M, Gershon T, Giambastiani L, Gibson V, Giemza HK, Gilman AL, Giovannetti M, Gioventù A, Gironella Gironell P, Giugliano C, Giza MA, Gizdov K, Gkougkousis EL, Gligorov VV, Göbel C, Golobardes E, Golubkov D, Golutvin A, Gomes A, Gomez Fernandez S, Goncalves Abrantes F, Goncerz M, Gong G, Gorelov IV, Gotti C, Grabowski JP, Grammatico T, Granado Cardoso LA, Graugés E, Graverini E, Graziani G, Grecu AT, Greeven LM, Grieser NA, Grillo L, Gromov S, Gruberg Cazon BR, Gu C, Guarise M, Guittiere M, Günther PA, Gushchin E, Guth A, Guz Y, Gys T, Hadavizadeh T, Hadjivasiliou C, Haefeli G, Haen C, Haimberger J, Haines SC, Halewood-Leagas T, Halvorsen MM, Hamilton PM, Hammerich J, Han Q, Han X, Hansen EB, Hansmann-Menzemer S, Hao L, Harnew N, Harrison T, Hasse C, Hatch M, He J, Heijhoff K, Hemmer FH, Henderson C, Henderson RDL, Hennequin AM, Hennessy K, Henry L, Herd J, Heuel J, Hicheur A, Hill D, Hilton M, Hollitt SE, Horswill J, Hou R, Hou Y, Hu J, Hu J, Hu W, Hu X, Huang W, Huang X, Hulsbergen W, Hunter RJ, Hushchyn M, Hutchcroft D, Ibis P, Idzik M, Ilin D, Ilten P, Inglessi A, Iniukhin A, Ishteev A, Ivshin K, Jacobsson R, Jage H, Jaimes Elles SJ, Jakobsen S, Jans E, Jashal BK, Jawahery A, Jevtic V, Jiang E, Jiang X, Jiang Y, John M, Johnson D, Jones CR, Jones TP, Jost B, Jurik N, Juszczak I, Kandybei S, Kang Y, Karacson M, Karpenkov D, Karpov M, Kautz JW, Keizer F, Keller DM, Kenzie M, Ketel T, Khanji B, Kharisova A, Kholodenko S, Khreich G, Kirn T, Kirsebom VS, Kitouni O, Klaver S, Kleijne N, Klimaszewski K, Kmiec MR, Koliiev S, Kolk L, Kondybayeva A, Konoplyannikov A, Kopciewicz P, Kopecna R, Koppenburg P, Korolev M, Kostiuk I, Kot O, Kotriakhova S, Kozachuk A, Kravchenko P, Kravchuk L, Krawczyk RD, Kreps M, Kretzschmar S, Krokovny P, Krupa W, Krzemien W, Kubat J, Kubis S, Kucewicz W, Kucharczyk M, Kudryavtsev V, Kulikova E, Kupsc A, Lacarrere D, Lafferty G, Lai A, Lampis A, Lancierini D, Landesa Gomez C, Lane JJ, Lane R, Langenbruch C, Langer J, Lantwin O, Latham T, Lazzari F, Lazzaroni M, Le Gac R, Lee SH, Lefèvre R, Leflat A, Legotin S, Lenisa P, Leroy O, Lesiak T, Leverington B, Li A, Li H, Li K, Li P, Li PR, Li S, Li T, Li T, Li Y, Li Z, Liang X, Lin C, Lin T, Lindner R, Lisovskyi V, Litvinov R, Liu G, Liu H, Liu Q, Liu S, Lobo Salvia A, Loi A, Lollini R, Lomba Castro J, Longstaff I, Lopes JH, Lopez Huertas A, López Soliño S, Lovell GH, Lu Y, Lucarelli C, Lucchesi D, Luchuk S, Lucio Martinez M, Lukashenko V, Luo Y, Lupato A, Luppi E, Lusiani A, Lynch K, Lyu XR, Ma R, Maccolini S, Machefert F, Maciuc F, Mackay I, Macko V, Madhan Mohan LR, Maevskiy A, Maisuzenko D, Majewski MW, Malczewski JJ, Malde S, Malecki B, Malinin A, Maltsev T, Manca G, Mancinelli G, Mancuso C, Manera Escalero R, Manuzzi D, Manzari CA, Marangotto D, Marchand JF, Marconi U, Mariani S, Marin Benito C, Marks J, Marshall AM, Marshall PJ, Martelli G, Martellotti G, Martinazzoli L, Martinelli M, Martinez Santos D, Martinez Vidal F, Massafferri A, Materok M, Matev R, Mathad A, Matiunin V, Matteuzzi C, Mattioli KR, Mauri A, Maurice E, Mauricio J, Mazurek M, McCann M, Mcconnell L, McGrath TH, McHugh NT, McNab A, McNulty R, Mead JV, Meadows B, Meier G, Melnychuk D, Meloni S, Merk M, Merli A, Meyer Garcia L, Miao D, Mikhasenko M, Milanes DA, Millard E, Milovanovic M, Minard MN, Minotti A, Miralles T, Mitchell SE, Mitreska B, Mitzel DS, Mödden A, Mohammed RA, Moise RD, Mokhnenko S, Mombächer T, Monk M, Monroy IA, Monteil S, Morello G, Morello MJ, Morgenthaler MP, Moron J, Morris AB, Morris AG, Mountain R, Mu H, Muhammad E, Muheim F, Mulder M, Müller K, Murphy CH, Murray D, Murta R, Muzzetto P, Naik P, Nakada T, Nandakumar R, Nanut T, Nasteva I, Needham M, Neri N, Neubert S, Neufeld N, Neustroev P, Newcombe R, Nicolini J, Nicotra D, Niel EM, Nieswand S, Nikitin N, Nolte NS, Normand C, Novoa Fernandez J, Nowak G, Nunez C, Oblakowska-Mucha A, Obraztsov V, Oeser T, Okamura S, Oldeman R, Oliva F, Onderwater CJG, O'Neil RH, Otalora Goicochea JM, Ovsiannikova T, Owen P, Oyanguren A, Ozcelik O, Padeken KO, Pagare B, Pais PR, Pajero T, Palano A, Palutan M, Pan Y, Panshin G, Paolucci L, Papanestis A, Pappagallo M, Pappalardo LL, Pappenheimer C, Parker W, Parkes C, Passalacqua B, Passaleva G, Pastore A, Patel M, Patrignani C, Pawley CJ, Pellegrino A, Pepe Altarelli M, Perazzini S, Pereima D, Pereiro Castro A, Perret P, Petridis K, Petrolini A, Petrov A, Petrucci S, Petruzzo M, Pham H, Philippov A, Piandani R, Pica L, Piccini M, Pietrzyk B, Pietrzyk G, Pili M, Pinci D, Pisani F, Pizzichemi M, Placinta V, Plews J, Plo Casasus M, Polci F, Poli Lener M, Poluektov A, Polukhina N, Polyakov I, Polycarpo E, Ponce S, Popov D, Poslavskii S, Prasanth K, Promberger L, Prouve C, Pugatch V, Puill V, Punzi G, Qi HR, Qian W, Qin N, Qu S, Quagliani R, Raab NV, Rachwal B, Rademacker JH, Rajagopalan R, Rama M, Ramos Pernas M, Rangel MS, Ratnikov F, Raven G, Rebollo De Miguel M, Redi F, Reich J, Reiss F, Remon Alepuz C, Ren Z, Resmi PK, Ribatti R, Ricci AM, Ricciardi S, Richardson K, Richardson-Slipper M, Rinnert K, Robbe P, Robertson G, Rodrigues AB, Rodrigues E, Rodriguez Fernandez E, Rodriguez Lopez JA, Rodriguez Rodriguez E, Rolf DL, Rollings A, Roloff P, Romanovskiy V, Romero Lamas M, Romero Vidal A, Roth JD, Rotondo M, Rudolph MS, Ruf T, Ruiz Fernandez RA, Ruiz Vidal J, Ryzhikov A, Ryzka J, Saborido Silva JJ, Sagidova N, Sahoo N, Saitta B, Salomoni M, Sanchez Gras C, Sanderswood I, Santacesaria R, Santamarina Rios C, Santimaria M, Santovetti E, Saranin D, Sarpis G, Sarpis M, Sarti A, Satriano C, Satta A, Saur M, Savrina D, Sazak H, Scantlebury Smead LG, Scarabotto A, Schael S, Scherl S, Schiller M, Schindler H, Schmelling M, Schmidt B, Schmitt S, Schneider O, Schopper A, Schubiger M, Schulte S, Schune MH, Schwemmer R, Sciascia B, Sciuccati A, Sellam S, Semennikov A, Senghi Soares M, Sergi A, Serra N, Sestini L, Seuthe A, Shang Y, Shangase DM, Shapkin M, Shchemerov I, Shchutska L, Shears T, Shekhtman L, Shen Z, Sheng S, Shevchenko V, Shi B, Shields EB, Shimizu Y, Shmanin E, Shorkin R, Shupperd JD, Siddi BG, Silva Coutinho R, Simi G, Simone S, Singla M, Skidmore N, Skuza R, Skwarnicki T, Slater MW, Smallwood JC, Smeaton JG, Smith E, Smith K, Smith M, Snoch A, Soares Lavra L, Sokoloff MD, Soler FJP, Solomin A, Solovev A, Solovyev I, Song R, Souza De Almeida FL, Souza De Paula B, Spaan B, Spadaro Norella E, Spedicato E, Spiridenkov E, Spradlin P, Sriskaran V, Stagni F, Stahl M, Stahl S, Stanislaus S, Stein EN, Steinkamp O, Stenyakin O, Stevens H, Stone S, Strekalina D, Su Y, Suljik F, Sun J, Sun L, Sun Y, Svihra P, Swallow PN, Swientek K, Szabelski A, Szumlak T, Szymanski M, Tan Y, Taneja S, Tat MD, Terentev A, Teubert F, Thomas E, Thompson DJD, Thomson KA, Tilquin H, Tisserand V, T'Jampens S, Tobin M, Tomassetti L, Tonani G, Tong X, Torres Machado D, Tou DY, Trilov SM, Trippl C, Tuci G, Tuning N, Ukleja A, Unverzagt DJ, Usachov A, Ustyuzhanin A, Uwer U, Vagner A, Vagnoni V, Valassi A, Valenti G, Valls Canudas N, Van Dijk M, Van Hecke H, van Herwijnen E, Van Hulse CB, van Veghel M, Vazquez Gomez R, Vazquez Regueiro P, Vázquez Sierra C, Vecchi S, Velthuis JJ, Veltri M, Venkateswaran A, Veronesi M, Vesterinen M, Vieira D, Vieites Diaz M, Vilasis-Cardona X, Vilella Figueras E, Villa A, Vincent P, Volle FC, Vom Bruch D, Vorobyev A, Vorobyev V, Voropaev N, Vos K, Vrahas C, Walsh J, Walton EJ, Wan G, Wang C, Wang G, Wang J, Wang J, Wang J, Wang J, Wang M, Wang R, Wang X, Wang Y, Wang Z, Wang Z, Wang Z, Ward JA, Watson NK, Websdale D, Wei Y, Westhenry BDC, White DJ, Whitehead M, Wiederhold AR, Wiedner D, Wilkinson G, Wilkinson MK, Williams I, Williams M, Williams MRJ, Williams R, Wilson FF, Wislicki W, Witek M, Witola L, Wong CP, Wormser G, Wotton SA, Wu H, Wu J, Wyllie K, Xiang Z, Xie Y, Xu A, Xu J, Xu L, Xu L, Xu M, Xu Q, Xu Z, Xu Z, Yang D, Yang S, Yang X, Yang Y, Yang Z, Yang Z, Yeomans LE, Yeroshenko V, Yeung H, Yin H, Yu J, Yuan X, Zaffaroni E, Zavertyaev M, Zdybal M, Zeng M, Zhang C, Zhang D, Zhang L, Zhang S, Zhang S, Zhang Y, Zhang Y, Zhao Y, Zharkova A, Zhelezov A, Zheng Y, Zhou T, Zhou X, Zhou Y, Zhovkovska V, Zhu X, Zhu X, Zhu Z, Zhukov V, Zou Q, Zucchelli S, Zuliani D, Zunica G. Evidence of a J/ψK_{S}^{0} Structure in B^{0}→J/ψϕK_{S}^{0} Decays. Phys Rev Lett 2023; 131:131901. [PMID: 37832008 DOI: 10.1103/physrevlett.131.131901] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/17/2023] [Accepted: 03/21/2023] [Indexed: 10/15/2023]
Abstract
An amplitude analysis of B^{0}→J/ψϕK_{S}^{0} decays is performed using proton-proton collision data, corresponding to an integrated luminosity of 9 fb^{-1}, collected with the LHCb detector at center-of-mass energies of 7, 8, and 13 TeV. Evidence with a significance of 4.0 standard deviations of a structure in the J/ψK_{S}^{0} system, named T_{ψs1}^{θ}(4000)^{0}, is seen, with its mass and width measured to be 3991_{-10}^{+12} _{-17}^{+9} MeV/c^{2} and 105_{-25}^{+29} _{-23}^{+17} MeV, respectively, where the first uncertainty is statistical and the second systematic. The T_{ψs1}^{θ}(4000)^{0} state is likely to be the isospin partner of the T_{ψs1}^{θ}(4000)^{+} state, previously observed in the J/ψK^{+} system of the B^{+}→J/ψϕK^{+} decay. When isospin symmetry for the charged and neutral T_{ψs1}^{θ}(4000) states is assumed, the signal significance increases to 5.4 standard deviations.
Collapse
Affiliation(s)
- R Aaij
- Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands
| | | | | | - F Abudinén
- Department of Physics, University of Warwick, Coventry, United Kingdom
| | - T Ackernley
- Oliver Lodge Laboratory, University of Liverpool, Liverpool, United Kingdom
| | - B Adeva
- Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
| | - M Adinolfi
- H.H. Wills Physics Laboratory, University of Bristol, Bristol, United Kingdom
| | - P Adlarson
- Department of Physics and Astronomy, Uppsala University, Uppsala, Sweden (associated with Institution School of Physics and Astronomy, University of Glasgow, Glasgow, United Kingdom)
| | - H Afsharnia
- Université Clermont Auvergne, CNRS/IN2P3, LPC, Clermont-Ferrand, France
| | - C Agapopoulou
- LPNHE, Sorbonne Université, Paris Diderot Sorbonne Paris Cité, CNRS/IN2P3, Paris, France
| | - C A Aidala
- University of Michigan, Ann Arbor, 48109 Michigan, USA (associated with Institution Syracuse University, Syracuse, New York, USA)
| | - Z Ajaltouni
- Université Clermont Auvergne, CNRS/IN2P3, LPC, Clermont-Ferrand, France
| | - S Akar
- University of Cincinnati, Cincinnati, 45221 Ohio, USA
| | - K Akiba
- Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands
| | - P Albicocco
- INFN Laboratori Nazionali di Frascati, Frascati, Italy
| | - J Albrecht
- Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
| | - F Alessio
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - M Alexander
- School of Physics and Astronomy, University of Glasgow, Glasgow, United Kingdom
| | | | - Z Aliouche
- Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
| | - P Alvarez Cartelle
- Cavendish Laboratory, University of Cambridge, Cambridge, United Kingdom
| | - R Amalric
- LPNHE, Sorbonne Université, Paris Diderot Sorbonne Paris Cité, CNRS/IN2P3, Paris, France
| | - S Amato
- Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil
| | - J L Amey
- H.H. Wills Physics Laboratory, University of Bristol, Bristol, United Kingdom
| | - Y Amhis
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, Orsay, France
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - L An
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | | | - M Andersson
- Physik-Institut, Universität Zürich, Zürich, Switzerland
| | - A Andreianov
- Affiliated with an institute covered by a cooperation agreement with CERN
| | | | - D Andreou
- Syracuse University, Syracuse, 13244 New York, USA
| | - D Ao
- University of Chinese Academy of Sciences, Beijing, China
| | - F Archilli
- INFN Sezione di Roma Tor Vergata, Roma, Italy
| | - A Artamonov
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - M Artuso
- Syracuse University, Syracuse, 13244 New York, USA
| | - E Aslanides
- Aix Marseille Univ, CNRS/IN2P3, CPPM, Marseille, France
| | - M Atzeni
- Physik-Institut, Universität Zürich, Zürich, Switzerland
| | - B Audurier
- Laboratoire Leprince-Ringuet, CNRS/IN2P3, Ecole Polytechnique, Institut Polytechnique de Paris, Palaiseau, France
| | | | - S Bachmann
- Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
| | - M Bachmayer
- Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
| | - J J Back
- Department of Physics, University of Warwick, Coventry, United Kingdom
| | - A Bailly-Reyre
- LPNHE, Sorbonne Université, Paris Diderot Sorbonne Paris Cité, CNRS/IN2P3, Paris, France
| | - P Baladron Rodriguez
- Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
| | - V Balagura
- Laboratoire Leprince-Ringuet, CNRS/IN2P3, Ecole Polytechnique, Institut Polytechnique de Paris, Palaiseau, France
| | - W Baldini
- INFN Sezione di Ferrara, Ferrara, Italy
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | | | | | - R J Barlow
- Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
| | - S Barsuk
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, Orsay, France
| | - W Barter
- School of Physics and Astronomy, University of Edinburgh, Edinburgh, United Kingdom
| | - M Bartolini
- Cavendish Laboratory, University of Cambridge, Cambridge, United Kingdom
| | - F Baryshnikov
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - J M Basels
- I. Physikalisches Institut, RWTH Aachen University, Aachen, Germany
| | - G Bassi
- INFN Sezione di Pisa, Pisa, Italy
| | - B Batsukh
- Institute of High Energy Physics (IHEP), Beijing, China
| | - A Battig
- Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
| | - A Bay
- Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
| | - A Beck
- Department of Physics, University of Warwick, Coventry, United Kingdom
| | - M Becker
- Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
| | | | - I B Bediaga
- Centro Brasileiro de Pesquisas Físicas (CBPF), Rio de Janeiro, Brazil
| | - A Beiter
- Syracuse University, Syracuse, 13244 New York, USA
| | - S Belin
- Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
| | - V Bellee
- Physik-Institut, Universität Zürich, Zürich, Switzerland
| | - K Belous
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - I Belov
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - I Belyaev
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - G Benane
- Aix Marseille Univ, CNRS/IN2P3, CPPM, Marseille, France
| | - G Bencivenni
- INFN Laboratori Nazionali di Frascati, Frascati, Italy
| | - E Ben-Haim
- LPNHE, Sorbonne Université, Paris Diderot Sorbonne Paris Cité, CNRS/IN2P3, Paris, France
| | - A Berezhnoy
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - R Bernet
- Physik-Institut, Universität Zürich, Zürich, Switzerland
| | - S Bernet Andres
- DS4DS, La Salle, Universitat Ramon Llull, Barcelona, Spain (associated with Institution ICCUB, Universitat de Barcelona, Barcelona, Spain)
| | - D Berninghoff
- Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
| | | | - C Bertella
- Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
| | - A Bertolin
- Università degli Studi di Padova, Università e INFN, Padova, Padova, Italy
| | - C Betancourt
- Physik-Institut, Universität Zürich, Zürich, Switzerland
| | - F Betti
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - Ia Bezshyiko
- Physik-Institut, Universität Zürich, Zürich, Switzerland
| | - S Bhasin
- H.H. Wills Physics Laboratory, University of Bristol, Bristol, United Kingdom
| | - J Bhom
- Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland
| | - L Bian
- School of Physics and Technology, Wuhan University, Wuhan, China (associated with Institution Center for High Energy Physics, Tsinghua University, Beijing, China)
| | - M S Bieker
- Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
| | | | - P Billoir
- LPNHE, Sorbonne Université, Paris Diderot Sorbonne Paris Cité, CNRS/IN2P3, Paris, France
| | - A Biolchini
- Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands
| | - M Birch
- Imperial College London, London, United Kingdom
| | - F C R Bishop
- Cavendish Laboratory, University of Cambridge, Cambridge, United Kingdom
| | - A Bitadze
- Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
| | - A Bizzeti
- Centro Brasileiro de Pesquisas Físicas (CBPF), Rio de Janeiro, Brazil
- Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil
- Center for High Energy Physics, Tsinghua University, Beijing, China
- Institute of High Energy Physics (IHEP), Beijing, China
- School of Physics State Key Laboratory of Nuclear Physics and Technology, Peking University, Beijing, China
- University of Chinese Academy of Sciences, Beijing, China
- Institute of Particle Physics, Central China Normal University, Wuhan, Hubei, China
- Université Savoie Mont Blanc, CNRS, IN2P3-LAPP, Annecy, France
- Université Clermont Auvergne, CNRS/IN2P3, LPC, Clermont-Ferrand, France
- Aix Marseille Univ, CNRS/IN2P3, CPPM, Marseille, France
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, Orsay, France
- Laboratoire Leprince-Ringuet, CNRS/IN2P3, Ecole Polytechnique, Institut Polytechnique de Paris, Palaiseau, France
- LPNHE, Sorbonne Université, Paris Diderot Sorbonne Paris Cité, CNRS/IN2P3, Paris, France
- I. Physikalisches Institut, RWTH Aachen University, Aachen, Germany
- Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
- Max-Planck-Institut für Kernphysik (MPIK), Heidelberg, Germany
- Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
- School of Physics, University College Dublin, Dublin, Ireland
- INFN Sezione di Bari, Bari, Italy
- INFN Sezione di Bologna, Bologna, Italy
- INFN Sezione di Ferrara, Ferrara, Italy
- INFN Sezione di Firenze, Firenze, Italy
- INFN Laboratori Nazionali di Frascati, Frascati, Italy
- INFN Sezione di Genova, Genova, Italy
- INFN Sezione di Milano, Milano, Italy
- INFN Sezione di Milano-Bicocca, Milano, Italy
- INFN Sezione di Cagliari, Monserrato, Italy
- Università degli Studi di Padova, Università e INFN, Padova, Padova, Italy
- INFN Sezione di Pisa, Pisa, Italy
- INFN Sezione di Roma La Sapienza, Roma, Italy
- INFN Sezione di Roma Tor Vergata, Roma, Italy
- Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands
- Nikhef National Institute for Subatomic Physics and VU University Amsterdam, Amsterdam, Netherlands
- AGH - University of Science and Technology, Faculty of Physics and Applied Computer Science, Kraków, Poland
- Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland
- National Center for Nuclear Research (NCBJ), Warsaw, Poland
- Horia Hulubei National Institute of Physics and Nuclear Engineering, Bucharest-Magurele, Romania
- Affiliated with an institute covered by a cooperation agreement with CERN
- ICCUB, Universitat de Barcelona, Barcelona, Spain
- Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
- Instituto de Fisica Corpuscular, Centro Mixto Universidad de Valencia - CSIC, Valencia, Spain
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
- Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
- Physik-Institut, Universität Zürich, Zürich, Switzerland
- NSC Kharkiv Institute of Physics and Technology (NSC KIPT), Kharkiv, Ukraine
- Institute for Nuclear Research of the National Academy of Sciences (KINR), Kyiv, Ukraine
- University of Birmingham, Birmingham, United Kingdom
- H.H. Wills Physics Laboratory, University of Bristol, Bristol, United Kingdom
- Cavendish Laboratory, University of Cambridge, Cambridge, United Kingdom
- Department of Physics, University of Warwick, Coventry, United Kingdom
- STFC Rutherford Appleton Laboratory, Didcot, United Kingdom
- School of Physics and Astronomy, University of Edinburgh, Edinburgh, United Kingdom
- School of Physics and Astronomy, University of Glasgow, Glasgow, United Kingdom
- Oliver Lodge Laboratory, University of Liverpool, Liverpool, United Kingdom
- Imperial College London, London, United Kingdom
- Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
- Department of Physics, University of Oxford, Oxford, United Kingdom
- Massachusetts Institute of Technology, Cambridge, 02139 Massachusetts, USA
- University of Cincinnati, Cincinnati, 45221 Ohio, USA
- University of Maryland, College Park, 20742 Maryland, USA
- Los Alamos National Laboratory (LANL), Los Alamos, 87545 New Mexico, USA
- Syracuse University, Syracuse, 13244 New York, USA
- School of Physics and Astronomy, Monash University, Melbourne, Australia (associated with Institution Department of Physics, University of Warwick, Coventry, United Kingdom)
- Pontifícia Universidade Católica do Rio de Janeiro (PUC-Rio), Rio de Janeiro, Brazil (associated with Institution Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil)
- Physics and Micro Electronic College, Hunan University, Changsha City, China (associated with Institution Institute of Particle Physics, Central China Normal University, Wuhan, Hubei, China)
- Guangdong Provincial Key Laboratory of Nuclear Science, Guangdong-Hong Kong Joint Laboratory of Quantum Matter, Institute of Quantum Matter, South China Normal University, Guangzhou, China (associated with Institution Center for High Energy Physics, Tsinghua University, Beijing, China)
- Lanzhou University, Lanzhou, China (associated with Institution Institute Of High Energy Physics (IHEP), Beijing, China)
- School of Physics and Technology, Wuhan University, Wuhan, China (associated with Institution Center for High Energy Physics, Tsinghua University, Beijing, China)
- Departamento de Fisica, Universidad Nacional de Colombia, Bogota, Colombia (associated with Institution LPNHE, Sorbonne Université, Paris Diderot Sorbonne Paris Cité, CNRS/IN2P3, Paris, France)
- Universität Bonn - Helmholtz-Institut für Strahlen und Kernphysik, Bonn, Germany (associated with Institution Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany)
- Eotvos Lorand University, Budapest, Hungary (associated with Institution European Organization for Nuclear Research (CERN), Geneva, Switzerland)
- INFN Sezione di Perugia, Perugia, Italy (associated with Institution INFN Sezione di Ferrara, Ferrara, Italy)
- Van Swinderen Institute, University of Groningen, Groningen, Netherlands (associated with Institution Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands)
- Universiteit Maastricht, Maastricht, Netherlands (associated with Institution Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands)
- Tadeusz Kosciuszko Cracow University of Technology, Cracow, Poland (associated with Institution Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland)
- DS4DS, La Salle, Universitat Ramon Llull, Barcelona, Spain (associated with Institution ICCUB, Universitat de Barcelona, Barcelona, Spain)
- Department of Physics and Astronomy, Uppsala University, Uppsala, Sweden (associated with Institution School of Physics and Astronomy, University of Glasgow, Glasgow, United Kingdom)
- University of Michigan, Ann Arbor, 48109 Michigan, USA (associated with Institution Syracuse University, Syracuse, New York, USA)
| | - M P Blago
- Cavendish Laboratory, University of Cambridge, Cambridge, United Kingdom
| | - T Blake
- Department of Physics, University of Warwick, Coventry, United Kingdom
| | - F Blanc
- Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
| | - J E Blank
- Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
| | - S Blusk
- Syracuse University, Syracuse, 13244 New York, USA
| | - D Bobulska
- School of Physics and Astronomy, University of Glasgow, Glasgow, United Kingdom
| | - J A Boelhauve
- Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
| | - O Boente Garcia
- Laboratoire Leprince-Ringuet, CNRS/IN2P3, Ecole Polytechnique, Institut Polytechnique de Paris, Palaiseau, France
| | - T Boettcher
- University of Cincinnati, Cincinnati, 45221 Ohio, USA
| | - A Boldyrev
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - C S Bolognani
- Universiteit Maastricht, Maastricht, Netherlands (associated with Institution Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands)
| | | | - N Bondar
- Affiliated with an institute covered by a cooperation agreement with CERN
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - F Borgato
- Università degli Studi di Padova, Università e INFN, Padova, Padova, Italy
| | - S Borghi
- Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
| | - M Borsato
- Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
| | - J T Borsuk
- Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland
| | - S A Bouchiba
- Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
| | - T J V Bowcock
- Oliver Lodge Laboratory, University of Liverpool, Liverpool, United Kingdom
| | - A Boyer
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - C Bozzi
- INFN Sezione di Ferrara, Ferrara, Italy
| | - M J Bradley
- Imperial College London, London, United Kingdom
| | - S Braun
- University of Maryland, College Park, 20742 Maryland, USA
| | - A Brea Rodriguez
- Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
| | - J Brodzicka
- Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland
| | - A Brossa Gonzalo
- Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
| | - J Brown
- Oliver Lodge Laboratory, University of Liverpool, Liverpool, United Kingdom
| | - D Brundu
- INFN Sezione di Cagliari, Monserrato, Italy
| | - A Buonaura
- Physik-Institut, Universität Zürich, Zürich, Switzerland
| | - L Buonincontri
- Università degli Studi di Padova, Università e INFN, Padova, Padova, Italy
| | - A T Burke
- Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
| | - C Burr
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - A Bursche
- Guangdong Provincial Key Laboratory of Nuclear Science, Guangdong-Hong Kong Joint Laboratory of Quantum Matter, Institute of Quantum Matter, South China Normal University, Guangzhou, China (associated with Institution Center for High Energy Physics, Tsinghua University, Beijing, China)
| | - A Butkevich
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - J S Butter
- Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands
| | - J Buytaert
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - W Byczynski
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - S Cadeddu
- INFN Sezione di Cagliari, Monserrato, Italy
| | - H Cai
- School of Physics and Technology, Wuhan University, Wuhan, China (associated with Institution Center for High Energy Physics, Tsinghua University, Beijing, China)
| | | | - L Calefice
- Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
| | - S Cali
- INFN Laboratori Nazionali di Frascati, Frascati, Italy
| | - M Calvi
- INFN Sezione di Milano-Bicocca, Milano, Italy
| | - M Calvo Gomez
- DS4DS, La Salle, Universitat Ramon Llull, Barcelona, Spain (associated with Institution ICCUB, Universitat de Barcelona, Barcelona, Spain)
| | - P Campana
- INFN Laboratori Nazionali di Frascati, Frascati, Italy
| | - D H Campora Perez
- Universiteit Maastricht, Maastricht, Netherlands (associated with Institution Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands)
| | | | - S Capelli
- INFN Sezione di Milano-Bicocca, Milano, Italy
| | | | - A Carbone
- INFN Sezione di Bologna, Bologna, Italy
| | | | - A Cardini
- INFN Sezione di Cagliari, Monserrato, Italy
| | - P Carniti
- INFN Sezione di Milano-Bicocca, Milano, Italy
| | - L Carus
- I. Physikalisches Institut, RWTH Aachen University, Aachen, Germany
| | - A Casais Vidal
- Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
| | - R Caspary
- Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
| | - G Casse
- Oliver Lodge Laboratory, University of Liverpool, Liverpool, United Kingdom
| | - M Cattaneo
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - G Cavallero
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
- Imperial College London, London, United Kingdom
| | | | - S Celani
- Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
| | - J Cerasoli
- Aix Marseille Univ, CNRS/IN2P3, CPPM, Marseille, France
| | - D Cervenkov
- Department of Physics, University of Oxford, Oxford, United Kingdom
| | - A J Chadwick
- Oliver Lodge Laboratory, University of Liverpool, Liverpool, United Kingdom
| | - I Chahrour
- University of Michigan, Ann Arbor, 48109 Michigan, USA (associated with Institution Syracuse University, Syracuse, New York, USA)
| | - M G Chapman
- H.H. Wills Physics Laboratory, University of Bristol, Bristol, United Kingdom
| | - M Charles
- LPNHE, Sorbonne Université, Paris Diderot Sorbonne Paris Cité, CNRS/IN2P3, Paris, France
| | - Ph Charpentier
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - C A Chavez Barajas
- Oliver Lodge Laboratory, University of Liverpool, Liverpool, United Kingdom
| | - M Chefdeville
- Université Savoie Mont Blanc, CNRS, IN2P3-LAPP, Annecy, France
| | - C Chen
- Aix Marseille Univ, CNRS/IN2P3, CPPM, Marseille, France
| | - S Chen
- Institute of High Energy Physics (IHEP), Beijing, China
| | - A Chernov
- Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland
| | - S Chernyshenko
- Institute for Nuclear Research of the National Academy of Sciences (KINR), Kyiv, Ukraine
| | - V Chobanova
- Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
| | - S Cholak
- Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
| | - M Chrzaszcz
- Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland
| | - A Chubykin
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - V Chulikov
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - P Ciambrone
- INFN Laboratori Nazionali di Frascati, Frascati, Italy
| | - M F Cicala
- Department of Physics, University of Warwick, Coventry, United Kingdom
| | - X Cid Vidal
- Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
| | - G Ciezarek
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - P Cifra
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - G Ciullo
- INFN Sezione di Ferrara, Ferrara, Italy
| | - P E L Clarke
- School of Physics and Astronomy, University of Edinburgh, Edinburgh, United Kingdom
| | - M Clemencic
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - H V Cliff
- Cavendish Laboratory, University of Cambridge, Cambridge, United Kingdom
| | - J Closier
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - J L Cobbledick
- Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
| | - V Coco
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - J Cogan
- Aix Marseille Univ, CNRS/IN2P3, CPPM, Marseille, France
| | - E Cogneras
- Université Clermont Auvergne, CNRS/IN2P3, LPC, Clermont-Ferrand, France
| | - L Cojocariu
- Horia Hulubei National Institute of Physics and Nuclear Engineering, Bucharest-Magurele, Romania
| | - P Collins
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - T Colombo
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | | | - A Contu
- INFN Sezione di Cagliari, Monserrato, Italy
| | - N Cooke
- University of Birmingham, Birmingham, United Kingdom
| | - I Corredoira
- Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
| | - G Corti
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - B Couturier
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - D C Craik
- Physik-Institut, Universität Zürich, Zürich, Switzerland
| | - M Cruz Torres
- Centro Brasileiro de Pesquisas Físicas (CBPF), Rio de Janeiro, Brazil
| | - R Currie
- School of Physics and Astronomy, University of Edinburgh, Edinburgh, United Kingdom
| | - C L Da Silva
- Los Alamos National Laboratory (LANL), Los Alamos, 87545 New Mexico, USA
| | - S Dadabaev
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - L Dai
- Physics and Micro Electronic College, Hunan University, Changsha City, China (associated with Institution Institute of Particle Physics, Central China Normal University, Wuhan, Hubei, China)
| | - X Dai
- School of Physics State Key Laboratory of Nuclear Physics and Technology, Peking University, Beijing, China
| | - E Dall'Occo
- Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
| | - J Dalseno
- Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
| | - C D'Ambrosio
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - J Daniel
- Université Clermont Auvergne, CNRS/IN2P3, LPC, Clermont-Ferrand, France
| | - A Danilina
- Affiliated with an institute covered by a cooperation agreement with CERN
| | | | - J E Davies
- Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
| | - A Davis
- Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
| | - O De Aguiar Francisco
- Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
| | - J de Boer
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - K De Bruyn
- Van Swinderen Institute, University of Groningen, Groningen, Netherlands (associated with Institution Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands)
| | - S De Capua
- Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
| | - M De Cian
- Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
| | | | - E De Lucia
- INFN Laboratori Nazionali di Frascati, Frascati, Italy
| | - J M De Miranda
- Centro Brasileiro de Pesquisas Físicas (CBPF), Rio de Janeiro, Brazil
| | - L De Paula
- Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil
| | | | - D De Simone
- Physik-Institut, Universität Zürich, Zürich, Switzerland
| | - P De Simone
- INFN Laboratori Nazionali di Frascati, Frascati, Italy
| | - F De Vellis
- Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
| | - J A de Vries
- Universiteit Maastricht, Maastricht, Netherlands (associated with Institution Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands)
| | - C T Dean
- Los Alamos National Laboratory (LANL), Los Alamos, 87545 New Mexico, USA
| | | | - D Decamp
- Université Savoie Mont Blanc, CNRS, IN2P3-LAPP, Annecy, France
| | - V Dedu
- Aix Marseille Univ, CNRS/IN2P3, CPPM, Marseille, France
| | - L Del Buono
- LPNHE, Sorbonne Université, Paris Diderot Sorbonne Paris Cité, CNRS/IN2P3, Paris, France
| | - B Delaney
- Massachusetts Institute of Technology, Cambridge, 02139 Massachusetts, USA
| | - H-P Dembinski
- Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
| | - V Denysenko
- Physik-Institut, Universität Zürich, Zürich, Switzerland
| | - O Deschamps
- Université Clermont Auvergne, CNRS/IN2P3, LPC, Clermont-Ferrand, France
| | - F Dettori
- INFN Sezione di Cagliari, Monserrato, Italy
| | - B Dey
- Eotvos Lorand University, Budapest, Hungary (associated with Institution European Organization for Nuclear Research (CERN), Geneva, Switzerland)
| | - P Di Nezza
- INFN Laboratori Nazionali di Frascati, Frascati, Italy
| | - I Diachkov
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - S Didenko
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - L Dieste Maronas
- Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
| | - S Ding
- Syracuse University, Syracuse, 13244 New York, USA
| | - V Dobishuk
- Institute for Nuclear Research of the National Academy of Sciences (KINR), Kyiv, Ukraine
| | - A Dolmatov
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - C Dong
- Center for High Energy Physics, Tsinghua University, Beijing, China
| | - A M Donohoe
- School of Physics, University College Dublin, Dublin, Ireland
| | - F Dordei
- INFN Sezione di Cagliari, Monserrato, Italy
| | - A C Dos Reis
- Centro Brasileiro de Pesquisas Físicas (CBPF), Rio de Janeiro, Brazil
| | - L Douglas
- School of Physics and Astronomy, University of Glasgow, Glasgow, United Kingdom
| | - A G Downes
- Université Savoie Mont Blanc, CNRS, IN2P3-LAPP, Annecy, France
| | - P Duda
- Tadeusz Kosciuszko Cracow University of Technology, Cracow, Poland (associated with Institution Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland)
| | - M W Dudek
- Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland
| | - L Dufour
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - V Duk
- INFN Sezione di Perugia, Perugia, Italy (associated with Institution INFN Sezione di Ferrara, Ferrara, Italy)
| | - P Durante
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - M M Duras
- Tadeusz Kosciuszko Cracow University of Technology, Cracow, Poland (associated with Institution Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland)
| | - J M Durham
- Los Alamos National Laboratory (LANL), Los Alamos, 87545 New Mexico, USA
| | - D Dutta
- Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
| | - A Dziurda
- Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland
| | - A Dzyuba
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - S Easo
- STFC Rutherford Appleton Laboratory, Didcot, United Kingdom
| | - U Egede
- School of Physics and Astronomy, Monash University, Melbourne, Australia (associated with Institution Department of Physics, University of Warwick, Coventry, United Kingdom)
| | - V Egorychev
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - C Eirea Orro
- Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
| | - S Eisenhardt
- School of Physics and Astronomy, University of Edinburgh, Edinburgh, United Kingdom
| | - E Ejopu
- Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
| | - S Ek-In
- Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
| | - L Eklund
- Department of Physics and Astronomy, Uppsala University, Uppsala, Sweden (associated with Institution School of Physics and Astronomy, University of Glasgow, Glasgow, United Kingdom)
| | - M Elashri
- University of Cincinnati, Cincinnati, 45221 Ohio, USA
| | - J Ellbracht
- Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
| | - S Ely
- Imperial College London, London, United Kingdom
| | - A Ene
- Horia Hulubei National Institute of Physics and Nuclear Engineering, Bucharest-Magurele, Romania
| | - E Epple
- University of Cincinnati, Cincinnati, 45221 Ohio, USA
| | - S Escher
- I. Physikalisches Institut, RWTH Aachen University, Aachen, Germany
| | - J Eschle
- Physik-Institut, Universität Zürich, Zürich, Switzerland
| | - S Esen
- Physik-Institut, Universität Zürich, Zürich, Switzerland
| | - T Evans
- Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
| | - F Fabiano
- INFN Sezione di Cagliari, Monserrato, Italy
| | - L N Falcao
- Centro Brasileiro de Pesquisas Físicas (CBPF), Rio de Janeiro, Brazil
| | - Y Fan
- University of Chinese Academy of Sciences, Beijing, China
| | - B Fang
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, Orsay, France
- School of Physics and Technology, Wuhan University, Wuhan, China (associated with Institution Center for High Energy Physics, Tsinghua University, Beijing, China)
| | - L Fantini
- INFN Sezione di Perugia, Perugia, Italy (associated with Institution INFN Sezione di Ferrara, Ferrara, Italy)
| | - M Faria
- Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
| | - S Farry
- Oliver Lodge Laboratory, University of Liverpool, Liverpool, United Kingdom
| | - D Fazzini
- INFN Sezione di Milano-Bicocca, Milano, Italy
| | - L Felkowski
- Tadeusz Kosciuszko Cracow University of Technology, Cracow, Poland (associated with Institution Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland)
| | - M Feo
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - M Fernandez Gomez
- Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
| | - A D Fernez
- University of Maryland, College Park, 20742 Maryland, USA
| | - F Ferrari
- INFN Sezione di Bologna, Bologna, Italy
| | - L Ferreira Lopes
- Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
| | | | - S Ferreres Sole
- Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands
| | - M Ferrillo
- Physik-Institut, Universität Zürich, Zürich, Switzerland
| | - M Ferro-Luzzi
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - S Filippov
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - R A Fini
- INFN Sezione di Bari, Bari, Italy
| | - M Fiorini
- INFN Sezione di Ferrara, Ferrara, Italy
| | - M Firlej
- AGH - University of Science and Technology, Faculty of Physics and Applied Computer Science, Kraków, Poland
| | - K M Fischer
- Department of Physics, University of Oxford, Oxford, United Kingdom
| | - D S Fitzgerald
- University of Michigan, Ann Arbor, 48109 Michigan, USA (associated with Institution Syracuse University, Syracuse, New York, USA)
| | - C Fitzpatrick
- Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
| | - T Fiutowski
- AGH - University of Science and Technology, Faculty of Physics and Applied Computer Science, Kraków, Poland
| | - F Fleuret
- Laboratoire Leprince-Ringuet, CNRS/IN2P3, Ecole Polytechnique, Institut Polytechnique de Paris, Palaiseau, France
| | - M Fontana
- LPNHE, Sorbonne Université, Paris Diderot Sorbonne Paris Cité, CNRS/IN2P3, Paris, France
| | | | - R Forty
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - D Foulds-Holt
- Cavendish Laboratory, University of Cambridge, Cambridge, United Kingdom
| | - V Franco Lima
- Oliver Lodge Laboratory, University of Liverpool, Liverpool, United Kingdom
| | | | - M Frank
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | | | - G Frau
- Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
| | - C Frei
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - D A Friday
- School of Physics and Astronomy, University of Glasgow, Glasgow, United Kingdom
| | | | - J Fu
- University of Chinese Academy of Sciences, Beijing, China
| | - Q Fuehring
- Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
| | - T Fulghesu
- LPNHE, Sorbonne Université, Paris Diderot Sorbonne Paris Cité, CNRS/IN2P3, Paris, France
| | - E Gabriel
- Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands
| | - G Galati
- INFN Sezione di Bari, Bari, Italy
| | - M D Galati
- Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands
| | - A Gallas Torreira
- Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
| | - D Galli
- INFN Sezione di Bologna, Bologna, Italy
| | - S Gambetta
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
- School of Physics and Astronomy, University of Edinburgh, Edinburgh, United Kingdom
| | - M Gandelman
- Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil
| | - P Gandini
- INFN Sezione di Milano, Milano, Italy
| | - Y Gao
- Institute of Particle Physics, Central China Normal University, Wuhan, Hubei, China
| | - Y Gao
- School of Physics State Key Laboratory of Nuclear Physics and Technology, Peking University, Beijing, China
| | - M Garau
- INFN Sezione di Cagliari, Monserrato, Italy
| | - L M Garcia Martin
- Department of Physics, University of Warwick, Coventry, United Kingdom
| | | | | | - B Garcia Plana
- Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
| | - F A Garcia Rosales
- Laboratoire Leprince-Ringuet, CNRS/IN2P3, Ecole Polytechnique, Institut Polytechnique de Paris, Palaiseau, France
| | - L Garrido
- ICCUB, Universitat de Barcelona, Barcelona, Spain
| | - C Gaspar
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - R E Geertsema
- Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands
| | - D Gerick
- Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
| | - L L Gerken
- Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
| | - E Gersabeck
- Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
| | - M Gersabeck
- Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
| | - T Gershon
- Department of Physics, University of Warwick, Coventry, United Kingdom
| | - L Giambastiani
- Università degli Studi di Padova, Università e INFN, Padova, Padova, Italy
| | - V Gibson
- Cavendish Laboratory, University of Cambridge, Cambridge, United Kingdom
| | - H K Giemza
- National Center for Nuclear Research (NCBJ), Warsaw, Poland
| | - A L Gilman
- Department of Physics, University of Oxford, Oxford, United Kingdom
| | - M Giovannetti
- INFN Laboratori Nazionali di Frascati, Frascati, Italy
| | - A Gioventù
- Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
| | | | | | - M A Giza
- Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland
| | - K Gizdov
- School of Physics and Astronomy, University of Edinburgh, Edinburgh, United Kingdom
| | - E L Gkougkousis
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - V V Gligorov
- LPNHE, Sorbonne Université, Paris Diderot Sorbonne Paris Cité, CNRS/IN2P3, Paris, France
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - C Göbel
- Pontifícia Universidade Católica do Rio de Janeiro (PUC-Rio), Rio de Janeiro, Brazil (associated with Institution Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil)
| | - E Golobardes
- DS4DS, La Salle, Universitat Ramon Llull, Barcelona, Spain (associated with Institution ICCUB, Universitat de Barcelona, Barcelona, Spain)
| | - D Golubkov
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - A Golutvin
- Affiliated with an institute covered by a cooperation agreement with CERN
- Imperial College London, London, United Kingdom
| | - A Gomes
- Centro Brasileiro de Pesquisas Físicas (CBPF), Rio de Janeiro, Brazil
| | | | | | - M Goncerz
- Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland
| | - G Gong
- Center for High Energy Physics, Tsinghua University, Beijing, China
| | - I V Gorelov
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - C Gotti
- INFN Sezione di Milano-Bicocca, Milano, Italy
| | - J P Grabowski
- Universität Bonn - Helmholtz-Institut für Strahlen und Kernphysik, Bonn, Germany (associated with Institution Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany)
| | - T Grammatico
- LPNHE, Sorbonne Université, Paris Diderot Sorbonne Paris Cité, CNRS/IN2P3, Paris, France
| | | | - E Graugés
- ICCUB, Universitat de Barcelona, Barcelona, Spain
| | - E Graverini
- Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
| | - G Graziani
- Centro Brasileiro de Pesquisas Físicas (CBPF), Rio de Janeiro, Brazil
- Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil
- Center for High Energy Physics, Tsinghua University, Beijing, China
- Institute of High Energy Physics (IHEP), Beijing, China
- School of Physics State Key Laboratory of Nuclear Physics and Technology, Peking University, Beijing, China
- University of Chinese Academy of Sciences, Beijing, China
- Institute of Particle Physics, Central China Normal University, Wuhan, Hubei, China
- Université Savoie Mont Blanc, CNRS, IN2P3-LAPP, Annecy, France
- Université Clermont Auvergne, CNRS/IN2P3, LPC, Clermont-Ferrand, France
- Aix Marseille Univ, CNRS/IN2P3, CPPM, Marseille, France
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, Orsay, France
- Laboratoire Leprince-Ringuet, CNRS/IN2P3, Ecole Polytechnique, Institut Polytechnique de Paris, Palaiseau, France
- LPNHE, Sorbonne Université, Paris Diderot Sorbonne Paris Cité, CNRS/IN2P3, Paris, France
- I. Physikalisches Institut, RWTH Aachen University, Aachen, Germany
- Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
- Max-Planck-Institut für Kernphysik (MPIK), Heidelberg, Germany
- Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
- School of Physics, University College Dublin, Dublin, Ireland
- INFN Sezione di Bari, Bari, Italy
- INFN Sezione di Bologna, Bologna, Italy
- INFN Sezione di Ferrara, Ferrara, Italy
- INFN Sezione di Firenze, Firenze, Italy
- INFN Laboratori Nazionali di Frascati, Frascati, Italy
- INFN Sezione di Genova, Genova, Italy
- INFN Sezione di Milano, Milano, Italy
- INFN Sezione di Milano-Bicocca, Milano, Italy
- INFN Sezione di Cagliari, Monserrato, Italy
- Università degli Studi di Padova, Università e INFN, Padova, Padova, Italy
- INFN Sezione di Pisa, Pisa, Italy
- INFN Sezione di Roma La Sapienza, Roma, Italy
- INFN Sezione di Roma Tor Vergata, Roma, Italy
- Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands
- Nikhef National Institute for Subatomic Physics and VU University Amsterdam, Amsterdam, Netherlands
- AGH - University of Science and Technology, Faculty of Physics and Applied Computer Science, Kraków, Poland
- Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland
- National Center for Nuclear Research (NCBJ), Warsaw, Poland
- Horia Hulubei National Institute of Physics and Nuclear Engineering, Bucharest-Magurele, Romania
- Affiliated with an institute covered by a cooperation agreement with CERN
- ICCUB, Universitat de Barcelona, Barcelona, Spain
- Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
- Instituto de Fisica Corpuscular, Centro Mixto Universidad de Valencia - CSIC, Valencia, Spain
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
- Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
- Physik-Institut, Universität Zürich, Zürich, Switzerland
- NSC Kharkiv Institute of Physics and Technology (NSC KIPT), Kharkiv, Ukraine
- Institute for Nuclear Research of the National Academy of Sciences (KINR), Kyiv, Ukraine
- University of Birmingham, Birmingham, United Kingdom
- H.H. Wills Physics Laboratory, University of Bristol, Bristol, United Kingdom
- Cavendish Laboratory, University of Cambridge, Cambridge, United Kingdom
- Department of Physics, University of Warwick, Coventry, United Kingdom
- STFC Rutherford Appleton Laboratory, Didcot, United Kingdom
- School of Physics and Astronomy, University of Edinburgh, Edinburgh, United Kingdom
- School of Physics and Astronomy, University of Glasgow, Glasgow, United Kingdom
- Oliver Lodge Laboratory, University of Liverpool, Liverpool, United Kingdom
- Imperial College London, London, United Kingdom
- Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
- Department of Physics, University of Oxford, Oxford, United Kingdom
- Massachusetts Institute of Technology, Cambridge, 02139 Massachusetts, USA
- University of Cincinnati, Cincinnati, 45221 Ohio, USA
- University of Maryland, College Park, 20742 Maryland, USA
- Los Alamos National Laboratory (LANL), Los Alamos, 87545 New Mexico, USA
- Syracuse University, Syracuse, 13244 New York, USA
- School of Physics and Astronomy, Monash University, Melbourne, Australia (associated with Institution Department of Physics, University of Warwick, Coventry, United Kingdom)
- Pontifícia Universidade Católica do Rio de Janeiro (PUC-Rio), Rio de Janeiro, Brazil (associated with Institution Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil)
- Physics and Micro Electronic College, Hunan University, Changsha City, China (associated with Institution Institute of Particle Physics, Central China Normal University, Wuhan, Hubei, China)
- Guangdong Provincial Key Laboratory of Nuclear Science, Guangdong-Hong Kong Joint Laboratory of Quantum Matter, Institute of Quantum Matter, South China Normal University, Guangzhou, China (associated with Institution Center for High Energy Physics, Tsinghua University, Beijing, China)
- Lanzhou University, Lanzhou, China (associated with Institution Institute Of High Energy Physics (IHEP), Beijing, China)
- School of Physics and Technology, Wuhan University, Wuhan, China (associated with Institution Center for High Energy Physics, Tsinghua University, Beijing, China)
- Departamento de Fisica, Universidad Nacional de Colombia, Bogota, Colombia (associated with Institution LPNHE, Sorbonne Université, Paris Diderot Sorbonne Paris Cité, CNRS/IN2P3, Paris, France)
- Universität Bonn - Helmholtz-Institut für Strahlen und Kernphysik, Bonn, Germany (associated with Institution Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany)
- Eotvos Lorand University, Budapest, Hungary (associated with Institution European Organization for Nuclear Research (CERN), Geneva, Switzerland)
- INFN Sezione di Perugia, Perugia, Italy (associated with Institution INFN Sezione di Ferrara, Ferrara, Italy)
- Van Swinderen Institute, University of Groningen, Groningen, Netherlands (associated with Institution Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands)
- Universiteit Maastricht, Maastricht, Netherlands (associated with Institution Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands)
- Tadeusz Kosciuszko Cracow University of Technology, Cracow, Poland (associated with Institution Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland)
- DS4DS, La Salle, Universitat Ramon Llull, Barcelona, Spain (associated with Institution ICCUB, Universitat de Barcelona, Barcelona, Spain)
- Department of Physics and Astronomy, Uppsala University, Uppsala, Sweden (associated with Institution School of Physics and Astronomy, University of Glasgow, Glasgow, United Kingdom)
- University of Michigan, Ann Arbor, 48109 Michigan, USA (associated with Institution Syracuse University, Syracuse, New York, USA)
| | - A T Grecu
- Horia Hulubei National Institute of Physics and Nuclear Engineering, Bucharest-Magurele, Romania
| | - L M Greeven
- Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands
| | - N A Grieser
- University of Cincinnati, Cincinnati, 45221 Ohio, USA
| | - L Grillo
- School of Physics and Astronomy, University of Glasgow, Glasgow, United Kingdom
| | - S Gromov
- Affiliated with an institute covered by a cooperation agreement with CERN
| | | | - C Gu
- Center for High Energy Physics, Tsinghua University, Beijing, China
| | - M Guarise
- INFN Sezione di Ferrara, Ferrara, Italy
| | - M Guittiere
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, Orsay, France
| | - P A Günther
- Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
| | - E Gushchin
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - A Guth
- I. Physikalisches Institut, RWTH Aachen University, Aachen, Germany
| | - Y Guz
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - T Gys
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - T Hadavizadeh
- School of Physics and Astronomy, Monash University, Melbourne, Australia (associated with Institution Department of Physics, University of Warwick, Coventry, United Kingdom)
| | | | - G Haefeli
- Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
| | - C Haen
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - J Haimberger
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - S C Haines
- Cavendish Laboratory, University of Cambridge, Cambridge, United Kingdom
| | - T Halewood-Leagas
- Oliver Lodge Laboratory, University of Liverpool, Liverpool, United Kingdom
| | - M M Halvorsen
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - P M Hamilton
- University of Maryland, College Park, 20742 Maryland, USA
| | - J Hammerich
- Oliver Lodge Laboratory, University of Liverpool, Liverpool, United Kingdom
| | - Q Han
- Institute of Particle Physics, Central China Normal University, Wuhan, Hubei, China
| | - X Han
- Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
| | - E B Hansen
- Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
| | - S Hansmann-Menzemer
- Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
| | - L Hao
- University of Chinese Academy of Sciences, Beijing, China
| | - N Harnew
- Department of Physics, University of Oxford, Oxford, United Kingdom
| | - T Harrison
- Oliver Lodge Laboratory, University of Liverpool, Liverpool, United Kingdom
| | - C Hasse
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - M Hatch
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - J He
- University of Chinese Academy of Sciences, Beijing, China
| | - K Heijhoff
- Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands
| | - F H Hemmer
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - C Henderson
- University of Cincinnati, Cincinnati, 45221 Ohio, USA
| | - R D L Henderson
- Department of Physics, University of Warwick, Coventry, United Kingdom
- School of Physics and Astronomy, Monash University, Melbourne, Australia (associated with Institution Department of Physics, University of Warwick, Coventry, United Kingdom)
| | - A M Hennequin
- Massachusetts Institute of Technology, Cambridge, 02139 Massachusetts, USA
| | - K Hennessy
- Oliver Lodge Laboratory, University of Liverpool, Liverpool, United Kingdom
| | - L Henry
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - J Herd
- Imperial College London, London, United Kingdom
| | - J Heuel
- I. Physikalisches Institut, RWTH Aachen University, Aachen, Germany
| | - A Hicheur
- Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil
| | - D Hill
- Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
| | - M Hilton
- Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
| | - S E Hollitt
- Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
| | - J Horswill
- Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
| | - R Hou
- Institute of Particle Physics, Central China Normal University, Wuhan, Hubei, China
| | - Y Hou
- Université Savoie Mont Blanc, CNRS, IN2P3-LAPP, Annecy, France
| | - J Hu
- Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
| | - J Hu
- Guangdong Provincial Key Laboratory of Nuclear Science, Guangdong-Hong Kong Joint Laboratory of Quantum Matter, Institute of Quantum Matter, South China Normal University, Guangzhou, China (associated with Institution Center for High Energy Physics, Tsinghua University, Beijing, China)
| | - W Hu
- School of Physics State Key Laboratory of Nuclear Physics and Technology, Peking University, Beijing, China
| | - X Hu
- Center for High Energy Physics, Tsinghua University, Beijing, China
| | - W Huang
- University of Chinese Academy of Sciences, Beijing, China
| | - X Huang
- School of Physics and Technology, Wuhan University, Wuhan, China (associated with Institution Center for High Energy Physics, Tsinghua University, Beijing, China)
| | - W Hulsbergen
- Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands
| | - R J Hunter
- Department of Physics, University of Warwick, Coventry, United Kingdom
| | - M Hushchyn
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - D Hutchcroft
- Oliver Lodge Laboratory, University of Liverpool, Liverpool, United Kingdom
| | - P Ibis
- Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
| | - M Idzik
- AGH - University of Science and Technology, Faculty of Physics and Applied Computer Science, Kraków, Poland
| | - D Ilin
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - P Ilten
- University of Cincinnati, Cincinnati, 45221 Ohio, USA
| | - A Inglessi
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - A Iniukhin
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - A Ishteev
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - K Ivshin
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - R Jacobsson
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - H Jage
- I. Physikalisches Institut, RWTH Aachen University, Aachen, Germany
| | - S J Jaimes Elles
- Instituto de Fisica Corpuscular, Centro Mixto Universidad de Valencia - CSIC, Valencia, Spain
| | - S Jakobsen
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - E Jans
- Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands
| | - B K Jashal
- Instituto de Fisica Corpuscular, Centro Mixto Universidad de Valencia - CSIC, Valencia, Spain
| | - A Jawahery
- University of Maryland, College Park, 20742 Maryland, USA
| | - V Jevtic
- Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
| | - E Jiang
- University of Maryland, College Park, 20742 Maryland, USA
| | - X Jiang
- Institute of High Energy Physics (IHEP), Beijing, China
- University of Chinese Academy of Sciences, Beijing, China
| | - Y Jiang
- University of Chinese Academy of Sciences, Beijing, China
| | - M John
- Department of Physics, University of Oxford, Oxford, United Kingdom
| | - D Johnson
- Massachusetts Institute of Technology, Cambridge, 02139 Massachusetts, USA
| | - C R Jones
- Cavendish Laboratory, University of Cambridge, Cambridge, United Kingdom
| | - T P Jones
- Department of Physics, University of Warwick, Coventry, United Kingdom
| | - B Jost
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - N Jurik
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - I Juszczak
- Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland
| | - S Kandybei
- NSC Kharkiv Institute of Physics and Technology (NSC KIPT), Kharkiv, Ukraine
| | - Y Kang
- Center for High Energy Physics, Tsinghua University, Beijing, China
| | - M Karacson
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - D Karpenkov
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - M Karpov
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - J W Kautz
- University of Cincinnati, Cincinnati, 45221 Ohio, USA
| | - F Keizer
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - D M Keller
- Syracuse University, Syracuse, 13244 New York, USA
| | - M Kenzie
- Department of Physics, University of Warwick, Coventry, United Kingdom
| | - T Ketel
- Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands
| | - B Khanji
- Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
| | - A Kharisova
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - S Kholodenko
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - G Khreich
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, Orsay, France
| | - T Kirn
- I. Physikalisches Institut, RWTH Aachen University, Aachen, Germany
| | - V S Kirsebom
- Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
| | - O Kitouni
- Massachusetts Institute of Technology, Cambridge, 02139 Massachusetts, USA
| | - S Klaver
- Nikhef National Institute for Subatomic Physics and VU University Amsterdam, Amsterdam, Netherlands
| | | | - K Klimaszewski
- National Center for Nuclear Research (NCBJ), Warsaw, Poland
| | - M R Kmiec
- National Center for Nuclear Research (NCBJ), Warsaw, Poland
| | - S Koliiev
- Institute for Nuclear Research of the National Academy of Sciences (KINR), Kyiv, Ukraine
| | - L Kolk
- Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
| | - A Kondybayeva
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - A Konoplyannikov
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - P Kopciewicz
- AGH - University of Science and Technology, Faculty of Physics and Applied Computer Science, Kraków, Poland
| | - R Kopecna
- Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
| | - P Koppenburg
- Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands
| | - M Korolev
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - I Kostiuk
- Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands
| | - O Kot
- Institute for Nuclear Research of the National Academy of Sciences (KINR), Kyiv, Ukraine
| | - S Kotriakhova
- Centro Brasileiro de Pesquisas Físicas (CBPF), Rio de Janeiro, Brazil
- Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil
- Center for High Energy Physics, Tsinghua University, Beijing, China
- Institute of High Energy Physics (IHEP), Beijing, China
- School of Physics State Key Laboratory of Nuclear Physics and Technology, Peking University, Beijing, China
- University of Chinese Academy of Sciences, Beijing, China
- Institute of Particle Physics, Central China Normal University, Wuhan, Hubei, China
- Université Savoie Mont Blanc, CNRS, IN2P3-LAPP, Annecy, France
- Université Clermont Auvergne, CNRS/IN2P3, LPC, Clermont-Ferrand, France
- Aix Marseille Univ, CNRS/IN2P3, CPPM, Marseille, France
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, Orsay, France
- Laboratoire Leprince-Ringuet, CNRS/IN2P3, Ecole Polytechnique, Institut Polytechnique de Paris, Palaiseau, France
- LPNHE, Sorbonne Université, Paris Diderot Sorbonne Paris Cité, CNRS/IN2P3, Paris, France
- I. Physikalisches Institut, RWTH Aachen University, Aachen, Germany
- Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
- Max-Planck-Institut für Kernphysik (MPIK), Heidelberg, Germany
- Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
- School of Physics, University College Dublin, Dublin, Ireland
- INFN Sezione di Bari, Bari, Italy
- INFN Sezione di Bologna, Bologna, Italy
- INFN Sezione di Ferrara, Ferrara, Italy
- INFN Sezione di Firenze, Firenze, Italy
- INFN Laboratori Nazionali di Frascati, Frascati, Italy
- INFN Sezione di Genova, Genova, Italy
- INFN Sezione di Milano, Milano, Italy
- INFN Sezione di Milano-Bicocca, Milano, Italy
- INFN Sezione di Cagliari, Monserrato, Italy
- Università degli Studi di Padova, Università e INFN, Padova, Padova, Italy
- INFN Sezione di Pisa, Pisa, Italy
- INFN Sezione di Roma La Sapienza, Roma, Italy
- INFN Sezione di Roma Tor Vergata, Roma, Italy
- Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands
- Nikhef National Institute for Subatomic Physics and VU University Amsterdam, Amsterdam, Netherlands
- AGH - University of Science and Technology, Faculty of Physics and Applied Computer Science, Kraków, Poland
- Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland
- National Center for Nuclear Research (NCBJ), Warsaw, Poland
- Horia Hulubei National Institute of Physics and Nuclear Engineering, Bucharest-Magurele, Romania
- Affiliated with an institute covered by a cooperation agreement with CERN
- ICCUB, Universitat de Barcelona, Barcelona, Spain
- Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
- Instituto de Fisica Corpuscular, Centro Mixto Universidad de Valencia - CSIC, Valencia, Spain
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
- Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
- Physik-Institut, Universität Zürich, Zürich, Switzerland
- NSC Kharkiv Institute of Physics and Technology (NSC KIPT), Kharkiv, Ukraine
- Institute for Nuclear Research of the National Academy of Sciences (KINR), Kyiv, Ukraine
- University of Birmingham, Birmingham, United Kingdom
- H.H. Wills Physics Laboratory, University of Bristol, Bristol, United Kingdom
- Cavendish Laboratory, University of Cambridge, Cambridge, United Kingdom
- Department of Physics, University of Warwick, Coventry, United Kingdom
- STFC Rutherford Appleton Laboratory, Didcot, United Kingdom
- School of Physics and Astronomy, University of Edinburgh, Edinburgh, United Kingdom
- School of Physics and Astronomy, University of Glasgow, Glasgow, United Kingdom
- Oliver Lodge Laboratory, University of Liverpool, Liverpool, United Kingdom
- Imperial College London, London, United Kingdom
- Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
- Department of Physics, University of Oxford, Oxford, United Kingdom
- Massachusetts Institute of Technology, Cambridge, 02139 Massachusetts, USA
- University of Cincinnati, Cincinnati, 45221 Ohio, USA
- University of Maryland, College Park, 20742 Maryland, USA
- Los Alamos National Laboratory (LANL), Los Alamos, 87545 New Mexico, USA
- Syracuse University, Syracuse, 13244 New York, USA
- School of Physics and Astronomy, Monash University, Melbourne, Australia (associated with Institution Department of Physics, University of Warwick, Coventry, United Kingdom)
- Pontifícia Universidade Católica do Rio de Janeiro (PUC-Rio), Rio de Janeiro, Brazil (associated with Institution Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil)
- Physics and Micro Electronic College, Hunan University, Changsha City, China (associated with Institution Institute of Particle Physics, Central China Normal University, Wuhan, Hubei, China)
- Guangdong Provincial Key Laboratory of Nuclear Science, Guangdong-Hong Kong Joint Laboratory of Quantum Matter, Institute of Quantum Matter, South China Normal University, Guangzhou, China (associated with Institution Center for High Energy Physics, Tsinghua University, Beijing, China)
- Lanzhou University, Lanzhou, China (associated with Institution Institute Of High Energy Physics (IHEP), Beijing, China)
- School of Physics and Technology, Wuhan University, Wuhan, China (associated with Institution Center for High Energy Physics, Tsinghua University, Beijing, China)
- Departamento de Fisica, Universidad Nacional de Colombia, Bogota, Colombia (associated with Institution LPNHE, Sorbonne Université, Paris Diderot Sorbonne Paris Cité, CNRS/IN2P3, Paris, France)
- Universität Bonn - Helmholtz-Institut für Strahlen und Kernphysik, Bonn, Germany (associated with Institution Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany)
- Eotvos Lorand University, Budapest, Hungary (associated with Institution European Organization for Nuclear Research (CERN), Geneva, Switzerland)
- INFN Sezione di Perugia, Perugia, Italy (associated with Institution INFN Sezione di Ferrara, Ferrara, Italy)
- Van Swinderen Institute, University of Groningen, Groningen, Netherlands (associated with Institution Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands)
- Universiteit Maastricht, Maastricht, Netherlands (associated with Institution Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands)
- Tadeusz Kosciuszko Cracow University of Technology, Cracow, Poland (associated with Institution Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland)
- DS4DS, La Salle, Universitat Ramon Llull, Barcelona, Spain (associated with Institution ICCUB, Universitat de Barcelona, Barcelona, Spain)
- Department of Physics and Astronomy, Uppsala University, Uppsala, Sweden (associated with Institution School of Physics and Astronomy, University of Glasgow, Glasgow, United Kingdom)
- University of Michigan, Ann Arbor, 48109 Michigan, USA (associated with Institution Syracuse University, Syracuse, New York, USA)
| | - A Kozachuk
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - P Kravchenko
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - L Kravchuk
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - R D Krawczyk
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - M Kreps
- Department of Physics, University of Warwick, Coventry, United Kingdom
| | - S Kretzschmar
- I. Physikalisches Institut, RWTH Aachen University, Aachen, Germany
| | - P Krokovny
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - W Krupa
- AGH - University of Science and Technology, Faculty of Physics and Applied Computer Science, Kraków, Poland
| | - W Krzemien
- National Center for Nuclear Research (NCBJ), Warsaw, Poland
| | - J Kubat
- Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
| | - S Kubis
- Tadeusz Kosciuszko Cracow University of Technology, Cracow, Poland (associated with Institution Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland)
| | - W Kucewicz
- Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland
| | - M Kucharczyk
- Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland
| | - V Kudryavtsev
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - E Kulikova
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - A Kupsc
- Department of Physics and Astronomy, Uppsala University, Uppsala, Sweden (associated with Institution School of Physics and Astronomy, University of Glasgow, Glasgow, United Kingdom)
| | - D Lacarrere
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - G Lafferty
- Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
| | - A Lai
- INFN Sezione di Cagliari, Monserrato, Italy
| | - A Lampis
- INFN Sezione di Cagliari, Monserrato, Italy
| | - D Lancierini
- Physik-Institut, Universität Zürich, Zürich, Switzerland
| | - C Landesa Gomez
- Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
| | - J J Lane
- Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
| | - R Lane
- H.H. Wills Physics Laboratory, University of Bristol, Bristol, United Kingdom
| | - C Langenbruch
- I. Physikalisches Institut, RWTH Aachen University, Aachen, Germany
| | - J Langer
- Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
| | - O Lantwin
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - T Latham
- Department of Physics, University of Warwick, Coventry, United Kingdom
| | | | | | - R Le Gac
- Aix Marseille Univ, CNRS/IN2P3, CPPM, Marseille, France
| | - S H Lee
- University of Michigan, Ann Arbor, 48109 Michigan, USA (associated with Institution Syracuse University, Syracuse, New York, USA)
| | - R Lefèvre
- Université Clermont Auvergne, CNRS/IN2P3, LPC, Clermont-Ferrand, France
| | - A Leflat
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - S Legotin
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - P Lenisa
- INFN Sezione di Ferrara, Ferrara, Italy
| | - O Leroy
- Aix Marseille Univ, CNRS/IN2P3, CPPM, Marseille, France
| | - T Lesiak
- Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland
| | - B Leverington
- Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
| | - A Li
- Center for High Energy Physics, Tsinghua University, Beijing, China
| | - H Li
- Guangdong Provincial Key Laboratory of Nuclear Science, Guangdong-Hong Kong Joint Laboratory of Quantum Matter, Institute of Quantum Matter, South China Normal University, Guangzhou, China (associated with Institution Center for High Energy Physics, Tsinghua University, Beijing, China)
| | - K Li
- Institute of Particle Physics, Central China Normal University, Wuhan, Hubei, China
| | - P Li
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - P-R Li
- Lanzhou University, Lanzhou, China (associated with Institution Institute Of High Energy Physics (IHEP), Beijing, China)
| | - S Li
- Institute of Particle Physics, Central China Normal University, Wuhan, Hubei, China
| | - T Li
- Institute of High Energy Physics (IHEP), Beijing, China
| | - T Li
- Guangdong Provincial Key Laboratory of Nuclear Science, Guangdong-Hong Kong Joint Laboratory of Quantum Matter, Institute of Quantum Matter, South China Normal University, Guangzhou, China (associated with Institution Center for High Energy Physics, Tsinghua University, Beijing, China)
| | - Y Li
- Institute of High Energy Physics (IHEP), Beijing, China
| | - Z Li
- Syracuse University, Syracuse, 13244 New York, USA
| | - X Liang
- Syracuse University, Syracuse, 13244 New York, USA
| | - C Lin
- University of Chinese Academy of Sciences, Beijing, China
| | - T Lin
- STFC Rutherford Appleton Laboratory, Didcot, United Kingdom
| | - R Lindner
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - V Lisovskyi
- Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
| | - R Litvinov
- INFN Sezione di Cagliari, Monserrato, Italy
| | - G Liu
- Guangdong Provincial Key Laboratory of Nuclear Science, Guangdong-Hong Kong Joint Laboratory of Quantum Matter, Institute of Quantum Matter, South China Normal University, Guangzhou, China (associated with Institution Center for High Energy Physics, Tsinghua University, Beijing, China)
| | - H Liu
- University of Chinese Academy of Sciences, Beijing, China
| | - Q Liu
- University of Chinese Academy of Sciences, Beijing, China
| | - S Liu
- Institute of High Energy Physics (IHEP), Beijing, China
- University of Chinese Academy of Sciences, Beijing, China
| | | | - A Loi
- INFN Sezione di Cagliari, Monserrato, Italy
| | - R Lollini
- INFN Sezione di Perugia, Perugia, Italy (associated with Institution INFN Sezione di Ferrara, Ferrara, Italy)
| | - J Lomba Castro
- Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
| | - I Longstaff
- School of Physics and Astronomy, University of Glasgow, Glasgow, United Kingdom
| | - J H Lopes
- Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil
| | | | - S López Soliño
- Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
| | - G H Lovell
- Cavendish Laboratory, University of Cambridge, Cambridge, United Kingdom
| | - Y Lu
- Institute of High Energy Physics (IHEP), Beijing, China
| | | | - D Lucchesi
- Università degli Studi di Padova, Università e INFN, Padova, Padova, Italy
| | - S Luchuk
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - M Lucio Martinez
- Universiteit Maastricht, Maastricht, Netherlands (associated with Institution Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands)
| | - V Lukashenko
- Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands
- Institute for Nuclear Research of the National Academy of Sciences (KINR), Kyiv, Ukraine
| | - Y Luo
- Center for High Energy Physics, Tsinghua University, Beijing, China
| | - A Lupato
- Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
| | - E Luppi
- INFN Sezione di Ferrara, Ferrara, Italy
| | | | - K Lynch
- School of Physics, University College Dublin, Dublin, Ireland
| | - X-R Lyu
- University of Chinese Academy of Sciences, Beijing, China
| | - R Ma
- University of Chinese Academy of Sciences, Beijing, China
| | - S Maccolini
- Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
| | - F Machefert
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, Orsay, France
| | - F Maciuc
- Horia Hulubei National Institute of Physics and Nuclear Engineering, Bucharest-Magurele, Romania
| | - I Mackay
- Department of Physics, University of Oxford, Oxford, United Kingdom
| | - V Macko
- Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
| | - L R Madhan Mohan
- H.H. Wills Physics Laboratory, University of Bristol, Bristol, United Kingdom
| | - A Maevskiy
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - D Maisuzenko
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - M W Majewski
- AGH - University of Science and Technology, Faculty of Physics and Applied Computer Science, Kraków, Poland
| | - J J Malczewski
- Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland
| | - S Malde
- Department of Physics, University of Oxford, Oxford, United Kingdom
| | - B Malecki
- Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - A Malinin
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - T Maltsev
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - G Manca
- INFN Sezione di Cagliari, Monserrato, Italy
| | - G Mancinelli
- Aix Marseille Univ, CNRS/IN2P3, CPPM, Marseille, France
| | - C Mancuso
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, Orsay, France
- INFN Sezione di Milano, Milano, Italy
| | | | - D Manuzzi
- INFN Sezione di Bologna, Bologna, Italy
| | - C A Manzari
- Physik-Institut, Universität Zürich, Zürich, Switzerland
| | | | - J F Marchand
- Université Savoie Mont Blanc, CNRS, IN2P3-LAPP, Annecy, France
| | - U Marconi
- INFN Sezione di Bologna, Bologna, Italy
| | - S Mariani
- INFN Sezione di Firenze, Firenze, Italy
| | | | - J Marks
- Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
| | - A M Marshall
- H.H. Wills Physics Laboratory, University of Bristol, Bristol, United Kingdom
| | - P J Marshall
- Oliver Lodge Laboratory, University of Liverpool, Liverpool, United Kingdom
| | - G Martelli
- INFN Sezione di Perugia, Perugia, Italy (associated with Institution INFN Sezione di Ferrara, Ferrara, Italy)
| | | | - L Martinazzoli
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | | | - D Martinez Santos
- Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
| | - F Martinez Vidal
- Instituto de Fisica Corpuscular, Centro Mixto Universidad de Valencia - CSIC, Valencia, Spain
| | - A Massafferri
- Centro Brasileiro de Pesquisas Físicas (CBPF), Rio de Janeiro, Brazil
| | - M Materok
- I. Physikalisches Institut, RWTH Aachen University, Aachen, Germany
| | - R Matev
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - A Mathad
- Physik-Institut, Universität Zürich, Zürich, Switzerland
| | - V Matiunin
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - C Matteuzzi
- INFN Sezione di Milano-Bicocca, Milano, Italy
| | - K R Mattioli
- Laboratoire Leprince-Ringuet, CNRS/IN2P3, Ecole Polytechnique, Institut Polytechnique de Paris, Palaiseau, France
| | - A Mauri
- Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands
| | - E Maurice
- Laboratoire Leprince-Ringuet, CNRS/IN2P3, Ecole Polytechnique, Institut Polytechnique de Paris, Palaiseau, France
| | - J Mauricio
- ICCUB, Universitat de Barcelona, Barcelona, Spain
| | - M Mazurek
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - M McCann
- Imperial College London, London, United Kingdom
| | - L Mcconnell
- School of Physics, University College Dublin, Dublin, Ireland
| | - T H McGrath
- Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
| | - N T McHugh
- School of Physics and Astronomy, University of Glasgow, Glasgow, United Kingdom
| | - A McNab
- Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
| | - R McNulty
- School of Physics, University College Dublin, Dublin, Ireland
| | - J V Mead
- Oliver Lodge Laboratory, University of Liverpool, Liverpool, United Kingdom
| | - B Meadows
- University of Cincinnati, Cincinnati, 45221 Ohio, USA
| | - G Meier
- Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
| | - D Melnychuk
- National Center for Nuclear Research (NCBJ), Warsaw, Poland
| | - S Meloni
- INFN Sezione di Milano-Bicocca, Milano, Italy
| | - M Merk
- Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands
- Universiteit Maastricht, Maastricht, Netherlands (associated with Institution Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands)
| | - A Merli
- INFN Sezione di Milano, Milano, Italy
| | - L Meyer Garcia
- Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil
| | - D Miao
- Institute of High Energy Physics (IHEP), Beijing, China
- University of Chinese Academy of Sciences, Beijing, China
| | - M Mikhasenko
- Universität Bonn - Helmholtz-Institut für Strahlen und Kernphysik, Bonn, Germany (associated with Institution Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany)
| | - D A Milanes
- Departamento de Fisica, Universidad Nacional de Colombia, Bogota, Colombia (associated with Institution LPNHE, Sorbonne Université, Paris Diderot Sorbonne Paris Cité, CNRS/IN2P3, Paris, France)
| | - E Millard
- Department of Physics, University of Warwick, Coventry, United Kingdom
| | - M Milovanovic
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - M-N Minard
- Université Savoie Mont Blanc, CNRS, IN2P3-LAPP, Annecy, France
| | - A Minotti
- INFN Sezione di Milano-Bicocca, Milano, Italy
| | - T Miralles
- Université Clermont Auvergne, CNRS/IN2P3, LPC, Clermont-Ferrand, France
| | - S E Mitchell
- School of Physics and Astronomy, University of Edinburgh, Edinburgh, United Kingdom
| | - B Mitreska
- Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
| | - D S Mitzel
- Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
| | - A Mödden
- Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
| | - R A Mohammed
- Department of Physics, University of Oxford, Oxford, United Kingdom
| | - R D Moise
- I. Physikalisches Institut, RWTH Aachen University, Aachen, Germany
| | - S Mokhnenko
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - T Mombächer
- Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
| | - M Monk
- Department of Physics, University of Warwick, Coventry, United Kingdom
- School of Physics and Astronomy, Monash University, Melbourne, Australia (associated with Institution Department of Physics, University of Warwick, Coventry, United Kingdom)
| | - I A Monroy
- Departamento de Fisica, Universidad Nacional de Colombia, Bogota, Colombia (associated with Institution LPNHE, Sorbonne Université, Paris Diderot Sorbonne Paris Cité, CNRS/IN2P3, Paris, France)
| | - S Monteil
- Université Clermont Auvergne, CNRS/IN2P3, LPC, Clermont-Ferrand, France
| | - G Morello
- INFN Laboratori Nazionali di Frascati, Frascati, Italy
| | | | - M P Morgenthaler
- Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
| | - J Moron
- AGH - University of Science and Technology, Faculty of Physics and Applied Computer Science, Kraków, Poland
| | - A B Morris
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - A G Morris
- Department of Physics, University of Warwick, Coventry, United Kingdom
| | - R Mountain
- Syracuse University, Syracuse, 13244 New York, USA
| | - H Mu
- Center for High Energy Physics, Tsinghua University, Beijing, China
| | - E Muhammad
- Department of Physics, University of Warwick, Coventry, United Kingdom
| | - F Muheim
- School of Physics and Astronomy, University of Edinburgh, Edinburgh, United Kingdom
| | - M Mulder
- Van Swinderen Institute, University of Groningen, Groningen, Netherlands (associated with Institution Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands)
| | - K Müller
- Physik-Institut, Universität Zürich, Zürich, Switzerland
| | - C H Murphy
- Department of Physics, University of Oxford, Oxford, United Kingdom
| | - D Murray
- Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
| | - R Murta
- Imperial College London, London, United Kingdom
| | - P Muzzetto
- INFN Sezione di Cagliari, Monserrato, Italy
| | - P Naik
- H.H. Wills Physics Laboratory, University of Bristol, Bristol, United Kingdom
| | - T Nakada
- Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
| | - R Nandakumar
- STFC Rutherford Appleton Laboratory, Didcot, United Kingdom
| | - T Nanut
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - I Nasteva
- Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil
| | - M Needham
- School of Physics and Astronomy, University of Edinburgh, Edinburgh, United Kingdom
| | - N Neri
- INFN Sezione di Milano, Milano, Italy
| | - S Neubert
- Universität Bonn - Helmholtz-Institut für Strahlen und Kernphysik, Bonn, Germany (associated with Institution Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany)
| | - N Neufeld
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - P Neustroev
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - R Newcombe
- Imperial College London, London, United Kingdom
| | - J Nicolini
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, Orsay, France
- Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
| | - D Nicotra
- Universiteit Maastricht, Maastricht, Netherlands (associated with Institution Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands)
| | - E M Niel
- Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
| | - S Nieswand
- I. Physikalisches Institut, RWTH Aachen University, Aachen, Germany
| | - N Nikitin
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - N S Nolte
- Massachusetts Institute of Technology, Cambridge, 02139 Massachusetts, USA
| | - C Normand
- Université Savoie Mont Blanc, CNRS, IN2P3-LAPP, Annecy, France
- INFN Sezione di Cagliari, Monserrato, Italy
| | - J Novoa Fernandez
- Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
| | - G Nowak
- University of Cincinnati, Cincinnati, 45221 Ohio, USA
| | - C Nunez
- University of Michigan, Ann Arbor, 48109 Michigan, USA (associated with Institution Syracuse University, Syracuse, New York, USA)
| | - A Oblakowska-Mucha
- AGH - University of Science and Technology, Faculty of Physics and Applied Computer Science, Kraków, Poland
| | - V Obraztsov
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - T Oeser
- I. Physikalisches Institut, RWTH Aachen University, Aachen, Germany
| | - S Okamura
- INFN Sezione di Ferrara, Ferrara, Italy
| | - R Oldeman
- INFN Sezione di Cagliari, Monserrato, Italy
| | - F Oliva
- School of Physics and Astronomy, University of Edinburgh, Edinburgh, United Kingdom
| | - C J G Onderwater
- Van Swinderen Institute, University of Groningen, Groningen, Netherlands (associated with Institution Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands)
| | - R H O'Neil
- School of Physics and Astronomy, University of Edinburgh, Edinburgh, United Kingdom
| | | | - T Ovsiannikova
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - P Owen
- Physik-Institut, Universität Zürich, Zürich, Switzerland
| | - A Oyanguren
- Instituto de Fisica Corpuscular, Centro Mixto Universidad de Valencia - CSIC, Valencia, Spain
| | - O Ozcelik
- School of Physics and Astronomy, University of Edinburgh, Edinburgh, United Kingdom
| | - K O Padeken
- Universität Bonn - Helmholtz-Institut für Strahlen und Kernphysik, Bonn, Germany (associated with Institution Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany)
| | - B Pagare
- Department of Physics, University of Warwick, Coventry, United Kingdom
| | - P R Pais
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - T Pajero
- Department of Physics, University of Oxford, Oxford, United Kingdom
| | - A Palano
- INFN Sezione di Bari, Bari, Italy
| | - M Palutan
- INFN Laboratori Nazionali di Frascati, Frascati, Italy
| | - Y Pan
- Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
| | - G Panshin
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - L Paolucci
- Department of Physics, University of Warwick, Coventry, United Kingdom
| | - A Papanestis
- STFC Rutherford Appleton Laboratory, Didcot, United Kingdom
| | | | | | | | - W Parker
- University of Maryland, College Park, 20742 Maryland, USA
| | - C Parkes
- Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
| | | | | | | | - M Patel
- Imperial College London, London, United Kingdom
| | | | - C J Pawley
- Universiteit Maastricht, Maastricht, Netherlands (associated with Institution Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands)
| | - A Pellegrino
- Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands
| | - M Pepe Altarelli
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | | | - D Pereima
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - A Pereiro Castro
- Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
| | - P Perret
- Université Clermont Auvergne, CNRS/IN2P3, LPC, Clermont-Ferrand, France
| | - K Petridis
- H.H. Wills Physics Laboratory, University of Bristol, Bristol, United Kingdom
| | | | - A Petrov
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - S Petrucci
- School of Physics and Astronomy, University of Edinburgh, Edinburgh, United Kingdom
| | | | - H Pham
- Syracuse University, Syracuse, 13244 New York, USA
| | - A Philippov
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - R Piandani
- University of Chinese Academy of Sciences, Beijing, China
| | - L Pica
- INFN Sezione di Pisa, Pisa, Italy
| | - M Piccini
- INFN Sezione di Perugia, Perugia, Italy (associated with Institution INFN Sezione di Ferrara, Ferrara, Italy)
| | - B Pietrzyk
- Université Savoie Mont Blanc, CNRS, IN2P3-LAPP, Annecy, France
| | - G Pietrzyk
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, Orsay, France
| | - M Pili
- Department of Physics, University of Oxford, Oxford, United Kingdom
| | - D Pinci
- INFN Sezione di Roma La Sapienza, Roma, Italy
| | - F Pisani
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - M Pizzichemi
- INFN Sezione di Milano-Bicocca, Milano, Italy
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - V Placinta
- Horia Hulubei National Institute of Physics and Nuclear Engineering, Bucharest-Magurele, Romania
| | - J Plews
- University of Birmingham, Birmingham, United Kingdom
| | - M Plo Casasus
- Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
| | - F Polci
- LPNHE, Sorbonne Université, Paris Diderot Sorbonne Paris Cité, CNRS/IN2P3, Paris, France
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - M Poli Lener
- INFN Laboratori Nazionali di Frascati, Frascati, Italy
| | - A Poluektov
- Aix Marseille Univ, CNRS/IN2P3, CPPM, Marseille, France
| | - N Polukhina
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - I Polyakov
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - E Polycarpo
- Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil
| | - S Ponce
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - D Popov
- University of Chinese Academy of Sciences, Beijing, China
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - S Poslavskii
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - K Prasanth
- Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland
| | - L Promberger
- Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
| | - C Prouve
- Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
| | - V Pugatch
- Institute for Nuclear Research of the National Academy of Sciences (KINR), Kyiv, Ukraine
| | - V Puill
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, Orsay, France
| | - G Punzi
- INFN Sezione di Pisa, Pisa, Italy
| | - H R Qi
- Center for High Energy Physics, Tsinghua University, Beijing, China
| | - W Qian
- University of Chinese Academy of Sciences, Beijing, China
| | - N Qin
- Center for High Energy Physics, Tsinghua University, Beijing, China
| | - S Qu
- Center for High Energy Physics, Tsinghua University, Beijing, China
| | - R Quagliani
- Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
| | - N V Raab
- School of Physics, University College Dublin, Dublin, Ireland
| | - B Rachwal
- AGH - University of Science and Technology, Faculty of Physics and Applied Computer Science, Kraków, Poland
| | - J H Rademacker
- H.H. Wills Physics Laboratory, University of Bristol, Bristol, United Kingdom
| | | | - M Rama
- INFN Sezione di Pisa, Pisa, Italy
| | - M Ramos Pernas
- Department of Physics, University of Warwick, Coventry, United Kingdom
| | - M S Rangel
- Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil
| | - F Ratnikov
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - G Raven
- Nikhef National Institute for Subatomic Physics and VU University Amsterdam, Amsterdam, Netherlands
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - M Rebollo De Miguel
- Instituto de Fisica Corpuscular, Centro Mixto Universidad de Valencia - CSIC, Valencia, Spain
| | - F Redi
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - J Reich
- H.H. Wills Physics Laboratory, University of Bristol, Bristol, United Kingdom
| | - F Reiss
- Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
| | - C Remon Alepuz
- Instituto de Fisica Corpuscular, Centro Mixto Universidad de Valencia - CSIC, Valencia, Spain
| | - Z Ren
- Center for High Energy Physics, Tsinghua University, Beijing, China
| | - P K Resmi
- Department of Physics, University of Oxford, Oxford, United Kingdom
| | | | - A M Ricci
- INFN Sezione di Cagliari, Monserrato, Italy
| | - S Ricciardi
- STFC Rutherford Appleton Laboratory, Didcot, United Kingdom
| | - K Richardson
- Massachusetts Institute of Technology, Cambridge, 02139 Massachusetts, USA
| | - M Richardson-Slipper
- School of Physics and Astronomy, University of Edinburgh, Edinburgh, United Kingdom
| | - K Rinnert
- Oliver Lodge Laboratory, University of Liverpool, Liverpool, United Kingdom
| | - P Robbe
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, Orsay, France
| | - G Robertson
- School of Physics and Astronomy, University of Edinburgh, Edinburgh, United Kingdom
| | - A B Rodrigues
- Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
| | - E Rodrigues
- Oliver Lodge Laboratory, University of Liverpool, Liverpool, United Kingdom
| | - E Rodriguez Fernandez
- Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
| | - J A Rodriguez Lopez
- Departamento de Fisica, Universidad Nacional de Colombia, Bogota, Colombia (associated with Institution LPNHE, Sorbonne Université, Paris Diderot Sorbonne Paris Cité, CNRS/IN2P3, Paris, France)
| | - E Rodriguez Rodriguez
- Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
| | - D L Rolf
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - A Rollings
- Department of Physics, University of Oxford, Oxford, United Kingdom
| | - P Roloff
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - V Romanovskiy
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - M Romero Lamas
- Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
| | - A Romero Vidal
- Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
| | - J D Roth
- University of Michigan, Ann Arbor, 48109 Michigan, USA (associated with Institution Syracuse University, Syracuse, New York, USA)
| | - M Rotondo
- INFN Laboratori Nazionali di Frascati, Frascati, Italy
| | - M S Rudolph
- Syracuse University, Syracuse, 13244 New York, USA
| | - T Ruf
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - R A Ruiz Fernandez
- Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
| | - J Ruiz Vidal
- Instituto de Fisica Corpuscular, Centro Mixto Universidad de Valencia - CSIC, Valencia, Spain
| | - A Ryzhikov
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - J Ryzka
- AGH - University of Science and Technology, Faculty of Physics and Applied Computer Science, Kraków, Poland
| | - J J Saborido Silva
- Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
| | - N Sagidova
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - N Sahoo
- University of Birmingham, Birmingham, United Kingdom
| | - B Saitta
- INFN Sezione di Cagliari, Monserrato, Italy
| | - M Salomoni
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - C Sanchez Gras
- Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands
| | - I Sanderswood
- Instituto de Fisica Corpuscular, Centro Mixto Universidad de Valencia - CSIC, Valencia, Spain
| | | | - C Santamarina Rios
- Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
| | - M Santimaria
- INFN Laboratori Nazionali di Frascati, Frascati, Italy
| | | | - D Saranin
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - G Sarpis
- I. Physikalisches Institut, RWTH Aachen University, Aachen, Germany
| | - M Sarpis
- Universität Bonn - Helmholtz-Institut für Strahlen und Kernphysik, Bonn, Germany (associated with Institution Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany)
| | - A Sarti
- INFN Sezione di Roma La Sapienza, Roma, Italy
| | - C Satriano
- INFN Sezione di Roma La Sapienza, Roma, Italy
| | - A Satta
- INFN Sezione di Roma Tor Vergata, Roma, Italy
| | - M Saur
- Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
| | - D Savrina
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - H Sazak
- Université Clermont Auvergne, CNRS/IN2P3, LPC, Clermont-Ferrand, France
| | | | - A Scarabotto
- LPNHE, Sorbonne Université, Paris Diderot Sorbonne Paris Cité, CNRS/IN2P3, Paris, France
| | - S Schael
- I. Physikalisches Institut, RWTH Aachen University, Aachen, Germany
| | - S Scherl
- Oliver Lodge Laboratory, University of Liverpool, Liverpool, United Kingdom
| | - M Schiller
- School of Physics and Astronomy, University of Glasgow, Glasgow, United Kingdom
| | - H Schindler
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - M Schmelling
- Max-Planck-Institut für Kernphysik (MPIK), Heidelberg, Germany
| | - B Schmidt
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - S Schmitt
- I. Physikalisches Institut, RWTH Aachen University, Aachen, Germany
| | - O Schneider
- Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
| | - A Schopper
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - M Schubiger
- Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands
| | - S Schulte
- Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
| | - M H Schune
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, Orsay, France
| | - R Schwemmer
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - B Sciascia
- INFN Laboratori Nazionali di Frascati, Frascati, Italy
| | - A Sciuccati
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - S Sellam
- Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
| | - A Semennikov
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - M Senghi Soares
- Nikhef National Institute for Subatomic Physics and VU University Amsterdam, Amsterdam, Netherlands
| | - A Sergi
- INFN Sezione di Genova, Genova, Italy
| | - N Serra
- Physik-Institut, Universität Zürich, Zürich, Switzerland
| | - L Sestini
- Università degli Studi di Padova, Università e INFN, Padova, Padova, Italy
| | - A Seuthe
- Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
| | - Y Shang
- School of Physics State Key Laboratory of Nuclear Physics and Technology, Peking University, Beijing, China
| | - D M Shangase
- University of Michigan, Ann Arbor, 48109 Michigan, USA (associated with Institution Syracuse University, Syracuse, New York, USA)
| | - M Shapkin
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - I Shchemerov
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - L Shchutska
- Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
| | - T Shears
- Oliver Lodge Laboratory, University of Liverpool, Liverpool, United Kingdom
| | - L Shekhtman
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - Z Shen
- School of Physics State Key Laboratory of Nuclear Physics and Technology, Peking University, Beijing, China
| | - S Sheng
- Institute of High Energy Physics (IHEP), Beijing, China
- University of Chinese Academy of Sciences, Beijing, China
| | - V Shevchenko
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - B Shi
- University of Chinese Academy of Sciences, Beijing, China
| | - E B Shields
- INFN Sezione di Milano-Bicocca, Milano, Italy
| | - Y Shimizu
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, Orsay, France
| | - E Shmanin
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - R Shorkin
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - J D Shupperd
- Syracuse University, Syracuse, 13244 New York, USA
| | - B G Siddi
- INFN Sezione di Ferrara, Ferrara, Italy
| | | | - G Simi
- Università degli Studi di Padova, Università e INFN, Padova, Padova, Italy
| | - S Simone
- INFN Sezione di Bari, Bari, Italy
| | - M Singla
- School of Physics and Astronomy, Monash University, Melbourne, Australia (associated with Institution Department of Physics, University of Warwick, Coventry, United Kingdom)
| | - N Skidmore
- Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
| | - R Skuza
- Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
| | - T Skwarnicki
- Syracuse University, Syracuse, 13244 New York, USA
| | - M W Slater
- University of Birmingham, Birmingham, United Kingdom
| | - J C Smallwood
- Department of Physics, University of Oxford, Oxford, United Kingdom
| | - J G Smeaton
- Cavendish Laboratory, University of Cambridge, Cambridge, United Kingdom
| | - E Smith
- Physik-Institut, Universität Zürich, Zürich, Switzerland
| | - K Smith
- Los Alamos National Laboratory (LANL), Los Alamos, 87545 New Mexico, USA
| | - M Smith
- Imperial College London, London, United Kingdom
| | - A Snoch
- Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands
| | - L Soares Lavra
- Université Clermont Auvergne, CNRS/IN2P3, LPC, Clermont-Ferrand, France
| | - M D Sokoloff
- University of Cincinnati, Cincinnati, 45221 Ohio, USA
| | - F J P Soler
- School of Physics and Astronomy, University of Glasgow, Glasgow, United Kingdom
| | - A Solomin
- Affiliated with an institute covered by a cooperation agreement with CERN
- H.H. Wills Physics Laboratory, University of Bristol, Bristol, United Kingdom
| | - A Solovev
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - I Solovyev
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - R Song
- School of Physics and Astronomy, Monash University, Melbourne, Australia (associated with Institution Department of Physics, University of Warwick, Coventry, United Kingdom)
| | | | - B Souza De Paula
- Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil
| | - B Spaan
- Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
| | | | | | - E Spiridenkov
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - P Spradlin
- School of Physics and Astronomy, University of Glasgow, Glasgow, United Kingdom
| | - V Sriskaran
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - F Stagni
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - M Stahl
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - S Stahl
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - S Stanislaus
- Department of Physics, University of Oxford, Oxford, United Kingdom
| | - E N Stein
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - O Steinkamp
- Physik-Institut, Universität Zürich, Zürich, Switzerland
| | - O Stenyakin
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - H Stevens
- Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
| | - S Stone
- Syracuse University, Syracuse, 13244 New York, USA
| | - D Strekalina
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - Y Su
- University of Chinese Academy of Sciences, Beijing, China
| | - F Suljik
- Department of Physics, University of Oxford, Oxford, United Kingdom
| | - J Sun
- INFN Sezione di Cagliari, Monserrato, Italy
| | - L Sun
- School of Physics and Technology, Wuhan University, Wuhan, China (associated with Institution Center for High Energy Physics, Tsinghua University, Beijing, China)
| | - Y Sun
- University of Maryland, College Park, 20742 Maryland, USA
| | - P Svihra
- Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
| | - P N Swallow
- University of Birmingham, Birmingham, United Kingdom
| | - K Swientek
- AGH - University of Science and Technology, Faculty of Physics and Applied Computer Science, Kraków, Poland
| | - A Szabelski
- National Center for Nuclear Research (NCBJ), Warsaw, Poland
| | - T Szumlak
- AGH - University of Science and Technology, Faculty of Physics and Applied Computer Science, Kraków, Poland
| | - M Szymanski
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - Y Tan
- Center for High Energy Physics, Tsinghua University, Beijing, China
| | - S Taneja
- Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
| | - M D Tat
- Department of Physics, University of Oxford, Oxford, United Kingdom
| | - A Terentev
- Physik-Institut, Universität Zürich, Zürich, Switzerland
| | - F Teubert
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - E Thomas
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | | | - K A Thomson
- Oliver Lodge Laboratory, University of Liverpool, Liverpool, United Kingdom
| | - H Tilquin
- Imperial College London, London, United Kingdom
| | - V Tisserand
- Université Clermont Auvergne, CNRS/IN2P3, LPC, Clermont-Ferrand, France
| | - S T'Jampens
- Université Savoie Mont Blanc, CNRS, IN2P3-LAPP, Annecy, France
| | - M Tobin
- Institute of High Energy Physics (IHEP), Beijing, China
| | | | - G Tonani
- INFN Sezione di Milano, Milano, Italy
| | - X Tong
- School of Physics State Key Laboratory of Nuclear Physics and Technology, Peking University, Beijing, China
| | - D Torres Machado
- Centro Brasileiro de Pesquisas Físicas (CBPF), Rio de Janeiro, Brazil
| | - D Y Tou
- Center for High Energy Physics, Tsinghua University, Beijing, China
| | - S M Trilov
- H.H. Wills Physics Laboratory, University of Bristol, Bristol, United Kingdom
| | - C Trippl
- Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
| | - G Tuci
- University of Chinese Academy of Sciences, Beijing, China
| | - N Tuning
- Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands
| | - A Ukleja
- National Center for Nuclear Research (NCBJ), Warsaw, Poland
| | - D J Unverzagt
- Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
| | - A Usachov
- Nikhef National Institute for Subatomic Physics and VU University Amsterdam, Amsterdam, Netherlands
| | - A Ustyuzhanin
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - U Uwer
- Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
| | - A Vagner
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - V Vagnoni
- INFN Sezione di Bologna, Bologna, Italy
| | - A Valassi
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - G Valenti
- INFN Sezione di Bologna, Bologna, Italy
| | - N Valls Canudas
- DS4DS, La Salle, Universitat Ramon Llull, Barcelona, Spain (associated with Institution ICCUB, Universitat de Barcelona, Barcelona, Spain)
| | - M Van Dijk
- Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
| | - H Van Hecke
- Los Alamos National Laboratory (LANL), Los Alamos, 87545 New Mexico, USA
| | | | - C B Van Hulse
- Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
| | - M van Veghel
- Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands
| | | | - P Vazquez Regueiro
- Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
| | - C Vázquez Sierra
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - S Vecchi
- INFN Sezione di Ferrara, Ferrara, Italy
| | - J J Velthuis
- H.H. Wills Physics Laboratory, University of Bristol, Bristol, United Kingdom
| | - M Veltri
- INFN Sezione di Firenze, Firenze, Italy
| | - A Venkateswaran
- Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
| | - M Veronesi
- Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands
| | - M Vesterinen
- Department of Physics, University of Warwick, Coventry, United Kingdom
| | - D Vieira
- University of Cincinnati, Cincinnati, 45221 Ohio, USA
| | - M Vieites Diaz
- Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
| | - X Vilasis-Cardona
- DS4DS, La Salle, Universitat Ramon Llull, Barcelona, Spain (associated with Institution ICCUB, Universitat de Barcelona, Barcelona, Spain)
| | - E Vilella Figueras
- Oliver Lodge Laboratory, University of Liverpool, Liverpool, United Kingdom
| | - A Villa
- INFN Sezione di Bologna, Bologna, Italy
| | - P Vincent
- LPNHE, Sorbonne Université, Paris Diderot Sorbonne Paris Cité, CNRS/IN2P3, Paris, France
| | - F C Volle
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, Orsay, France
| | - D Vom Bruch
- Aix Marseille Univ, CNRS/IN2P3, CPPM, Marseille, France
| | - A Vorobyev
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - V Vorobyev
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - N Voropaev
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - K Vos
- Universiteit Maastricht, Maastricht, Netherlands (associated with Institution Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands)
| | - C Vrahas
- School of Physics and Astronomy, University of Edinburgh, Edinburgh, United Kingdom
| | - J Walsh
- INFN Sezione di Pisa, Pisa, Italy
| | - E J Walton
- School of Physics and Astronomy, Monash University, Melbourne, Australia (associated with Institution Department of Physics, University of Warwick, Coventry, United Kingdom)
| | - G Wan
- School of Physics State Key Laboratory of Nuclear Physics and Technology, Peking University, Beijing, China
| | - C Wang
- Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
| | - G Wang
- Institute of Particle Physics, Central China Normal University, Wuhan, Hubei, China
| | - J Wang
- School of Physics State Key Laboratory of Nuclear Physics and Technology, Peking University, Beijing, China
| | - J Wang
- Institute of High Energy Physics (IHEP), Beijing, China
| | - J Wang
- Center for High Energy Physics, Tsinghua University, Beijing, China
| | - J Wang
- School of Physics and Technology, Wuhan University, Wuhan, China (associated with Institution Center for High Energy Physics, Tsinghua University, Beijing, China)
| | - M Wang
- INFN Sezione di Milano, Milano, Italy
| | - R Wang
- H.H. Wills Physics Laboratory, University of Bristol, Bristol, United Kingdom
| | - X Wang
- Guangdong Provincial Key Laboratory of Nuclear Science, Guangdong-Hong Kong Joint Laboratory of Quantum Matter, Institute of Quantum Matter, South China Normal University, Guangzhou, China (associated with Institution Center for High Energy Physics, Tsinghua University, Beijing, China)
| | - Y Wang
- Institute of Particle Physics, Central China Normal University, Wuhan, Hubei, China
| | - Z Wang
- Physik-Institut, Universität Zürich, Zürich, Switzerland
| | - Z Wang
- Center for High Energy Physics, Tsinghua University, Beijing, China
| | - Z Wang
- University of Chinese Academy of Sciences, Beijing, China
| | - J A Ward
- Department of Physics, University of Warwick, Coventry, United Kingdom
- School of Physics and Astronomy, Monash University, Melbourne, Australia (associated with Institution Department of Physics, University of Warwick, Coventry, United Kingdom)
| | - N K Watson
- University of Birmingham, Birmingham, United Kingdom
| | - D Websdale
- Imperial College London, London, United Kingdom
| | - Y Wei
- School of Physics State Key Laboratory of Nuclear Physics and Technology, Peking University, Beijing, China
| | - B D C Westhenry
- H.H. Wills Physics Laboratory, University of Bristol, Bristol, United Kingdom
| | - D J White
- Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
| | - M Whitehead
- School of Physics and Astronomy, University of Glasgow, Glasgow, United Kingdom
| | - A R Wiederhold
- Department of Physics, University of Warwick, Coventry, United Kingdom
| | - D Wiedner
- Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
| | - G Wilkinson
- Department of Physics, University of Oxford, Oxford, United Kingdom
| | - M K Wilkinson
- University of Cincinnati, Cincinnati, 45221 Ohio, USA
| | - I Williams
- Cavendish Laboratory, University of Cambridge, Cambridge, United Kingdom
| | - M Williams
- Massachusetts Institute of Technology, Cambridge, 02139 Massachusetts, USA
| | - M R J Williams
- School of Physics and Astronomy, University of Edinburgh, Edinburgh, United Kingdom
| | - R Williams
- Cavendish Laboratory, University of Cambridge, Cambridge, United Kingdom
| | - F F Wilson
- STFC Rutherford Appleton Laboratory, Didcot, United Kingdom
| | - W Wislicki
- National Center for Nuclear Research (NCBJ), Warsaw, Poland
| | - M Witek
- Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland
| | - L Witola
- Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
| | - C P Wong
- Los Alamos National Laboratory (LANL), Los Alamos, 87545 New Mexico, USA
| | - G Wormser
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, Orsay, France
| | - S A Wotton
- Cavendish Laboratory, University of Cambridge, Cambridge, United Kingdom
| | - H Wu
- Syracuse University, Syracuse, 13244 New York, USA
| | - J Wu
- Institute of Particle Physics, Central China Normal University, Wuhan, Hubei, China
| | - K Wyllie
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - Z Xiang
- University of Chinese Academy of Sciences, Beijing, China
| | - Y Xie
- Institute of Particle Physics, Central China Normal University, Wuhan, Hubei, China
| | - A Xu
- School of Physics State Key Laboratory of Nuclear Physics and Technology, Peking University, Beijing, China
| | - J Xu
- University of Chinese Academy of Sciences, Beijing, China
| | - L Xu
- Center for High Energy Physics, Tsinghua University, Beijing, China
| | - L Xu
- Center for High Energy Physics, Tsinghua University, Beijing, China
| | - M Xu
- Department of Physics, University of Warwick, Coventry, United Kingdom
| | - Q Xu
- University of Chinese Academy of Sciences, Beijing, China
| | - Z Xu
- Université Clermont Auvergne, CNRS/IN2P3, LPC, Clermont-Ferrand, France
| | - Z Xu
- University of Chinese Academy of Sciences, Beijing, China
| | - D Yang
- Center for High Energy Physics, Tsinghua University, Beijing, China
| | - S Yang
- University of Chinese Academy of Sciences, Beijing, China
| | - X Yang
- School of Physics State Key Laboratory of Nuclear Physics and Technology, Peking University, Beijing, China
| | - Y Yang
- University of Chinese Academy of Sciences, Beijing, China
| | - Z Yang
- School of Physics State Key Laboratory of Nuclear Physics and Technology, Peking University, Beijing, China
| | - Z Yang
- University of Maryland, College Park, 20742 Maryland, USA
| | - L E Yeomans
- Oliver Lodge Laboratory, University of Liverpool, Liverpool, United Kingdom
| | - V Yeroshenko
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, Orsay, France
| | - H Yeung
- Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
| | - H Yin
- Institute of Particle Physics, Central China Normal University, Wuhan, Hubei, China
| | - J Yu
- Physics and Micro Electronic College, Hunan University, Changsha City, China (associated with Institution Institute of Particle Physics, Central China Normal University, Wuhan, Hubei, China)
| | - X Yuan
- Syracuse University, Syracuse, 13244 New York, USA
| | - E Zaffaroni
- Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
| | - M Zavertyaev
- Max-Planck-Institut für Kernphysik (MPIK), Heidelberg, Germany
| | - M Zdybal
- Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland
| | - M Zeng
- Center for High Energy Physics, Tsinghua University, Beijing, China
| | - C Zhang
- School of Physics State Key Laboratory of Nuclear Physics and Technology, Peking University, Beijing, China
| | - D Zhang
- Institute of Particle Physics, Central China Normal University, Wuhan, Hubei, China
| | - L Zhang
- Center for High Energy Physics, Tsinghua University, Beijing, China
| | - S Zhang
- Physics and Micro Electronic College, Hunan University, Changsha City, China (associated with Institution Institute of Particle Physics, Central China Normal University, Wuhan, Hubei, China)
| | - S Zhang
- School of Physics State Key Laboratory of Nuclear Physics and Technology, Peking University, Beijing, China
| | - Y Zhang
- School of Physics State Key Laboratory of Nuclear Physics and Technology, Peking University, Beijing, China
| | - Y Zhang
- Department of Physics, University of Oxford, Oxford, United Kingdom
| | - Y Zhao
- Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
| | - A Zharkova
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - A Zhelezov
- Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
| | - Y Zheng
- University of Chinese Academy of Sciences, Beijing, China
| | - T Zhou
- School of Physics State Key Laboratory of Nuclear Physics and Technology, Peking University, Beijing, China
| | - X Zhou
- University of Chinese Academy of Sciences, Beijing, China
| | - Y Zhou
- University of Chinese Academy of Sciences, Beijing, China
| | - V Zhovkovska
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, Orsay, France
| | - X Zhu
- Center for High Energy Physics, Tsinghua University, Beijing, China
| | - X Zhu
- Institute of Particle Physics, Central China Normal University, Wuhan, Hubei, China
| | - Z Zhu
- University of Chinese Academy of Sciences, Beijing, China
| | - V Zhukov
- I. Physikalisches Institut, RWTH Aachen University, Aachen, Germany
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - Q Zou
- Institute of High Energy Physics (IHEP), Beijing, China
- University of Chinese Academy of Sciences, Beijing, China
| | | | - D Zuliani
- Università degli Studi di Padova, Università e INFN, Padova, Padova, Italy
| | - G Zunica
- Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
| |
Collapse
|
194
|
Sun M, Niu W, Shi L, Lv Y, Fu B, Xia Y, Li H, Wang K, Li Y. Host response of Nicotiana benthamiana to the parasitism of five populations of root-lesion nematode, Pratylenchus coffeae, from China. J Helminthol 2023; 97:e73. [PMID: 37771040 DOI: 10.1017/s0022149x2300055x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 09/30/2023]
Abstract
In a recent survey of nematodes associated with tobacco in Shandong, China, the root-lesion nematode Pratylenchus coffeae was identified using a combination of morphology and molecular techniques. This nematode species is a serious parasite that damages a variety of plant species. The model plant benthi, Nicotiana benthamiana, is frequently used to study plant-disease interactions. However, it is not known whether this plant species is a host of P. coffeae. The objectives of this study were to evaluate the parasitism and pathogenicity of five populations of the root-lesion nematode P. coffeae on N. benthamiana.N. benthamiana seedlings with the same growth status were chosen and inoculated with 1,000 nematodes per pot. At 60 days after inoculation, the reproductive factors (Rf = final population densities (Pf)/initial population densities (Pi)) for P. coffeae in the rhizosphere of N. benthamiana were all more than 1, suggesting that N. benthamiana was a good host plant for P. coffeae.Nicotiana. benthamiana infected by P. coffeae showed weak growth, decreased tillering, high root reduction, and noticeable brown spots on the roots. Thus, we determined that the model plant N. benthamiana can be used to study plant-P. coffeae interactions.
Collapse
Affiliation(s)
- M Sun
- College of Plant Protection, Henan Agricultural University, Zhengzhou450046, P.R.China
- National Key Laboratory of Wheat and Maize Crop Science, Henan Agricultural University, Zhengzhou450046, P.R.China
| | - W Niu
- College of Plant Protection, Henan Agricultural University, Zhengzhou450046, P.R.China
| | - L Shi
- College of Plant Protection, Henan Agricultural University, Zhengzhou450046, P.R.China
| | - Y Lv
- College of Plant Protection, Henan Agricultural University, Zhengzhou450046, P.R.China
| | - B Fu
- College of Tobacco Science, Henan Agricultural University, Zhengzhou450046, P.R.China
| | - Y Xia
- College of Plant Protection, Henan Agricultural University, Zhengzhou450046, P.R.China
- State Key Laboratory of Hybrid Rice, College of Life Sciences, Wuhan University, Wuhan430072, P.R.China
| | - H Li
- College of Plant Protection, Henan Agricultural University, Zhengzhou450046, P.R.China
- National Key Laboratory of Wheat and Maize Crop Science, Henan Agricultural University, Zhengzhou450046, P.R.China
| | - K Wang
- College of Plant Protection, Henan Agricultural University, Zhengzhou450046, P.R.China
| | - Y Li
- College of Plant Protection, Henan Agricultural University, Zhengzhou450046, P.R.China
- National Key Laboratory of Wheat and Maize Crop Science, Henan Agricultural University, Zhengzhou450046, P.R.China
| |
Collapse
|
195
|
Li Y, Kim M, Pial TH, Lin Y, Cui H, Olvera de la Cruz M. Aggregation-Induced Asymmetric Charge States of Amino Acids in Supramolecular Nanofibers. J Phys Chem B 2023; 127:8176-8184. [PMID: 37721979 DOI: 10.1021/acs.jpcb.3c05598] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 09/20/2023]
Abstract
Electrostatic interactions contribute critically to the kinetic pathways and thermodynamic outcomes of peptide self-assembly involving one or more than one charged amino acids. While it is well understood in protein folding that those amino acids with acidic/basic side chains could shift their pKas when placed in a hydrophobic microenvironment, to what extent aggregation of monomeric peptide units from the bulk solution could alter their charged status and how this change in pKa values would reciprocally impact their assembly outcomes. Here, we design and analyze two solution systems containing peptide amphiphiles with hydrocarbon chains of different lengths to determine the factor of deprotonation on assembly. Our results suggest that models of supramolecular nanofibers with uniformly distributed, fully charged amino acids are oversimplified. We demonstrate, with molecular dynamics simulations, and validate with experimental results that asymmetric, different protonation states of the peptides lead to distinct nanostructures after self-assembly. The results give estimates on the electrostatic interactions in peptide amphiphiles required for their self-assembly and shed light on modeling molecular assembly systems containing charged amino acids.
Collapse
Affiliation(s)
- Y Li
- Department of Chemical and Biomolecular Engineering, Northwestern University, 2145 Sheridan Road, Evanston, Illinois 60208, United States
- Center of Computation and Theory of Soft Materials, Northwestern University, 2145 Sheridan Road, Evanston, Illinois 60208, United States
| | - M Kim
- Department of Chemical and Biomolecular Engineering and Institute for NanoBiotechnology, Johns Hopkins University, 3400 North Charles Street, Baltimore, Maryland 21218, United States
| | - T H Pial
- Center of Computation and Theory of Soft Materials, Northwestern University, 2145 Sheridan Road, Evanston, Illinois 60208, United States
- Department of Materials Science and Engineering, Northwestern University, 2220 Campus Drive, Evanston, Illinois 60208, United States
| | - Y Lin
- Center of Computation and Theory of Soft Materials, Northwestern University, 2145 Sheridan Road, Evanston, Illinois 60208, United States
- Department of Chemistry, Northwestern University, 2145 Sheridan Road, Evanston, Illinois 60208, United States
| | - H Cui
- Department of Chemical and Biomolecular Engineering and Institute for NanoBiotechnology, Johns Hopkins University, 3400 North Charles Street, Baltimore, Maryland 21218, United States
- Department of Oncology and Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, United States
| | - M Olvera de la Cruz
- Department of Chemical and Biomolecular Engineering, Northwestern University, 2145 Sheridan Road, Evanston, Illinois 60208, United States
- Center of Computation and Theory of Soft Materials, Northwestern University, 2145 Sheridan Road, Evanston, Illinois 60208, United States
- Department of Materials Science and Engineering, Northwestern University, 2220 Campus Drive, Evanston, Illinois 60208, United States
- Department of Physics and Astronomy, Northwestern University, 2145 Sheridan Road, Evanston, Illinois 60208, United States
- Department of Chemistry, Northwestern University, 2145 Sheridan Road, Evanston, Illinois 60208, United States
| |
Collapse
|
196
|
Hoogendoorn BW, Karlsson O, Xiao X, Pandey A, Mattsson SE, Ström V, Andersson RL, Li Y, Olsson RT. Cellulose nanofibers (CNFs) in the recycling of nickel and cadmium battery metals using electrodeposition. Nanoscale Adv 2023; 5:5263-5275. [PMID: 37767029 PMCID: PMC10521207 DOI: 10.1039/d3na00401e] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 06/09/2023] [Accepted: 07/11/2023] [Indexed: 09/29/2023]
Abstract
Cellulose nanofibers (CNFs) were employed in the aqueous electrodeposition of nickel and cadmium for battery metal recycling. The electrowinning of mixed Ni-Cd metal ion recycling solutions demonstrated that cadmium with a purity of over 99% could be selectively extracted while leaving the nickel in the solution. Two types of CNFs were evaluated: negatively charged CNFs (a-CNF) obtained through acid hydrolysis (-75 μeq. g-1) and positively charged CNFs (q-CNF) functionalized with quaternary ammonium groups (+85 μeq. g-1). The inclusion of CNFs in the Ni-Cd electrolytes induced growth of cm-sized dendrites in conditions where dendrites were otherwise not observed, or increased the degree of dendritic growth when it was already present to a lesser extent. The augmented dendritic growth correlated with an increase in deposition yields of up to 30%. Additionally, it facilitated the formation of easily detachable dendritic structures, enabling more efficient processing on a large scale and enhancing the recovery of the toxic cadmium metal. Regardless of the charged nature of the CNFs, both negatively and positively charged CNFs led to a significant formation of protruding cadmium dendrites. When deposited separately, dendritic growth and increased deposition yields remained consistent for the cadmium metal. However, dendrites were not observed during the deposition of nickel; instead, uniformly deposited layers were formed, albeit at lower yields (20%), when positively charged CNFs were present. This paper explores the potential of utilizing cellulose and its derivatives as the world's largest biomass resource to enhance battery metal recycling processes.
Collapse
Affiliation(s)
- B W Hoogendoorn
- Department of Fibre and Polymer Technology, School of Engineering Sciences in Chemistry, Biotechnology and Health, KTH Royal Institute of Technology Teknikringen 56 114 28 Stockholm Sweden
| | - O Karlsson
- Department of Fibre and Polymer Technology, School of Engineering Sciences in Chemistry, Biotechnology and Health, KTH Royal Institute of Technology Teknikringen 56 114 28 Stockholm Sweden
| | - X Xiao
- Department of Fibre and Polymer Technology, School of Engineering Sciences in Chemistry, Biotechnology and Health, KTH Royal Institute of Technology Teknikringen 56 114 28 Stockholm Sweden
| | - A Pandey
- Department of Fibre and Polymer Technology, School of Engineering Sciences in Chemistry, Biotechnology and Health, KTH Royal Institute of Technology Teknikringen 56 114 28 Stockholm Sweden
| | - S E Mattsson
- SAFT AB Jungnergatan 25 572 32 Oskarshamn Sweden
| | - V Ström
- Department of Material Science and Engineering, School of Industrial Engineering and Management, KTH Royal Institute of Technology Brinellvägen 23 SE-100 24 Stockholm Sweden
| | - R L Andersson
- Department of Fibre and Polymer Technology, School of Engineering Sciences in Chemistry, Biotechnology and Health, KTH Royal Institute of Technology Teknikringen 56 114 28 Stockholm Sweden
| | - Y Li
- Department of Fibre and Polymer Technology, School of Engineering Sciences in Chemistry, Biotechnology and Health, KTH Royal Institute of Technology Teknikringen 56 114 28 Stockholm Sweden
| | - R T Olsson
- Department of Fibre and Polymer Technology, School of Engineering Sciences in Chemistry, Biotechnology and Health, KTH Royal Institute of Technology Teknikringen 56 114 28 Stockholm Sweden
| |
Collapse
|
197
|
Huang Y, Gao S, Li Y. [The first imported case of visceral leishmaniasis in Shenzhen City]. Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi 2023; 35:424-426. [PMID: 37926481 DOI: 10.16250/j.32.1374.2023105] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Subscribe] [Scholar Register] [Indexed: 11/07/2023]
Abstract
A patient with fever, chills, and pancytopenia as major clinical manifestations was presented. To investigate the cause, the patient's peripheral blood was collected for pathogen screening using metagenomic next - generation sequencing (mNGS). The DNA sequence of Leishmania donovani was detected, and Leishmania amastigotes were found in bone marrow smears using microscopy. The case was therefore definitively diagnosed as visceral leishmaniasis, and was cured and discharged from hospital following treatment with liposomal amphotericin B for 14 days. This is the first imported case of visceral leishmaniasis since the founding of Shenzhen City in 1979.
Collapse
Affiliation(s)
- Y Huang
- Nanshan District Center for Disease Control and Prevention, Shenzhen, Guangdong 518054, China
| | - S Gao
- Shenzhen Center for Disease Control and Prevention, Shenzhen, Guangdong 518055, China
| | - Y Li
- Shenzhen Center for Disease Control and Prevention, Shenzhen, Guangdong 518055, China
| |
Collapse
|
198
|
Zheng ZQ, Liu YY, Luo WW, Zhang HW, Wang YY, Wang H, Li XM, Chen HP, Li Y, Jin WD, Huang H, Guan YT, Zhang HM, Li SK, Ren JA, Wang PG. [Investigation and factor analysis of postoperative surgical site infections in emergency abdominal surgery in China from 2018 to 2021 based on Chinese SSI Surveillance]. Zhonghua Wei Chang Wai Ke Za Zhi 2023; 26:827-836. [PMID: 37709690 DOI: 10.3760/cma.j.cn441530-20230619-00216] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Subscribe] [Scholar Register] [Indexed: 09/16/2023]
Abstract
Objective: We investigated the incidence of surgical site infection (SSI) following emergency abdominal surgery (EAS) in China and further explored its risk factors, providing a reference for preventing and controlling SSI after EAS. Methods: This was an observational study. Data of patients who had undergone EAS and been enrolled in the Chinese SSI Surveillance Program during 2018-2021were retrospectively analyzed. All included patients had been followed up for 30 days after surgery. The analyzed data consisted of relevant patient characteristics and perioperative clinical data, including preoperative hemoglobin, albumin, and blood glucose concentrations, American Society of Anesthesiologists (ASA) score, grade of surgical incision, intestinal preparation, skin preparation, location of surgical site, approach, and duration. The primary outcome was the incidence of SSI occurring within 30 days following EAS. SSI was defined as both superficial and deep incisional infections and organ/space infections, diagnoses being supported by results of microbiological culture of secretions and pus. Secondary outcomes included 30-day postoperative mortality rates, length of stay in the intensive care unit (ICU), duration of postoperative hospitalization, and associated costs. The patients were classified into two groups, SSI and non-SSI, based on whether an infection had been diagnosed. Univariate and multivariate logistic regression analyses were performed to identify risk factors associated with SSI following EAS. Results: The study cohort comprised 5491 patients who had undergone EAS, comprising 3169 male and 2322 female patients. SSIs were diagnosed in 168 (3.1%) patients after EAS (SSI group); thus, the non-SSI group consisted of 5323 patients. The SSIs comprised superficial incision infections in 69 (41.1%), deep incision infections in 51 (30.4%), and organ or space infections in 48 (28.6%). Cultures of secretions and pus were positive in 115 (68.5%) cases. The most frequently detected organism was Escherichia coli (47/115; 40.9%). There were no significant differences in sex or body mass index between the SSI and non-SSI groups (both P>0.05). However, the proportion of individuals aged 60 years or older was significantly greater in the SSI than in the non-SSI group (49.4% [83/168] vs. 27.5% [1464/5323), χ2=38.604, P<0.001). Compared with the non-SSI group, the SSI group had greater proportions of patients with diabetes (11.9% [20/168] vs. 4.8% [258/5323], χ2=16.878, P<0.001), hypertension (25.6% [43/168] vs. 12.2% [649/5323], χ2=26.562, P<0.001); hemoglobin <110 g/L (27.4% [46/168] vs. 13.1% [697/5323], χ2=28.411, P<0.001), and albuminemia <30 g/L (24.4% [41/168] vs. 5.9% [316/5323], χ2=91.352, P<0.001), and a reduced rate of preoperative skin preparation (66.7% [112/168] vs. 75.9% [4039/5323], χ2=7.491, P=0.006). Furthermore, fewer patients in the SSI group had preoperative ASA scores of between one and two (56.0% [94/168] vs. 88.7% [4724/5323], χ2=162.869, P<0.001) in the non-SSI group. The incidences of contaminated and infected incisions were greater in the SSI group (63.1% [106/168] vs. 38.6% [2056/5323], χ2=40.854, P<0.001). There was a significant difference in surgical site distribution between the SSI and non-SSI groups (small intestine 29.8% [50/168] vs. 10.6% [565/5323], colorectal 26.2% [44/168] vs. 5.6% [298/5 323], and appendix 24.4% [41/168] vs. 65.1% [3465/5323]) χ2=167.897, P<0.001), respectively. There was a significantly lower proportion of laparoscope or robotic surgery in the non-SSI group (24.4 % [41/168] vs. 74.2% [3949/5323], χ2=203.199, P<0.001); the percentage of operations of duration less than 2 hours was significantly lower in the SSI than non-SSI group (35.7% [60/168] vs. 77.4% [4119/5323], χ2=155.487, P<0.001). As to clinical outcomes, there was a higher 30-day postoperative mortality rate (3.0%[5/168] vs. 0.2%[10/5323], χ2=36.807, P<0.001) and higher postoperative ICU occupancy rate (41.7% [70/168] vs. 19.7% [1046/5323], χ2=48.748, P<0.001) in the SSI group. The median length of stay in the ICU (0[2] vs. 0[0] days, U=328597.000, P<0.001), median total length of stay after surgery (16[13] vs. 6[5] days, U=128146.000, P<0.001), and median hospitalization cost (ten thousand yuan, 4.7[4.4] vs. 1.7[1.8], U=175965.000, P<0.001) were all significantly greater in the SSI group. Multivariate logistic regression analysis revealed that the absence of skin preparation before surgery (OR=2.435,95%CI: 1.690-3.508, P<0.001), preoperative albuminemia <30 g/L (OR=1.680, 95%CI: 1.081-2.610, P=0.021), contaminated or infected incisions (OR=3.031, 95%CI: 2.151-4.271, P<0.001), and laparotomy (OR=3.436, 95% CI: 2.123-5.564, P<0.001) were independent risk factors of SSI. Operative duration less than 2 hours (OR=0.465, 95%CI: 0.312-0.695, P<0.001) and ASA score of 1-2 (OR=0.416, 95% CI: 0.289-0.601, P<0.001) were identified as independent protective factors for SSI. Conclusions: It is important to consider the nutritional status in the perioperative period of patients undergoing EAS. Preoperative skin preparation should be conducted and, whenever possible, laparoscope or robot-assisted surgery. Duration of surgery should be as short as possible while maintaining surgery quality and improving patient care.
Collapse
Affiliation(s)
- Z Q Zheng
- Department of Emergency Surgery, The Affiliated Hospital of Qingdao University, Qingdao 266000, China
| | - Y Y Liu
- Department of Emergency Surgery, The Affiliated Hospital of Qingdao University, Qingdao 266000, China
| | - W W Luo
- Department of Emergency Surgery, The Affiliated Hospital of Qingdao University, Qingdao 266000, China
| | - H W Zhang
- Department of Emergency Surgery, The Affiliated Hospital of Qingdao University, Qingdao 266000, China
| | - Y Y Wang
- Department of Emergency Surgery, The Affiliated Hospital of Qingdao University, Qingdao 266000, China
| | - H Wang
- Department of Gastrointestinal Surgery, The Affiliated Hospital of Qingdao University, Qingdao 266000, China
| | - X M Li
- Department of Hepatopancreatobiliary Surgery, Zhengzhou Central Hospital Affiliated to Zhengzhou University, Zhengzhou 450007, China
| | - H P Chen
- Department of Nosocomial Infection Management, Jinchen General Hospital, Jinchen 048006, China
| | - Y Li
- Department of General Surgery, Zigong First People's Hospital, Zigong 643000, China
| | - W D Jin
- Department of General Surgery, General Hospital of Central Theater Command of PLA, Wuhan 430070, China
| | - H Huang
- Department of General Surgery, The First Hospital of Shanxi Medical University, Taiyuan 030001, China
| | - Y T Guan
- Department of Emergency Surgery, The Affiliated Hospital of Qingdao University, Qingdao 266000, China
| | - H M Zhang
- Department of Emergency Surgery, The Affiliated Hospital of Qingdao University, Qingdao 266000, China
| | - S K Li
- Department of Emergency Surgery, The Affiliated Hospital of Qingdao University, Qingdao 266000, China
| | - J A Ren
- Research Institute of General Surgery, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing 210002, China
| | - P G Wang
- Department of Emergency Surgery, The Affiliated Hospital of Qingdao University, Qingdao 266000, China
| |
Collapse
|
199
|
Zuo Y, Xu M, Li Y, Wang S, Zhou S, Luo H. [Construction of a schistosomiasis transmission risk assessment system in Wuhan City based on analytic hierarchy process]. Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi 2023; 35:374-378. [PMID: 37926472 DOI: 10.16250/j.32.1374.2022244] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Subscribe] [Scholar Register] [Indexed: 11/07/2023]
Abstract
OBJECTIVE To construct a schistosomiasis transmission risk assessment system in Wuhan City and preliminary evaluate its application effect, so as to promote the rational allocation of schistosomiasis control resources and accelerate the progress towards schistosomiasis elimination. METHODS The schistosomiasis risk assessment indicators were collected through referring schistosomiasis surveillance data of Wuhan City from 2014 to 2020, literature review and expert interviews. Indicators within each criterion and sub-criterion were screened using the Delphi method, and a hierarchical structure model was created based on analytic hierarchy process. Quantitative assignment of each indicator was conducted according to relative importance, and the weight and combination weight of each criterion were calculated in each analytic hierarchy framework to create a schistosomiasis transmission risk assessment system, which was used for the schistosomiasis transmission risk assessment in 12 national schistosomiasis surveillance sites in Wuhan City. RESULTS A three-level schistosomiasis transmission risk assessment system was preliminarily constructed, which included a target layer, 5 criterion layers and 21 sub-criterion layers. Of all indicators in the criterion layer, transmission route had the highest weight (0.433), followed by source of Schistosoma japonicum infection (0.294); and among all indicators in the sub-criterion layer, S. japonicum infection in Oncomelania hupensis and sentinel mice had the highest combination weight (0.125), followed by prevalence of S. japonicum infection in humans (0.091) and bovines (0.053), snail control by chemical treatment (0.049), positive rate of inquiry examinations (0.048), allocation of schistosomiasis control professionals (0.045), and areas of submerged snail-infested settings (0.041). Of the 12 national schistosomiasis surveillance sites in Wuhan City, there were 5 sites with weights of > 0.8, 4 sites with weights of 0.6 to 0.8, and 3 sites with weights of < 0.6 in 2020. CONCLUSIONS A schistosomiasis transmission risk assessment system has been constructed based on analytic hierarchy process in Wuhan City, which may provide a evidence-based basis for health resource allocation and decision-making for schistosomiasis control.
Collapse
Affiliation(s)
- Y Zuo
- Institute of Schistosomiasis Control, Wuhan Municipal Center for Disease Control and Prevention, Wuhan, Hubei 430015, China
| | - M Xu
- Institute of Schistosomiasis Control, Wuhan Municipal Center for Disease Control and Prevention, Wuhan, Hubei 430015, China
| | - Y Li
- Institute of Schistosomiasis Control, Wuhan Municipal Center for Disease Control and Prevention, Wuhan, Hubei 430015, China
| | - S Wang
- Institute of Schistosomiasis Control, Wuhan Municipal Center for Disease Control and Prevention, Wuhan, Hubei 430015, China
| | - S Zhou
- Institute of Schistosomiasis Control, Wuhan Municipal Center for Disease Control and Prevention, Wuhan, Hubei 430015, China
| | - H Luo
- Institute of Schistosomiasis Control, Wuhan Municipal Center for Disease Control and Prevention, Wuhan, Hubei 430015, China
| |
Collapse
|
200
|
Gao Y, Zhao YJ, Li Y, Song JN, Zhang XZ, Sun Y, Yu M, Zhou Q. [The predictive value of melanin-concentrating hormone combined with other related biomarkers in cerebrospinal fluid in preoperative cognitive dysfunction of elderly patients]. Zhonghua Yi Xue Za Zhi 2023; 103:2772-2777. [PMID: 37723051 DOI: 10.3760/cma.j.cn112137-20230119-00112] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Subscribe] [Scholar Register] [Indexed: 09/20/2023]
Abstract
Objective: To explore the predictive value of cerebrospinal fluid melanin-concentrating hormone (MCH) combined with other related biomarkers in preoperative cognitive dysfunction of elderly patients. Methods: A total of 80 patients who underwent elective hip or knee replacement under intravertebral anesthesia in Chifeng Municipal Hospital, Inner Mongolia, from March to November 2022 were prospectively included, with 32 males and 48 females, and aged 65-85 (70.7±5.2) years old. According to the evaluation results of the Montreal Cognitive Assessment (MoCA), patients were divided into the preoperative cognitive dysfunction (n=23) and control (n=57) groups. The levels of MCH, amyloid-β 40 (Aβ40), amyloid-β 42 (Aβ42), and phosphorylated tau protein (p-tau) in cerebrospinal fluid were determined by enzyme-linked immunosorbent assay (ELISA). The receiver operating characteristic (ROC) curve was drawn to evaluate the predictive value of each biomarker separately or in combination for preoperative cognitive dysfunction. Spearman's rank correlation analysis was utilized to test the correlation between the level of each biomarker and MoCA scores. Results: The levels of MCH, Aβ40, Aβ42, p-tau, and Aβ42/p-tau in the preoperative cognitive dysfunction group were (35.53±5.94) μg/L, (39.21±9.18) ng/L, (221.83±43.17) ng/L, (42.64±9.74) ng/L, and 5.53±1.92, and the levels of these biomarkers in the control group were (28.74±4.90) μg/L, (36.37±7.87) ng/L, (280.23±45.67) ng/L, (35.00±9.27) ng/L, and 8.62±2.78, respectively. Compared with the control group, the levels of cerebrospinal fluid MCH and p-tau in the preoperative cognitive dysfunction group were significantly increased (all P<0.01), and the levels of Aβ42 and Aβ42/p-tau were significantly decreased (all P<0.001). MCH and Aβ42/p-tau provided higher predictive values. The area under the curve (AUC) of MCH and Aβ42/p-tau were 0.807 (95%CI: 0.703-0.911) and 0.842 (95%CI: 0.741-0.943), the sensitivity were 78.3% and 87.0%, and the specificity were 75.4% and 94.7%. MCH combined with Aβ42/p-tau have the higher AUC of 0.915 (95%CI: 0.837-0.992), the sensitivity (87.0%) and specificity (86.0%) were both high, which had a higher predictive value. The levels of cerebrospinal fluid MCH and p-tau were negatively correlated with MoCA score (r=-0.467, -0.321, all P<0.01), and the levels of Aβ42 and Aβ42/p-tau were positively correlated with MoCA score (r=0.480, 0.520, all P<0.001). Conclusion: The increase in cerebrospinal fluid MCH levels is associated with preoperative cognitive dysfunction in elderly patients. MCH combined with Aβ42/p-tau has the greatest predictive value.
Collapse
Affiliation(s)
- Y Gao
- Chifeng Clinical Medical College of Inner Mongolia Medical University, Chifeng 024000, China
| | - Y J Zhao
- Chifeng Clinical Medical College of Inner Mongolia Medical University, Chifeng 024000, China
| | - Y Li
- Department of Anesthesiology, Tianjin Medical University General Hospital, Tianjin Research Institute of Anesthesiology, Tianjin 300052, China
| | - J N Song
- Department of Anesthesiology, Chifeng Municipal Hospital of Inner Mongolia, Chifeng 024000, China
| | - X Z Zhang
- Department of Anesthesiology, Chifeng Municipal Hospital of Inner Mongolia, Chifeng 024000, China
| | - Y Sun
- Department of Anesthesiology, Chifeng Municipal Hospital of Inner Mongolia, Chifeng 024000, China
| | - M Yu
- Department of Anesthesiology, Chifeng Municipal Hospital of Inner Mongolia, Chifeng 024000, China
| | - Q Zhou
- Department of Anesthesiology, Chifeng Municipal Hospital of Inner Mongolia, Chifeng 024000, China
| |
Collapse
|